10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2023

Or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                      to                     

(Commission File Number) 001-39317 

ON SEMICONDUCTOR CORPORATION

(Exact name of registrant as specified in its charter)  

Delaware	36-3840979
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

5701 N. Pima Road

Scottsdale, AZ 85250

(602) 244-6600

(Address, zip code and telephone number, including area code, of principal executive offices)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.01 per share	ON	The Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes  x    No  o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act

Large Accelerated Filer	☒	Accelerated filer	☐
Non-accelerated filer	☐	Smaller reporting company	☐
		Emerging growth company	☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes  ☐    No  x

The number of shares outstanding of the issuer's class of common stock as of the close of business on April 26, 2023:

Title of Each Class	Number of Shares
Common Stock, par value $0.01 per share	431,872,829

ON SEMICONDUCTOR CORPORATION FORM 10-Q

TABLE OF CONTENTS

 

Part I: Financial Information
	Item 1. Financial Statements (unaudited)	4
	Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations	27
	Item 3. Quantitative and Qualitative Disclosures About Market Risk	32
	Item 4. Controls and Procedures	32
Part II: Other Information
	Item 1. Legal Proceedings	34
	Item 1A. Risk Factors	34
	Item 2. Unregistered Sales of Equity Securities and Use of Proceeds	35
	Item 3. Defaults Upon Senior Securities	35
	Item 4. Mine Safety Disclosures	35
	Item 5. Other Information	35
	Item 6. Exhibits	36
	Signatures	37

(See the glossary of selected terms immediately following this table of contents for definitions of certain abbreviated terms)

ON SEMICONDUCTOR CORPORATION

FORM 10-Q

GLOSSARY OF SELECTED ABBREVIATED TERMS*

Abbreviated Term	Defined Term
0% Notes	0% Convertible Senior Notes due 2027
0.50% Notes	0.50% Convertible Senior Notes due 2029
1.625% Notes	1.625% Convertible Senior Notes due 2023
3.875% Notes	3.875% Senior Notes due 2028
ADAS	Advanced driver-assistance systems
Amended Credit Agreement	Credit Agreement, dated as of April 15, 2016, as subsequently amended, by and among the Company, as borrower, the several lenders party thereto, Deutsche Bank AG, New York Branch, as administrative agent and collateral agent, and certain other parties, providing for the Revolving Credit Facility and the Term Loan “B” Facility
Amended and Restated SIP	ON Semiconductor Corporation Amended and Restated Stock Incentive Plan, as amended
ASU	Accounting Standards Update
Commission or SEC	Securities and Exchange Commission
EFK	East Fishkill, New York fabrication facility
ESPP	ON Semiconductor Corporation 2000 Employee Stock Purchase Plan, as amended
Exchange Act	Securities Exchange Act of 1934, as amended
FASB	Financial Accounting Standards Board
GTAT	GT Advanced Technologies Inc.
IP	Intellectual property
IRS	United States Internal Revenue Service
IT	Information Technology
OEM	Original Equipment Manufacturer
QCS	Division within ASG, primarily associated with the legacy Quantenna division
Revolving Credit Facility	A $1.97 billion revolving credit facility created pursuant to the Amended Credit Agreement
ROU	Right-of-use
RSU	Restricted stock unit
SiC	Silicon carbide
Securities Act	Securities Act of 1933, as amended
Term Loan "B" Facility	A $2.4 billion term loan "B" facility created pursuant to the Amended Credit Agreement
U.S. or United States	United States of America

* Terms used, but not defined, within the body of the Form 10-Q are defined in this Glossary.

PART I: FINANCIAL INFORMATION

Item 1. Financial Statements (unaudited)

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED BALANCE SHEETS

(in millions, except share and per share data)

(unaudited)

	March 31, 2023		December 31, 2022
Assets
Cash and cash equivalents	$	2,702.4	$	2,919.0
Receivables, net	880.9		842.3
Inventories	1,814.9		1,616.8
Other current assets	318.1		351.3
Total current assets	5,716.3		5,729.4
Property, plant and equipment, net	3,692.9		3,450.7
Goodwill	1,577.6		1,577.6
Intangible assets, net	339.8		359.7
Deferred tax assets	473.1		376.7
Right-of-use financing lease	45.2		45.8
Other assets	429.4		438.6
Total assets	$	12,274.3	$	11,978.5
Liabilities and Stockholders’ Equity
Accounts payable	$	976.2	$	852.1
Accrued expenses and other current liabilities	666.0		1,047.3
Current portion of financing lease liabilities	11.6		14.2
Current portion of long-term debt	926.2		147.8
Total current liabilities	2,580.0		2,061.4
Long-term debt	2,538.0		3,045.7
Deferred tax liabilities	36.6		34.1
Long-term financing lease liabilities	24.0		23.0
Other long-term liabilities	628.7		607.3
Total liabilities	5,807.3		5,771.5
Commitments and contingencies (Note 9)
ON Semiconductor Corporation stockholders’ equity:
Common stock ($0.01 par value, 1,250,000,000 shares authorized, 610,278,043 and 608,367,713 issued, 431,851,090 and 431,936,415 outstanding, respectively)	6.1		6.1
Additional paid-in capital	4,633.6		4,670.9
Accumulated other comprehensive loss	(29.6)		(23.2)
Accumulated earnings	4,826.1		4,364.4
Less: Treasury stock, at cost: 178,426,953 and 176,431,298 shares, respectively	(2,988.2)		(2,829.7)
Total ON Semiconductor Corporation stockholders’ equity	6,448.0		6,188.5
Non-controlling interest	19.0		18.5
Total stockholders’ equity	6,467.0		6,207.0
Total liabilities and stockholders’ equity	$	12,274.3	$	11,978.5

See accompanying notes to consolidated financial statements

4

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME

(in millions, except per share data)

(unaudited)

	Quarters Ended
	March 31, 2023		April 1, 2022
Revenue	$	1,959.7	$	1,945.0
Cost of revenue	1,042.2		983.7
Gross profit	917.5		961.3
Operating expenses:
Research and development	138.4		156.8
Selling and marketing	71.8		71.1
General and administrative	75.9		77.9
Amortization of acquisition-related intangible assets	15.0		21.3
Restructuring, asset impairments and other charges, net	51.5		(13.0)
Total operating expenses	352.6		314.1
Operating income	564.9		647.2
Other income (expense), net:
Interest expense	(26.4)		(21.6)
Interest income	17.1		0.4
Loss on debt prepayment	(13.3)		—
Loss on divestiture of business	(1.1)		—
Other income	4.7		2.1
Other income (expense), net	(19.0)		(19.1)
Income before income taxes	545.9		628.1
Income tax provision	(83.7)		(97.1)
Net income	462.2		531.0
Less: Net income attributable to non-controlling interest	(0.5)		(0.8)
Net income attributable to ON Semiconductor Corporation	$	461.7	$	530.2
Net income for diluted earnings per share of common stock (Note 7)	462.1		530.7
Net income per share of common stock attributable to ON Semiconductor Corporation:
Basic	$	1.07	$	1.22
Diluted	$	1.03	$	1.18
Weighted-average shares of common stock outstanding:
Basic	431.9		433.3
Diluted	448.5		448.9
Comprehensive income (loss), net of tax:
Net income	$	462.2	$	531.0
Foreign currency translation adjustments	0.3		(2.4)
Effects of cash flow hedges and other adjustments	(6.7)		16.6
Other comprehensive income (loss), net of tax	(6.4)		14.2
Comprehensive income	455.8		545.2
Comprehensive income attributable to non-controlling interest	(0.5)		(0.8)
Comprehensive income attributable to ON Semiconductor Corporation	$	455.3	$	544.4

See accompanying notes to consolidated financial statements

5

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

(in millions, except share data) 

(unaudited)

	Common Stock			Additional Paid-in Capital		Accumulated Other Comprehensive Loss				Treasury Stock			Non-Controlling Interest
	Number of shares	At Par Value						Accumulated Earnings		Number of shares	At Cost				Total Equity
Balance at December 31, 2022	608,367,713	$	6.1	$	4,670.9	$	(23.2)	$	4,364.4	(176,431,298)	$	(2,829.7)	$	18.5	$	6,207.0
Shares issued pursuant to the ESPP	136,856	—		7.3		—		—		—	—		—		7.3
RSUs released and stock grant awards issued	1,680,376	—		—		—		—		—	—		—		—
Partial settlement - 1.625% Notes	93,098	—		—		—		—		—	—		—		—
Partial settlement of bond hedges - 1.625% Notes	—	—		6.9		—		—		(93,098)	(6.9)		—		—
Warrants and bond hedges, net - 0.50% Notes	—	—		(171.5)		—		—		—	—		—		(171.5)
Tax impact of warrants and bond hedges, net	—	—		92.3		—		—		—	—		—		92.3
Payment of tax withholding for RSUs	—	—		—		—		—		(578,406)	(47.6)		—		(47.6)
Share-based compensation	—	—		27.7		—		—		—	—		—		27.7
Repurchase of common stock	—	—		—		—		—		(1,324,151)	(104.0)		—		(104.0)
Comprehensive income (loss)	—	—		—		(6.4)		461.7		—	—		0.5		455.8
Balance at March 31, 2023	610,278,043	$	6.1	$	4,633.6	$	(29.6)	$	4,826.1	(178,426,953)	$	(2,988.2)	$	19.0	$	6,467.0

Balance at December 31, 2021	603,044,079	$	6.0	$	4,633.3	$	(40.6)	$	2,435.1	(170,571,261)	$	(2,448.4)	$	19.0	$	4,604.4
Impact of the adoption of ASU 2020-06	—	—		(129.1)		—		27.1		—	—		—		(102.0)
Shares issued pursuant to the ESPP	126,388	—		6.7		—		—		—	—		—		6.7
RSUs released and stock grant awards issued	2,851,188	0.1		(0.1)		—		—		—	—		—		—
Payment of tax withholding for RSUs	—	—		—		—		—		(955,641)	(58.8)		—		(58.8)
Share-based compensation	—	—		22.5		—		—		—	—		—		22.5
Comprehensive income	—	—		—		14.2		530.2		—	—		0.8		545.2
Balance at April 1, 2022	606,021,655	$	6.1	$	4,533.3	$	(26.4)	$	2,992.4	(171,526,902)	$	(2,507.2)	$	19.8	$	5,018.0

See accompanying notes to consolidated financial statements

6

ON SEMICONDUCTOR CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in millions) 

(unaudited)

	Quarters Ended
	March 31, 2023		April 1, 2022
Cash flows from operating activities:
Net income	$	462.2	$	531.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	145.0		140.6
Loss (gain) on sale or disposal of fixed assets	1.2		(16.6)
Loss on divestiture of business	1.1		—
Loss on debt prepayment	13.3		—
Amortization of debt discount and issuance costs	2.9		3.2
Share-based compensation	27.7		22.5
Non-cash asset impairment charges	12.7		6.7
Change in deferred tax balances	(1.5)		38.3
Other	(7.0)		0.5
Changes in assets and liabilities (exclusive of divestitures):
Receivables	(37.7)		(107.2)
Inventories	(198.1)		(116.7)
Other assets	54.8		(0.8)
Accounts payable	53.5		35.7
Accrued expenses and other current liabilities	(154.6)		(83.2)
Other long-term liabilities	33.4		24.6
Net cash provided by operating activities	$	408.9	$	478.6
Cash flows from investing activities:
Purchase of property, plant and equipment	$	(321.5)	$	(173.8)
Proceeds from sale of property, plant and equipment	1.7		36.7
Deposits utilized (made) for purchase of property, plant and equipment	(16.7)		1.6
Divestiture of business, net of cash transferred and deposits received	—		12.9
Purchase of available-for-sale securities	—		(7.8)
Proceeds from sale or maturity of available-for-sale securities	10.8		3.4
Payments related to acquisition of business, net of cash acquired	(236.3)		(2.4)
Net cash used in investing activities	$	(562.0)	$	(129.4)
Cash flows from financing activities:
Proceeds for the issuance of common stock under the ESPP	$	7.3	$	7.8
Payment of tax withholding for RSUs	(47.6)		(58.8)
Repurchase of common stock	(104.0)		—
Issuance and borrowings under debt agreements	1,470.0		—
Reimbursement of debt issuance and other financing costs	4.5		—
Payment of debt issuance and other financing costs	(4.8)		—
Repayment of borrowings under debt agreements	(1,213.7)		(4.1)
Payment for purchase of bond hedges	(414.0)		—
Proceeds from issuance of warrants	242.5		—
Payment of financing lease obligations	(3.6)		—
Dividend to non-controlling shareholder	—		(2.2)
Net cash used in financing activities	$	(63.4)	$	(57.3)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.1		(0.7)
Net (decrease) increase in cash, cash equivalents and restricted cash	(216.4)		291.2
Cash, cash equivalents and restricted cash, beginning of period (Note 5)	2,933.0		1,377.7
Cash, cash equivalents and restricted cash, end of period (Note 5)	$	2,716.6	$	1,668.9

See accompanying notes to consolidated financial statements

7

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

(unaudited)

Note 1: Background and Basis of Presentation

ON Semiconductor Corporation (“onsemi,” “we,” “us,” “our,” or the “Company”), with its wholly and majority-owned subsidiaries, operates under the onsemiTM brand.

The Company is organized into three operating and reportable segments: the Power Solutions Group ("PSG"), the Advanced Solutions Group ("ASG"), and the Intelligent Sensing Group ("ISG").

The Company's fiscal calendar year begins on January 1 and ends on December 31. The fiscal quarters contain a thirteen-week accounting period. Minor day adjustments are required in the first and fourth quarters to account for the Company's fiscal calendar year's starting and ending dates. The quarters ended March 31, 2023 and April 1, 2022 contained 90 days and 91 days, respectively.

The accompanying unaudited financial statements as of and for the quarter ended March 31, 2023 have been prepared following generally accepted accounting principles in the United States of America ("GAAP") for interim financial reporting and the rules and regulations of the SEC for interim reporting. Accordingly, the unaudited financial statements do not include all of the information and footnotes required by GAAP for audited financial statements. The balance sheet as of December 31, 2022 was derived from the Company's audited financial statements but does not include all disclosures required by GAAP for annual financial statements. In the opinion of the Company's management, the interim information contains all adjustments, which include normal recurring adjustments necessary for a fair statement of the results for the interim periods. The footnote disclosures related to the interim financial information contained herein are also unaudited. Such financial information should be read in conjunction with the consolidated financial statements and related notes thereto for the year ended December 31, 2022, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 6, 2023 (the "2022 Form 10-K").

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances. Significant estimates have been used by management in conjunction with the following: (i) future payouts for customer incentives and amounts subject to allowances and returns; (ii) valuation and obsolescence relating to inventories; (iii) measurement of valuation allowances against deferred tax assets and evaluations of uncertain tax positions and (iv) testing for impairment of long-lived assets and goodwill. Additionally, during periods where it becomes applicable, significant estimates will be used by management in determining the future cash flows used in connection with business combinations. Actual results may differ from the estimates and assumptions used in the consolidated financial statements.

8

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 2: Revenue and Segment Information

The Company is organized into three operating and reportable segments consisting of PSG, ASG and ISG. These segments represent the Company's view of the business, and its gross profit is used to evaluate the performance of the Company's segments, the progress of major initiatives and the allocation of resources.

A significant portion of the Company’s orders are firm commitments that are non-cancellable, including certain orders or contracts with a duration of less than one year. Certain of the Company's customer contracts are multi-year agreements that include committed amounts ("Long-term Supply Agreements" or "LTSA's").

The estimated remaining performance obligations as of March 31, 2023, are approximately $17.6 billion (excluding the remaining performance obligations for contracts having an original duration of one year or less). This amount is subject to contractual increases based on negotiated contract prices and volumes, defined product mix flexibility, and the timing of new part introductions, among other contractual provisions. The Company expects to recognize approximately 33% of the remaining purchase obligation as revenue during the next twelve months upon shipment of products under these contracts. Total revenue estimates could be influenced by risks and uncertainties including manufacturing or supply chain constraints, modifications to customer agreements, and regulatory changes, among other factors. Accordingly, our actual revenue recognized for the remaining performance obligation in future periods may fluctuate from estimates.

Certain of the Company’s LTSA’s include non-cancellable capacity payments from the customer, which are generally due within 30 days of the agreement. These payments reserve production availability or are prepayments to secure production availability and are not recognized as revenue until the performance obligations are satisfied. For the periods ending March 31, 2023, and April 1, 2022, the Company recognized revenue of $14.8 million and $4.5 million, respectively, for the portion of performance obligations fulfilled during those periods.

As of March 31, 2023, and December 31, 2022, the remaining capacity payments were $225.5 million and $190.4 million, respectively, of which $69.0 million and $60.5 million were recorded as current liabilities, with the remainder recorded as other long-term liabilities.

Revenue and gross profit for the Company’s operating and reportable segments are as follows (in millions):

	PSG		ASG		ISG		Total
For the quarter ended March 31, 2023:
Revenue from external customers	$	1,012.8	$	592.8	$	354.1	$	1,959.7
Gross profit	$	480.3	$	260.1	$	177.1	$	917.5
For the quarter ended April 1, 2022:
Revenue from external customers	$	986.7	$	689.3	$	269.0	$	1,945.0
Gross profit	$	474.7	$	366.7	$	119.9	$	961.3

The Company had one customer, a distributor, whose revenue accounted for approximately 10.1% and 12.4% of the Company's total revenue for the quarters ended March 31, 2023 and April 1, 2022, respectively.

9

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Revenue for the Company's operating and reportable segments disaggregated into geographic locations based on sales billed from the respective country and sales channels are as follows (in millions):

	Quarter Ended March 31, 2023
	PSG		ASG		ISG		Total
Geographic Location
Hong Kong	$	286.9	$	139.7	$	63.8	490.4
Singapore	276.4		116.1		58.2		450.7
United Kingdom	204.1		128.1		81.1		413.3
United States	166.3		121.3		101.5		389.1
Other	79.1		87.6		49.5		216.2
Total	$	1,012.8	$	592.8	$	354.1	$	1,959.7
Sales Channel
Distributors	$	629.3	$	222.8	$	187.1	$	1,039.2
Direct Customers	383.5		370.0		167.0		920.5
Total	$	1,012.8	$	592.8	$	354.1	$	1,959.7

	Quarter Ended April 1, 2022
	PSG		ASG		ISG		Total
Geographic Location
Singapore	$	280.5	$	233.8	$	41.4	$	555.7
Hong Kong	303.1		173.9		52.6		529.6
United Kingdom	186.9		106.6		52.0		345.5
United States	144.9		92.3		74.5		311.7
Other	71.3		82.7		48.5		202.5
Total	$	986.7	$	689.3	$	269.0	$	1,945.0
Sales Channel
Distributors	$	633.9	$	356.9	$	150.6	$	1,141.4
Direct Customers	352.8		332.4		118.4		803.6
Total	$	986.7	$	689.3	$	269.0	$	1,945.0

The Company operates in various geographic locations. Sales to external customers have little correlation with the location of the Company's manufacturing or the location of the end-customers. It is, therefore, not meaningful to present operating profit by geographical location. The Company does not discretely allocate assets to its operating segments, nor does management evaluate operating segments using discrete asset information. The Company’s consolidated assets are not specifically ascribed to its individual reportable segments. Instead, assets used in operations are generally shared across the Company’s operating and reportable segments.

10

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Property, plant and equipment, net by geographic location, is summarized as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
United States	$	1,360.8	$	1,329.2
South Korea	990.9		871.0
Czech Republic	335.3		279.3
Philippines	287.1		296.8
China	227.4		215.3
Malaysia	199.0		190.2
Japan	128.1		133.2
Other	164.3		135.7
Total	$	3,692.9	$	3,450.7

Note 3: Acquisition and Divestitures

Acquisition:

During the year ended December 31, 2022, the Company closed the acquisition of EFK. The preliminary allocation of the purchase price of EFK to the assets acquired and liabilities assumed based on their relative fair values is as follows (in millions):

	Purchase Price Allocation
Inventory	$	3.3
Other current assets	4.4
Property, plant and equipment	396.5
Other non-current assets	11.4
Total assets acquired	415.6
Current liabilities	3.0
Other long-term liabilities	6.3
Total liabilities assumed	9.3
Net assets acquired/purchase price	$	406.3

The preliminary allocation, assumptions and disclosures are materially consistent with the amounts included in the 2022 Form 10-K.

The Company paid the remaining acquisition consideration of $236.3 million on January 3, 2023, which is disclosed under investing activities in the Consolidated statement of cash flows.

11

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 4: Restructuring, Asset Impairments and Other, Net

Details of restructuring, asset impairments and other charges, net are as follows (in millions):        

	Restructuring		Asset Impairments			Other		Total
Quarter ended March 31, 2023
2023 Business Realignment	$	36.1	$	2.5	(1)	$	2.8	$	41.4
QCS wind down	—		—			(2.3)		(2.3)
Other	—		10.2		(2)	2.2		12.4
Total	$	36.1	$	12.7		$	2.7	$	51.5

(1)Includes $1.7 million property, plant and equipment asset impairments charges and $0.8 million of ROU asset impairment charges associated with the 2023 Business Realignment efforts.

(2)Includes $10.2 million of property, plant and equipment and ROU lease asset impairment charges associated with site consolidation efforts in the United States.

A summary of changes in accrued restructuring balance is as follows (in millions):

	As of						As of
	December 31, 2022		Charges		Usage		March 31, 2023
Employee separation charges	$	4.4	$	36.1	$	(4.9)	$	35.6
Total	$	4.4	$	36.1	$	(4.9)	$	35.6

2023 Business Realignment

During the first quarter of 2023, the Company announced the elimination of approximately 400 jobs in an effort to realign its operating models, drive organizational effectiveness and efficiencies, and increase collaboration primarily within its ASG business unit and IT support organizations. As a result, ASG ceased its design and test operations in certain Asia and U.S.-based locations and initiated a plan to exit its Toulouse, France design center location. The announcement also included changes in the Company's IT operating model by transferring selected IT functions to strategic service providers.

In connection with these actions, the Company recognized severance costs, related benefit expenses and other ancillary charges of $36.1 million and expects to record an additional $1.5 million during the remainder of 2023. The Company paid approximately $2.5 million of the aggregate expense and had $33.6 million accrued as of March 31, 2023, which is expected to be paid during the remainder of 2023. As of March 31, 2023, 137 employees have been terminated.

The Company continues to evaluate employee positions and locations for potential operating improvements and efficiencies, and may incur additional severance and related charges in the future.

QCS wind down

On September 16, 2022, the Company's Board of Directors approved an exit plan to wind down QCS as part of its ongoing efforts to focus on growth drivers and key markets and to streamline its operations. As part of the exit plan, during the third quarter of 2022, the Company notified approximately 330 employees of their employment termination and incurred severance costs and other benefits of approximately $12.7 million.

As of March 31, 2023, $1.5 million of severance costs and other benefits remained accrued and, based on the exit dates of the notified employees, is expected to be paid during the fourth quarter of 2023.

12

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 5: Balance Sheet Information and Other Supplemental Disclosures

Goodwill

There was no change in the balance of goodwill from December 31, 2022 to March 31, 2023. Goodwill is tested for impairment annually on the first day of the fourth quarter or more frequently if events or changes in circumstances (each, a "triggering event") would more likely-than-not reduce the fair value of a reporting unit below its carrying value. Management did not identify any triggering events during the quarter ended March 31, 2023 that would require an interim impairment analysis.

Inventory

Details of Inventory included in the Company’s Consolidated Balance Sheets are as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
Inventories:
Raw materials	$	271.3	$	236.8
Work in process	1,053.5		951.0
Finished goods	490.1		429.0
	$	1,814.9	$	1,616.8

Defined Benefit Plans

The Company recognizes the aggregate amount of all over-funded plans as assets and the aggregate amount of all underfunded plans as liabilities in its financial statements. As of March 31, 2023, the net assets for the over-funded plans totaled $13.5 million. The total accrued pension liability for underfunded plans was $69.1 million, of which the current portion of $1.5 million was classified as accrued expenses and other current liabilities. As of December 31, 2022, the net funded status for all the plans was a liability of $53.8 million, of which the current portion of $0.4 million was classified as accrued expenses and other current liabilities.

The components of the net periodic pension expense were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Service cost	$	1.2	$	2.2
Interest cost	1.6		1.1
Expected return on plan assets	(1.2)		(1.2)
Total net periodic pension cost	$	1.6	$	2.1

Leases

Operating lease arrangements are comprised primarily of real estate and equipment agreements. The components of lease expense were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Operating lease	$	12.4	$	11.2
Variable lease	1.8		1.6
Short-term lease	0.5		0.4
Total lease expense	$	14.7	$	13.2

13

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

The ROU assets and lease liabilities recognized in the Consolidated Balance Sheets are as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
Operating lease liabilities included in:
Accrued expenses and other current liabilities	$	33.5	$	35.2
Other long-term liabilities	244.8		246.5
Total	$	278.3	$	281.7
Operating ROU assets included in:
Other assets	$	251.9	$	262.1
Current portion of financing lease liabilities	$	11.6	$	14.2
Long-term financing lease liabilities	24.0		23.0
Total	$	35.6	$	37.2
Right-of-use financing lease	$	45.2	$	45.8

As of March 31, 2023, the weighted-average remaining lease-terms were 10.8 years and 18.8 years, and the weighted-average discount rates were 4.8% and 6.0%, for operating and financing leases, respectively.

Supplemental Disclosure of Cash Flow Information

Certain of the Company's cash and non-cash activities were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Non-cash investing activities:
Capital expenditures in accounts payable and other long-term liabilities	$	388.8	$	225.4
Operating ROU assets obtained in exchange of lease liabilities	4.6		10.7
Cash paid for:
Interest expense	$	29.1	$	24.0
Income taxes	35.2		15.7
Operating lease payments in operating cash flows	11.2		11.0

Reconciliation of the captions in the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows (in millions):

	As of
	March 31, 2023		December 31, 2022		April 1, 2022		December 31, 2021
Consolidated Balance Sheets:
Cash and cash equivalents	$	2,702.4	$	2,919.0	$	1,645.1	$	1,352.6
Restricted cash (included in other current assets)	14.2		14.0		18.8		20.1
Restricted cash (included in other non-current assets)	—		—		5.0		5.0
Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$	2,716.6	$	2,933.0	$	1,668.9	$	1,377.7

As of March 31, 2023, $5.8 million of the restricted cash balance relating to the acquisition of GTAT was held in escrow and will be released during the fourth quarter of 2023 upon satisfaction of certain outstanding items contained in the Agreement and Plan of Merger relating to such acquisition.

14

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 6: Long-Term Debt

The Company's long-term debt consists of the following (annualized interest rates, dollars in millions):

	As of
	March 31, 2023		December 31, 2022
Amended Credit Agreement:
Revolving Credit Facility due 2024, interest payable monthly at 6.16% and 5.67%, respectively	$	375.0	$	500.0
Term Loan "B" Facility due 2026, interest payable monthly at 6.91% and 6.42%, respectively	—		1,086.0
0.50% Notes due 2029 (1)	1,500.0		—
0% Notes due 2027	805.0		805.0
3.875% Notes due 2028 (2)	700.0		700.0
1.625% Notes due 2023 (3)	134.6		137.3
Gross long-term debt, including current maturities	$	3,514.6	$	3,228.3
Less: Debt discount (4)	(4.7)		(9.2)
Less: Debt issuance costs (5)	(45.7)		(25.6)
Net long-term debt, including current maturities	$	3,464.2	$	3,193.5
Less: Current maturities	(926.2)		(147.8)
Net long-term debt	$	2,538.0	$	3,045.7

(1)Interest is payable on March 1 and September 1 of each year at 0.50% annually.

(2)Interest is payable on March 1 and September 1 of each year at 3.875% annually.

(3)Interest is payable on April 15 and October 15 of each year at 1.625% annually.

(4)Debt discount of $0.0 million and $4.2 million for the Term Loan "B" Facility and $4.7 million and $5.0 million for the 3.875% Notes, in each case as of March 31, 2023 and December 31, 2022, respectively.

(5)Debt issuance costs of $0.0 million and $9.7 million for the Term Loan "B" Facility, $30.7 million and $0.0 million for the 0.50% Notes, $13.1 million and $13.9 million for the 0% Notes, $1.7 million and $1.7 million for the 3.875% Notes and $0.2 million and $0.3 million for the 1.625% Notes, in each case as of March 31, 2023 and December 31, 2022, respectively.

15

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Expected maturities of gross long-term debt (including current portion - see section regarding 1.625% and 0% Notes below) as of March 31, 2023 were as follows (in millions):

Period	Expected Maturities
Remainder of 2023	$	939.6
2024	375.0
2025	—
2026	—
2027	—
Thereafter	2,200.0
Total	$	3,514.6

The Company was in compliance with its covenants under all debt agreements as of March 31, 2023.

0.50% Convertible Senior Notes due 2029

On February 28, 2023, the Company completed a private unregistered offering of $1.5 billion aggregate principal amount of its 0.50% Convertible Senior Notes due 2029 (the "0.50% Notes"). The Company received net proceeds of approximately $1,470 million after deducting the initial purchasers' discount. The Company used the net proceeds to repay $1,086.0 million of the existing outstanding indebtedness under the Company’s Term Loan “B” Facility, the related transaction fees and expenses, to pay approximately $171.5 million net cost of the related convertible note hedges after such costs were offset by the proceeds from the sale of warrants, and for general corporate purposes. The 0.50% Notes were issued under an indenture (the "0.50% Indenture"), dated as of February 28, 2023, by and among the Company, the guarantors (as defined therein) and Computershare Trust Company, National Association, as trustee, which provides, among other things, that the 0.50% Notes will mature on March 1, 2029, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms. On or after December 1, 2028, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the 0.50% Notes may convert all or a portion of their 0.50% Notes at any time. The 0.50% Notes are the Company’s senior unsecured obligations and are fully and unconditionally guaranteed, on a joint and several basis, by each of the Company’s subsidiaries that is a borrower or guarantor under the Company’s Amended Credit Agreement. The Company may satisfy any conversion elections by paying cash up to the aggregate principal amount of the 0.50% Notes to be converted, and paying or delivering, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at the Company’s election, in respect of the remainder, if any, of its conversion obligation in excess of the aggregate principal amount of the 0.50% Notes to be converted.

The initial conversion rate of the 0.50% Notes is 9.6277 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of approximately $103.87 per share of common stock. The Company may redeem for cash all or any portion of the 0.50% Notes, at the Company’s option, on or after March 6, 2026, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the related notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Prior to December 1, 2028, the holders may convert their 0.50% Notes at their option only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on June 30, 2023 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five consecutive business-day period after any five consecutive trading-day period in which the trading price per $1,000 principal amount of the 0.50% Notes for each trading day of such period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (iii) if the Company calls any or all of the 0.50% Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate transactions described in the 0.50% Indenture.

The conversion rate is subject to adjustment upon the occurrence of certain specified events as set forth in the 0.50% Indenture. The maximum number of shares of common stock issuable in connection with the conversion of the 0.50% Notes is approximately 19.1 million. In addition to the initial purchasers' discount of $30.0 million, the Company also incurred issuance

16

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

costs of approximately $1.3 million, all of which was capitalized as debt issuance costs. The effective interest rate, including the impact of the debt discount and debt issuance costs is approximately 0.85% over the contractual term of the 0.50% Notes.

In addition, the Company entered into convertible note hedge transactions with respect to the common stock with the initial purchasers or their affiliates and certain other financial institutions. The Company will exercise the note hedges simultaneously when the 0.50% Notes are settled. The convertible note hedges cover, subject to customary anti-dilution adjustments, the number of shares of common stock that initially underlie the 0.50% Notes, and are expected to reduce the potential dilution to the common stock and/or offset potential cash payments in excess of the principal amount upon conversion of the 0.50% Notes. The Company paid approximately $414.0 million in cash for the convertible note hedges, which was recorded to stockholders’ equity.

The Company also entered into warrant transactions with certain other financial institutions, whereby the Company sold warrants to acquire 14.4 million shares of the Company's common stock, which is the same number of shares of the Company’s common stock covered by the convertible note hedges at an initial strike price of $156.78 per share, which represents a 100% premium over the closing price of the Company's common stock of $78.39 per share on February 23, 2023, subject to antidilution adjustments. The warrants expire on June 1, 2029. The maximum number of shares of common stock issuable in connection with the warrants is approximately 28.9 million. The Company received $242.5 million in cash for the sale of warrants, which was recorded to stockholders’ equity.

The Company recorded $92.3 million deferred tax asset related to the tax treatment of entering into the 0.50% Notes and the convertible note hedge.

Loss on debt prepayment

As mentioned above, with a portion of the proceeds of 0.50% Convertible Senior Notes due 2029, the Company repaid the remaining principal balance of $1.1 billion associated with its Term Loan "B" Facility. As a result of the prepayment, $13.3 million of unamortized debt discount and issuance costs were expensed and recorded as loss on debt prepayment.

Repayments under the Revolving Credit Facility

During the quarter ended March 31, 2023, the Company repaid $125.0 million of the outstanding balance under the Revolving Credit Facility. As of March 31, 2023, the Company had approximately $1.6 billion available under the Revolving Credit Facility for future borrowings, except for amounts utilized for the letters of credit.

1.625% Notes due 2023

Pursuant to the indenture governing the 1.625% Notes, as of March 31, 2023, the $134.4 million remaining outstanding principal amount of the 1.625% Notes, net of unamortized issuance costs, continued to be classified as a current portion of long-term debt since the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on March 31, 2023 was greater than or equal to $26.94 (130% of the conversion price) on each applicable trading day. This condition gives holders the right to surrender any portion of their 1.625% Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending June 30, 2023, and only during such calendar quarter.

0% Notes due 2027

Pursuant to the indenture governing the 0% Notes, as of March 31, 2023, the $791.9 million outstanding principal amount of the 0% Notes, net of unamortized issuance costs, was classified as a current portion of long-term debt since the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on March 31, 2023 was greater than or equal to $68.86 (130% of the conversion price) on each applicable trading day. This condition gives holders the right to surrender any portion of their 0% Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending June 30, 2023, and only during such calendar quarter.

17

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 7: Earnings Per Share and Equity

Earnings Per Share

Net income per share of common stock for calculating basic and diluted earnings per share is calculated as follows (in millions, except per share data):

	Quarters Ended
	March 31, 2023		April 1, 2022
Net income for basic earnings per share of common stock	$	461.7	$	530.2
Add: Interest on 1.625% Notes	0.4		0.5
Net income for diluted earnings per share of common stock	$	462.1	$	530.7
Basic weighted-average shares of common stock outstanding	431.9		433.3
Dilutive effect of share-based awards	1.4		2.4
Dilutive effect of convertible notes and warrants	15.2		13.2
Diluted weighted-average shares of common stock outstanding	448.5		448.9
Net income per share of common stock attributable to ON Semiconductor Corporation:
Basic	$	1.07	$	1.22
Diluted	$	1.03	$	1.18

Basic income per share of common stock is computed by dividing net income for basic earnings by the weighted-average number of shares of common stock outstanding during the period. To calculate the diluted weighted-average shares of common stock outstanding, the treasury stock method has been applied to calculate the number of incremental shares from the assumed issuance of shares relating to RSUs. The excluded number of anti-dilutive share-based awards was 0.2 million and 0.2 million for the quarters ended March 31, 2023 and April 1, 2022, respectively.

The dilutive impacts related to the 0.50% Notes, 0% Notes and 1.625% Notes have been calculated using the if-converted method. The 0.50% Notes and the 0% Notes are repayable in cash up to the par value and in cash or shares of common stock for the excess over par value, while the 1.625% Notes are repayable in cash, shares of common stock, or any combination of cash and shares of common stock at the election of the Company for their entire value. Prior to conversion, the convertible note hedges are not considered for purposes of the earnings per share calculations, as their effect would be anti-dilutive. Upon conversion, the convertible note hedges are expected to offset the dilutive effect of the 0.50% Notes, 0% Notes, and 1.625% Notes when the stock price is above $103.87, $52.97 and $20.72 per share, respectively.

The dilutive impact of the warrants issued concurrently with the issuance of the 0.50% Notes, 0% Notes and 1.625% Notes with exercise prices of $156.78, $74.34 and $30.70, respectively, has been included in the calculation of diluted weighted-average common shares outstanding, if applicable.

Equity

Share Repurchase Program

Under the Company's share repurchase program announced on February 6, 2023 (the "Share Repurchase Program"), the Company may repurchase up to $3.0 billion (exclusive of fees, commissions and other expenses) of the Company's common stock through December 31, 2025.

The Company repurchased approximately 1.3 million shares of common stock for an aggregate purchase price of $104.0 million during the quarter ended March 31, 2023. As of March 31, 2023, the authorized amount remaining under the Share Repurchase Program was approximately $2.9 billion.

18

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Shares for Restricted Stock Units Tax Withholding

The amounts remitted for employee withholding taxes during the quarters ended March 31, 2023 and April 1, 2022 were $47.6 million and $58.8 million, respectively, for which the Company withheld approximately 0.6 million and 1.0 million shares of common stock, respectively, that were underlying the RSUs that vested. This tax withholding activity is separate from our Share Repurchase Program.

Non-Controlling Interest in Leshan-Phoenix Semiconductor Company Limited (“Leshan”)

The results of Leshan have been consolidated in the Company's financial statements. As of December 31, 2022, the non-controlling interest, which represents 20% of the Leshan balance, amounted to $18.5 million. This amount increased to $19.0 million as of March 31, 2023, after including the $0.5 million share of earnings for the quarter ending March 31, 2023.

Note 8: Share-Based Compensation

Total share-based compensation expense related to the Company's RSUs, stock grant awards and the ESPP was recorded within the Consolidated Statements of Operations and Comprehensive Income as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Cost of revenue	$	3.7	$	2.6
Research and development	4.5		4.4
Selling and marketing	4.1		3.8
General and administrative	15.4		11.7
Share-based compensation expense	$	27.7	$	22.5
Income tax benefit	(5.8)		(4.7)
Share-based compensation expense, net of taxes	$	21.9	$	17.8

As of March 31, 2023, total unrecognized expected share-based compensation expense, net of estimated forfeitures, related to non-vested RSUs with service, performance and market conditions was $149.4 million, which is expected to be recognized over a weighted-average period of 1.7 years. Upon vesting of RSUs, stock grant awards or completion of a purchase under the ESPP, the Company issues new shares of common stock. The annualized pre-vesting forfeiture rate for RSUs was estimated to be 8% for the quarter ended March 31, 2023 and 6% for the quarter ended April 1, 2022.

Shares Available

As of March 31, 2023 and December 31, 2022, there was an aggregate of 38.3 million and 40.1 million shares of common stock, respectively, available for grant under the Amended and Restated SIP.

Restricted Stock Units

RSUs generally vest ratably over three years for awards with service conditions and over two or three years for awards with performance or market conditions, or a combination thereof, and are settled in shares of the Company's common stock upon vesting. A summary of the RSU transactions for the quarter ended March 31, 2023 is as follows (in millions, except per share data):

19

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
Non-vested RSUs at December 31, 2022	3.8	$	46.56
Granted	0.9	77.85
Achieved	0.3	54.16
Released	(1.7)	42.12
Forfeited	(0.1)	48.33
Non-vested RSUs at March 31, 2023	3.2	58.00

Note 9: Commitments and Contingencies

Environmental Contingencies

The Company has encountered and dealt with a number of environmental issues over time relating to the various locations that comprise its operations, and has incurred certain costs related to clean-up activities and environmental remediation efforts. In certain instances, the Company has been indemnified for such costs, often times from third parties who were the prior owners of such facilities. Any costs to the Company in connection with such environmental matters have generally not been, and, based on the information available, are not expected to be material.

Financing Contingencies

In the ordinary course of business, the Company provides standby letters of credit or other guarantee instruments to certain parties initiated by either the Company or its subsidiaries, as required for transactions, including, but not limited to, material purchase commitments, agreements to mitigate collection risk, leases, utilities or customs guarantees. As of March 31, 2023, the Company's Revolving Credit Facility included $15.0 million available for the issuance of letters of credit. There were $0.9 million in letters of credit outstanding under the Revolving Credit Facility as of March 31, 2023, which reduced the Company's borrowing capacity. As of March 31, 2023, the Company also had outstanding guarantees and letters of credit outside of its Revolving Credit Facility totaling $16.5 million.

As part of obtaining financing in the ordinary course of business, the Company issued guarantees related to certain of its subsidiaries, which totaled $0.9 million as of March 31, 2023. Based on historical experience and information currently available, the Company believes that it will not be required to make payments under the standby letters of credit or guarantee arrangements for the foreseeable future.

Indemnification Contingencies

The Company is a party to a variety of agreements entered into in the ordinary course of business, including acquisition agreements, pursuant to which it may be obligated to indemnify the other parties for certain liabilities that arise out of or relate to the subject matter of the agreements. Some of the agreements entered into by the Company require it to indemnify the other party against losses due to IP infringement, property damage (including environmental contamination), personal injury, failure to comply with applicable laws, the Company’s negligence or willful misconduct or breach of representations and warranties and covenants related to such matters as title to sold assets. In the case of certain acquisition agreements, these agreements may require us to maintain such indemnification provisions for the acquiree’s directors, officers and other employees and agents, in certain cases for a number of years following the acquisition.

While the Company’s future obligations under certain agreements may contain limitations on liability for indemnification, other agreements do not contain such limitations and under such agreements it is not possible to predict the maximum potential amount of future payments due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under any of these indemnities have not had a material effect on the Company’s business, financial condition, results of operations or cash flows. Additionally, the Company does not believe that any amounts that it may be required to pay under these indemnities in the future will be material to the Company’s business, financial position, results of operations, or cash flows.

20

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Legal Matters

The Company is currently involved in a variety of legal matters that arise in the ordinary course of business. Based on information currently available, the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations or liquidity. The litigation process is inherently uncertain, and the Company cannot guarantee that the outcome of any litigation matter will be favorable to the Company.

Intellectual Property Matters

The Company faces risk of exposure from claims of infringement of the IP rights of others. In the ordinary course of business, the Company receives letters asserting that the Company’s products or components breach another party’s rights. Such letters may request royalty payments from the Company, that the Company cease and desist using certain IP, and/or request other remedies.

Note 10: Fair Value Measurements

Fair Value of Financial Instruments

During the year ended December 31, 2022, the Company began investing portions of its excess cash in different marketable

securities, which are classified as available-for-sale.

The Company uses the following fair value tier level hierarchy to determine fair values of its financial instruments:

• Level 1: based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets

• Level 2: based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability either

directly or indirectly.

• Level 3: based on the use of unobservable inputs for the assets and liabilities and other types of analyses.

The carrying value of cash and cash equivalents which includes time deposits, money market funds, corporate bonds and commercial paper approximates fair value because of the short-term maturity of these instruments. Demand and time deposits and money market funds are classified as Level 1 within the fair value hierarchy, while corporate bonds and commercial paper are classified as Level 2. The carrying amount of other current assets and liabilities, such as accounts receivable and accounts payable approximates fair value due to the short-term maturity of the amounts and are considered Level 2 in the fair value hierarchy.

The following table summarizes the Company's financial assets and liabilities, excluding pension assets, disaggregated by the security type, measured at fair value on a recurring basis (in millions):

21

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

As of March 31, 2023									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	371.4	$	—	$	—	$	371.4	$	371.4	$	—	$	—
Money market funds	28.4		—		—		28.4		28.4		—		—
Other current assets:
Corporate bonds	$	15.2	$	—	$	—	$	15.2	$	—	$	15.2	$	—
Certificate of deposit	2.7		—		—		2.7		—		2.7		—
Commercial paper	2.2		—		—		2.2		0.2		2.0		—
US Treasury bonds	1.7		—		—		1.7		—		1.7		—
Other assets:
Corporate bonds	$	0.5	$	—	$	—	$	0.5	$	—	$	0.5	$	—

The investments included in other assets have maturity dates ranging between one and five years.

As of December 31, 2022									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	233.1	$	—	$	—	$	233.1	$	233.1	$	—	$	—
Money market funds	17.0		—		—		17.0		17.0		—		—
Other current assets:
Corporate bonds	$	23.8	$	—	$	—	$	23.8	$	—	$	23.8	$	—
Certificate of deposit	3.1		—		—		3.1		—		3.1		—
Commercial paper	3.2		—		—		3.2		1.2		2.0		—
US Treasury bonds	2.1		—		—		2.1		—		2.1		—
Other assets:
Corporate bonds	$	0.8	$	—	$	—	$	0.8	$	—	$	0.8	$	—

Other

The carrying amounts of other current assets and liabilities, such as accounts receivable and accounts payable, approximate fair value based on the short-term nature of these instruments.

Fair Value of Long-Term Debt, including Current Portion

22

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

The carrying amounts and fair values of the Company’s long-term borrowings were as follows (in millions):

	As of
	March 31, 2023				December 31, 2022
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Long-term debt, including current portion (1)
0% Notes	$	791.9	$	1,306.2	$	791.1	$	1,057.8
0.50% Notes	1,469.3		1,572.8		—		—
1.625% Notes	134.4		517.6		137.0		417.8
3.875% Notes	693.6		641.1		693.3		618.3
Other long-term debt	375.0		377.0		1,572.1		1,549.2

(1)    Carrying amounts shown are net of debt discount, if applicable, and debt issuance costs.

The fair values of the 3.875% Notes, 1.625% Notes, 0.50% Notes and 0% Notes were estimated based on market prices in active markets (Level 1). The fair value of the Term Loan "B" Facility was estimated based on discounting the remaining principal and interest payments using current market rates for similar debt (Level 2).

23

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 11: Financial Instruments

Foreign Currencies

As a multinational business, the Company engages in transactions that are denominated in a variety of currencies. When appropriate, the Company uses forward foreign currency contracts to reduce its overall exposure to the effects of currency fluctuations on its results of operations and cash flows. The Company’s policy prohibits trading in currencies for which there are no underlying exposures and entering into trades for any currency to intentionally increase the underlying exposure. The Company primarily hedges existing assets and liabilities associated with transactions currently on its balance sheet, which are undesignated hedges for accounting purposes. The Company is exposed to credit-related losses if counterparties to hedge contracts fail to perform their obligations. As of March 31, 2023, the counterparties to the Company’s hedge contracts were held at financial institutions that the Company believes to be highly-rated, and no credit-related losses are anticipated.

As of March 31, 2023 and December 31, 2022, the Company had net outstanding foreign exchange contracts with notional amounts of $279.2 million and $272.0 million, respectively. Such contracts were obtained through financial institutions and were scheduled to mature within one to three months from the time of purchase. Management believes that these financial instruments should not subject the Company to increased risks from foreign exchange movements because gains and losses on these contracts should offset losses and gains on the underlying assets, liabilities and transactions to which they are related.

The following summarizes the Company’s net foreign exchange positions in U.S. Dollars (in millions):

	As of
	March 31, 2023				December 31, 2022
	Buy (Sell)		Notional Amount		Buy (Sell)		Notional Amount
Japanese Yen	69.5		69.5		27.0		27.0
Philippine Peso	49.4		49.4		63.9		63.9
Czech Koruna	40.4		40.4		41.7		41.7
Euro	39.5		39.5		26.0		26.0
Korean Won	20.0		20.0		35.7		35.7
Other Currencies - Buy	46.5		46.5		66.5		66.5
Other Currencies - Sell	(13.9)		13.9		(11.2)		11.2
	$	251.4	$	279.2	$	249.6	$	272.0

Amounts receivable or payable under the contracts were not material as of March 31, 2023 or December 31, 2022. During the quarters ended March 31, 2023 and April 1, 2022, net of the impact of the hedge positions, the realized and unrealized foreign currency transactions totaled a loss of $1.9 million and a gain of $1.9 million, respectively. The realized and unrealized foreign currency transactions are included in other income (expense) in the Company's Consolidated Statements of Operations and Comprehensive Income.

Cash Flow Hedges

All derivatives are recognized on the Company’s Consolidated Balance Sheets at their fair value and classified based on the applicable instrument's maturity date.

Interest Rate Risk

The Company uses interest rate swap contracts to mitigate its exposure to variable interest rate fluctuations.

24

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

As of March 31, 2023, the Company did not have any outstanding derivatives related to cash flow hedges as the Company terminated its interest rate swap agreements with a notional value of $500 million for fiscal years 2023 and 2024, respectively and received cash proceeds of $27.7 million (net of termination fees). The Company recognized $6.9 million of other income related to the termination of these agreements. As of March 31, 2023, approximately $20.7 million was recorded in Accumulated Other Comprehensive Income and will be amortized to income over a period of twenty-one months, which represents the remaining original period of the swap agreements. If the Company prepays the Revolving Credit Facility balance, the Company will release the corresponding amounts from Accumulated Other Comprehensive Income concurrently.

As of December 31, 2022, the Company had interest rate swap agreements for notional amounts of $750 million, $500 million and $500 million for fiscal years 2022, 2023 and 2024, respectively. The fair value of these swaps totaled $36.0 million as of December 31, 2022. The Company did not identify any ineffectiveness with respect to the notional amounts of the interest rate swap contracts effective as of December 31, 2022. These derivatives are recognized on the balance sheet at their fair value and classified based on each instrument’s maturity dates.

See Note 13: ''Changes in Accumulated Other Comprehensive Loss'' for the effective amounts related to derivative instruments designated as cash flow hedges affecting accumulated other comprehensive loss and the Consolidated Statements of Operations

and Comprehensive Income for the quarter ended March 31, 2023.

Convertible Note Hedges

The Company entered into convertible note hedges in connection with the issuance of the 0% Notes, 0.50% Notes and 1.625% Notes. See Note 6: ''Long-Term Debt'' for additional information.

Other

As of March 31, 2023, the Company had no outstanding commodity derivatives, currency swaps, options, or equity investments held at subsidiaries or affiliated companies. The Company does not hedge the value of its equity investments in its subsidiaries or affiliated companies.

The Company is exposed to credit-related losses if its hedge counterparties fail to perform their obligations. As of March 31, 2023, the counterparties to the Company's hedge contracts are held at financial institutions which the Company believes to be highly rated, and no credit related losses are anticipated.

Note 12: Income Taxes

The Company recognizes interest and penalties related to uncertain tax positions in tax expense on the Company's Consolidated Statements of Operations and Comprehensive Income. The Company had approximately $4.3 million and $2.7 million of net interest and penalties accrued as of March 31, 2023 and December 31, 2022, respectively. It is reasonably possible that $68.2 million of its uncertain tax positions will be reduced in the next 12 months due to settlement with tax authorities or expiration of the applicable statute of limitations.

The Company maintains a partial valuation allowance on its U.S. state deferred tax assets and a valuation allowance on foreign net operating losses and tax credits in certain foreign jurisdictions, a substantial portion of which relate to Japan and Hong Kong net operating losses, which are projected to expire prior to utilization.

The Company is currently under IRS examination for the 2017 and 2018 tax years. Tax years prior to 2017 are generally not subject to examination by the IRS. For state tax returns, the Company is generally not subject to income tax examinations for tax years prior to 2018. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. With respect to jurisdictions outside the United States, the Company is generally not subject to examination for tax years prior to 2012. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.

25

ON SEMICONDUCTOR CORPORATION

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS - Continued

(unaudited)

Note 13: Changes in Accumulated Other Comprehensive Loss

Amounts comprising the Company's accumulated other comprehensive loss and reclassifications are as follows (in millions):

	Currency Translation Adjustments		Effects of Cash Flow Hedges and Other Adjustments		Total
Balance as of December 31, 2022	$	(50.4)	$	27.2	$	(23.2)
Other comprehensive income (loss) prior to reclassifications	0.3		5.2		5.5
Amounts reclassified from accumulated other comprehensive loss	—		(11.9)		(11.9)
Net current period other comprehensive income (loss)	0.3		(6.7)		(6.4)
Balance as of March 31, 2023	$	(50.1)	$	20.5	$	(29.6)

Amounts reclassified from accumulated other comprehensive loss to the specific caption within Consolidated Statements of Operations and Comprehensive Income were as follows:

	Quarters Ended
	March 31, 2023		April 1, 2022		To caption
Interest rate swaps	$	(5.0)	$	0.7	Interest expense
Interest rate swaps terminations	(6.9)		—		Other Income
Total reclassifications	$	(11.9)	$	0.7

26

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

You should read the following discussion in conjunction with our audited historical consolidated financial statements, which are included in the 2022 Form 10-K and our unaudited consolidated financial statements for the fiscal quarter ended March 31, 2023, which are included elsewhere in this Form 10-Q. This Management's Discussion and Analysis of Financial Condition and Results of Operations contains statements that are forward-looking. These statements are based on current expectations and assumptions that are subject to risks, uncertainties and other factors. Actual results could differ materially because of the factors discussed below or elsewhere in this Form 10-Q. See Part II, Item 1A. "Risk Factors" of this Form 10-Q and Part I, Item 1A. "Risk Factors" of the 2022 Form 10-K.

Executive Overview

onsemi Overview

We provide industry-leading intelligent power and sensing solutions to help our customers solve challenging problems and create cutting-edge products for a better future. Our intelligent power technologies enable the electrification of the automotive industry that allows for lighter and longer-range electric vehicles, empowers efficient fast-charging systems and propels sustainable energy for the highest efficiency solar strings, industrial power and storage systems. Our intelligent power solutions for automotive allows customers to exceed range targets with lower weight and reduce system cost through efficiency. Our intelligent sensing technologies support the next generation industry, allowing for smarter factories and buildings while also enhancing the automotive mobility experience with imaging and depth sensing that make advanced vehicle safety and automated driving systems possible. We believe the evolution of the automotive industry, with advancements in autonomous driving, ADAS, vehicle electrification, and the increase in electronics content for vehicle platforms, is reshaping the boundaries

of transportation.

Through sensing integration, we believe our intelligent power solutions achieve superior efficiencies compared to our peers. This integration allows lower temperature operation, and reduced cooling requirements, while saving costs and minimizing weight. In addition, our power solutions deliver power with less die per module, achieving higher range for a given battery capacity.

We serve a broad base of end-user markets, with a primary focus towards automotive and industrial and including communications, computing and consumer.

As of March 31, 2023, we were organized into the three operating and reportable segments of PSG, ASG and ISG.

Business Strategy Developments

Our primary focus continues to be on profitable revenue growth in our focused end-markets of automotive and industrial infrastructure, as well as obtaining longer-term supply arrangements with strategic end-customers. We are focused on achieving efficiencies in our operating and capital expenditures. Additionally, we continue to rationalize our product portfolio by moving away from non-differentiated, non-strategic products, which in most cases had lower gross and operating margins.

2023 Business Realignment

In order to streamline our operations and achieve organizational efficiencies, we realigned our operating models in ASG and the Corporate Information Technology ("IT") organization during the first quarter of 2023. Under this business realignment, approximately 400 employees were notified of their employment termination, and we incurred severance and related charges of approximately $41.4 million. We continue to evaluate employee positions and locations for potential efficiencies and may incur additional severance and related charges in the future. For additional information, see Note 4: ''Restructuring, Asset Impairments and Other, Net'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.

0.50% Convertible Senior Notes due 2029

During the first quarter of 2023, we completed the offering of $1.5 billion aggregate principal amount of our 0.50% Notes and utilized the net proceeds along with cash generated from operations to which were used (i) to repay $1,086.0 million of the existing outstanding indebtedness under the Company’s Term Loan “B” Facility and the related transaction fees and expenses, (ii) to pay approximately $171.5 million net cost of the related convertible note hedges after such costs were offset by the proceeds from the sale of warrants, and (iii) for general corporate purposes.

27

Repayments under the Revolving Credit Facility

During the quarter ended March 31, 2023, we repaid $125.0 million of the outstanding balance under the Revolving Credit Facility.

For additional information, see Note 6: ''Long-Term Debt'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q.

Results of Operations

Quarter Ended March 31, 2023 compared to the Quarter Ended April 1, 2022

The following table summarizes certain information relating to our operating results that has been derived from our unaudited consolidated financial statements (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022		Dollar Change
Revenue	$	1,959.7	$	1,945.0	$	14.7
Cost of revenue	1,042.2		983.7		58.5
Gross profit	917.5		961.3		(43.8)
Operating expenses:
Research and development	138.4		156.8		(18.4)
Selling and marketing	71.8		71.1		0.7
General and administrative	75.9		77.9		(2.0)
Amortization of acquisition-related intangible assets	15.0		21.3		(6.3)
Restructuring, asset impairments and other charges, net	51.5		(13.0)		64.5
Total operating expenses	352.6		314.1		38.5
Operating income	564.9		647.2		(82.3)
Other income (expense), net:
Interest expense	(26.4)		(21.6)		(4.8)
Interest income	17.1		0.4		16.7
Loss on debt prepayment	(13.3)		—		(13.3)
Loss on divestiture of business	(1.1)		—		(1.1)
Other income	4.7		2.1		2.6
Other income (expense), net	(19.0)		(19.1)		0.1
Income before income taxes	545.9		628.1		(82.2)
Income tax provision	(83.7)		(97.1)		13.4
Net income	462.2		531.0		(68.8)
Less: Net income attributable to non-controlling interest	(0.5)		(0.8)		0.3
Net income attributable to ON Semiconductor Corporation	$	461.7	$	530.2	$	(68.5)

Revenue

Revenue was $1,959.7 million and $1,945.0 million for the quarters ended March 31, 2023 and April 1, 2022, respectively, representing an increase of $14.7 million, or approximately 1%. We had one customer, a distributor, whose revenue accounted for approximately 10.1% and 12.4% of our total revenue for the quarters ended March 31, 2023 and April 1, 2022, respectively.

28

Revenue by operating and reportable segments was as follows (dollars in millions):

 

	Quarter Ended March 31, 2023		As a % of Total Revenue (1)		Quarter Ended April 1, 2022		As a % of Total Revenue (1)
PSG	$	1,012.8	51.7	%	$	986.7	50.7	%
ASG	592.8		30.2	%	689.3		35.4	%
ISG	354.1		18.1	%	269.0		13.8	%
Total revenue	$	1,959.7			$	1,945.0

(1) Certain amounts may not total due to rounding of individual amounts.

Revenue from PSG increased by $26.1 million, or approximately 3%, for the quarter ended March 31, 2023 compared to the quarter ended April 1, 2022. The revenue from our Advanced Power Division increased by $96.6 million, which was partially offset by a decrease of $70.5 million in our Integrated Circuits, Protection and Signal Division. The increases were primarily driven by our continued ramp in SiC and other high-power automotive solutions, compared to the quarter ended April 1, 2022. The decrease in revenue generated by our Integrated Circuits, Protection and Signal Division was driven by planned customer product exits and reduced demand driven by lower end-market requirements for these products.

Revenue from ASG decreased by $96.5 million, or approximately 14%, for the quarter ended March 31, 2023 compared to the quarter ended April 1, 2022. The revenue from our Mobile, Computing and Cloud Division decreased by $109.5 million, which was partially offset by an increase of $18.0 million and $19.8 million, respectively, in our Automotive Division and Industrial Solutions Division driven by Foundry business through our new EFK location. The decrease in revenue generated by our Mobile, Computing and Cloud Division was influenced by our 2023 exit of our Quantenna business, planned end of life for targeted products as well as a general drop in end market demand for these products.

Revenue from ISG increased by $85.1 million, or approximately 32%, for the quarter ended March 31, 2023 compared to the quarter ended April 1, 2022, largely driven by an increase in revenue from our Automotive Sensing Division of $90.9 million. The increase was due to an increase in demand for these products and an increase in average selling prices, compared to the quarter ended April 1, 2022.

Revenue by geographic location, based on sales billed from the respective country or region, was as follows (dollars in millions): 

	Quarter Ended March 31, 2023		As a % of Total Revenue (1)		Quarter Ended April 1, 2022		As a % of Total Revenue (1)
Singapore	$	450.7	23.0	%	$	555.7	28.6	%
Hong Kong	490.4		25.0	%	529.6		27.2	%
United Kingdom	413.3		21.1	%	345.5		17.8	%
United States	389.1		19.9	%	311.7		16.0	%
Other	216.2		11.0	%	202.5		10.4	%
Total revenue	$	1,959.7			$	1,945.0

(1) Certain amounts may not total due to rounding of individual amounts.

Gross Profit and Gross Margin (exclusive of amortization of acquisition-related intangible assets)

Our gross profit by operating and reportable segments was as follows (dollars in millions):

 

	Quarter Ended March 31, 2023		As a % of Segment Revenue (1)		Quarter Ended April 1, 2022		As a % of Segment Revenue (1)
PSG	$	480.3	47.4	%	$	474.7	48.1	%
ASG	260.1		43.9	%	366.7		53.2	%
ISG	177.1		50.0	%	119.9		44.6	%
Total gross profit	$	917.5	46.8	%	$	961.3	49.4	%

(1)Certain amounts may not total due to rounding of individual amounts.

29

During the quarter ended March 31, 2023 our gross profit was $917.5 million and our gross margin was 46.8%, representing a decline of approximately $43.8 million and a 4.6% decrease compared to a gross profit of $961.3 million and a gross margin of 49.4% reported for the quarter ended April 1, 2022.

The decline in both gross profit and gross margin was primarily driven by start-up and ramp-up costs associated with the ramp up of our EFK facility and new products.

Operating Expenses

Research and development expenses were $138.4 million for the quarter ended March 31, 2023, as compared to $156.8 million for the quarter ended April 1, 2022, representing a decrease of $18.4 million, or approximately 12%. The decrease was primarily due to a reduction in payroll, variable compensation and other expenses as a result of the restructuring programs implemented during the period.

Selling and marketing expenses were $71.8 million for the quarter ended March 31, 2023, as compared to $71.1 million for the quarter ended April 1, 2022, representing an increase of $0.7 million, or approximately 1%.

General and administrative expenses were $75.9 million for the quarter ended March 31, 2023, as compared to $77.9 million for the quarter ended April 1, 2022, representing a decrease of $2.0 million, or approximately 3%. The decrease was primarily due to a reduction in variable compensation and other expenses as a result of the restructuring programs implemented during the period.

Other Operating Expenses

Amortization of Acquisition-Related Intangible Assets

Amortization of acquisition-related intangible assets was $15.0 million for the quarter ended March 31, 2023, as compared to $21.3 million for the quarter ended April 1, 2022, representing a decrease of $6.3 million, or approximately 30%. The decrease in expense was due to the impairment of certain intangible assets recorded due to the QCS shutdown during the third quarter of 2022 and a reduction in amortization expense as certain intangible technology-related assets became fully amortized in 2022.

Restructuring, Asset Impairments and Other, Net

Restructuring, asset impairments and other, net was $51.5 million for the quarter ended March 31, 2023, as compared to a credit of $13.0 million for the quarter ended April 1, 2022. Amounts incurred during the quarter ended March 31, 2023 primarily related to the business realignment that was announced in the first quarter of 2023. Amounts incurred for the quarter ended April 1, 2022 were partially offset by a gain from the sale of an office building in the first quarter of 2022. See Note 4: ''Restructuring, Asset Impairments and Other, Net'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

Interest Expense

Interest expense increased by $4.8 million to $26.4 million during the quarter ended March 31, 2023, as compared to $21.6 million during the quarter ended April 1, 2022. The increase was primarily due to an increase in our outstanding long-term debt balances and an increase in interest rates offset by effects of interest rate swap agreements. Our average gross long-term debt balance (including current maturities) for the quarter ended March 31, 2023 was $3,371.4 million at a weighted-average interest rate of 3.1%, as compared to $3,256.3 million at a weighted-average interest rate of 2.7% for the quarter ended April 1, 2022. The calculation of our weighted-average interest rates includes the effect of our interest rate swap agreements.

Loss on Debt Prepayment

We recorded loss on debt prepayment of $13.3 million during the quarter ended March 31, 2023. The loss is attributable to the unamortized debt discount and issuance costs written-off relating to the repayment of the Term Loan "B" Facility. See Note 6: ''Long-Term Debt'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

30

Other Income (Expense)

During the quarter ended March 31, 2023, Other income (expense) resulted in an income of $4.7 million compared to an income of $2.1 million during the quarter ended April 1, 2022. The increase was primarily due to a gain resulting from the termination of interest rate swaps partially offset by transaction losses resulting from fluctuations in foreign currencies.

Income Tax Provision

We recorded an income tax provision of $83.7 million and $97.1 million for the quarters ended March 31, 2023 and April 1, 2022, respectively, representing effective tax rates of 15.3% and 15.5%.

For additional information, see Note 12: ''Income Taxes'' in the notes to the unaudited consolidated financial statements included elsewhere in this Form 10-Q.

Liquidity and Capital Resources

Overview

Our principal sources of liquidity are cash on hand, cash generated from operations, available borrowings under our Revolving Credit Facility as well as debt and/or equity issuances. In the near term, we expect to fund our cash requirements (including any amounts required to satisfy our current portion of long-term debt) utilizing any or a combination of these principal sources. Our balance of cash and cash equivalents was $2.7 billion as of March 31, 2023, and the Revolving Credit Facility has approximately $1.6 billion available for future borrowings.

We require cash to: (i) fund our operating expenses, working capital requirements, outlays for strategic acquisitions and investments; (ii) service our debt, including principal and interest; (iii) conduct research and development; (iv) incur capital expenditures; and (v) repurchase our common stock.

During the ordinary course of business, we evaluate our cash requirements and, if necessary, adjust our expenditures to reflect the current market conditions and our projected sales and demand. Our capital expenditures are primarily directed towards manufacturing equipment and can materially influence our available cash for other initiatives. Future capital expenditures may be impacted by events and transactions that are not currently forecasted.

We believe that our cash on hand, cash generated from our operations and the Revolving Credit Facility are adequate to meet our working capital requirements and other business needs for at least the next 12 months.

Operating Activities

Our long-term cash generation is dependent on the ability of our operations to generate cash. Our cash flows from operating activities were $408.9 million and $478.6 million for the quarters ended March 31, 2023 and April 1, 2022, respectively. The decrease of $69.7 million was primarily attributable to a reduction in net income driven by lower end-market requirements for our products

Our ability to maintain positive operating cash flows is dependent on, among other factors, our success in achieving our revenue goals and manufacturing and operating cost targets. Management of our assets and liabilities, including both working capital and long-term assets and liabilities, also influences our operating cash flows.

Investing Activities

Our cash flows used in investing activities were $562.0 million and $129.4 million for the quarters ended March 31, 2023 and April 1, 2022, respectively. The increase of $432.6 million was primarily attributable to capital expenditures and the remaining payment of $236.3 million related to the acquisition of the EFK facility. During the quarters ended March 31, 2023 and April 1, 2022, we paid $321.5 million and $173.8 million, respectively, for capital expenditures. Our capital expenditures as a percent of revenue in the first quarter of 2023 increased to approximately 16%, primarily as a result of the SiC expansion and our facility expansion investments. As a result of these investments, for 2023, we expect capital expenditures to be approximately 18% to 20% of revenue.

31

Financing Activities

Our cash flows used in financing activities were $63.4 million and $57.3 million for the quarters ended March 31, 2023 and April 1, 2022, respectively. The increase of $6.1 million was primarily attributable to proceeds and payments related to long-term borrowings and share repurchase activity. Cash used in financing activities includes repayments of outstanding indebtedness under the Company’s Term Loan “B” Facility of $1.1 billion and $125.0 million under the Revolving Credit Facility. The Company also paid approximately $414 million for convertible note hedges and approximately $104.0 million for the repurchase of common stock, offset by $1.5 billion of proceeds from the private unregistered offering of our 0.50% Notes and $242.5 million of proceeds from the issuance of warrants.

See Note 6: ''Long-Term Debt'' and Note 7: ''Earnings Per Share and Equity'' in the notes to our unaudited consolidated financial statements included elsewhere in this Form 10-Q for additional information.

Key Factors Potentially Affecting Liquidity:

We believe that the key factors that could adversely affect our internal and external sources of cash include, among other considerations:

•Changes in demand for our products, competitive pricing pressures, supply chain constraints, effective management of our manufacturing capacity, our ability to achieve further reductions in operating expenses, our ability to make progress on the achievement of our business strategy and sustainability goals, the impact of our restructuring programs on our production and cost efficiency, and our ability to make the research and development expenditures required to remain competitive in our business; and

•The debt and equity capital markets could impact our ability to obtain needed financing on acceptable terms or to respond to business opportunities and developments as they arise, including interest rate fluctuations, macroeconomic conditions, sudden reductions in the general availability of lending from banks or the related increase in cost to obtain bank financing and our ability to maintain compliance with covenants under our debt agreements in effect from time to time.

Debt Guarantees and Related Covenants

As of March 31, 2023, we were in compliance with the indentures relating to our 0% Notes, 0.50% Notes, 3.875% Notes and 1.625% Notes, and with covenants relating to our Term Loan "B" Facility and Revolving Credit Facility. The 0% Notes, 0.50% Notes, 3.875% Notes and 1.625% Notes are senior to the existing and future subordinated indebtedness of onsemi and its guarantor subsidiaries, rank equally in right of payment to all of our existing and future senior debt and, as unsecured obligations, are subordinated to all of our existing and future secured debt to the extent of the assets securing such debt.

Recent Accounting Pronouncements

For a discussion of recent accounting pronouncements, see our Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 6, 2023.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

There have been no material changes in market risk from the information presented in Part II, Item 7A “Quantitative and Qualitative Disclosures About Market Risk,” in the 2022 Form 10-K.

Item 4.  Controls and Procedures

Evaluation of Disclosure Controls and Procedures

We carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Exchange Act). Based upon that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of the end of the period covered in this report, our disclosure controls and procedures were

32

effective to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the required time periods and is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

We also carried out an evaluation, under the supervision and with the participation of our management, including our Chief Executive Officer and Chief Financial Officer, of changes to our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) of the Exchange Act) that occurred during the fiscal quarter ended March 31, 2023.

There have been no changes to our internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) that occurred during the fiscal quarter ended March 31, 2023 which have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

33

PART II: OTHER INFORMATION

Item 1. Legal Proceedings

See Note 9: ''Commitments and Contingencies'' under the heading "Legal Matters" in the notes to the consolidated unaudited financial statements included elsewhere in this Form 10-Q for additional information on our legal proceedings and related matters. See also Part I, Item 1 "Business - Government Regulation" of the 2022 Form 10-K for information on certain environmental matters.

Item 1A. Risk Factors

Our business, financial condition and results of operations are subject to a number of trends, risks and uncertainties. We review and, where applicable, update our risk factors each quarter. There have been no material changes from the risk factors disclosed in Part I, Item 1A of the 2022 Form 10-K.

Forward-Looking Statements

This Quarterly Report on Form 10-Q includes "forward-looking statements," as that term is defined in Section 27A of the Securities Act and Section 21E of the Exchange Act. All statements, other than statements of historical facts, included or incorporated in this Form 10-Q could be deemed forward-looking statements, particularly statements about our plans, strategies and prospects under the heading "Management’s Discussion and Analysis of Financial Condition and Results of Operations." Forward-looking statements are often characterized by the use of words such as "believes," "estimates," "expects," "projects," "may," "will," "intends," "plans," "anticipates," "should" or similar expressions, or by discussions of strategy, plans or intentions. All forward-looking statements in this Form 10-Q are made based on our current expectations, forecasts, estimates and assumptions and involve risks, uncertainties and other factors that could cause results or events to differ materially from those expressed in the forward-looking statements.

Important factors that could cause our actual results to differ materially from those anticipated in the forward-looking statements are described under Part I, Item 1A "Risk Factors" in the 2022 Form 10-K, in this Form 10-Q and from time to time in our other SEC reports. Readers are cautioned not to place undue reliance on forward-looking statements. We assume no obligation to update such information, which speaks only as of the date made, except as may be required by law. Investing in our securities involves a high degree of risk and uncertainty, and you should carefully consider the trends, risks and uncertainties described in the aforementioned reports and subsequent reports filed with or furnished to the SEC before making any investment decision with respect to our securities. The risk factors described herein and in our 2022 Form 10-K are not all of the risks we may face. Other risks not presently known to us or that we currently believe are immaterial may materially affect our business. If any of the following trends, risks or uncertainties actually occurs or continues, our business, financial condition or operating results could be materially adversely affected, the trading prices of our securities could decline and you could lose all or part of your investment. All forward-looking statements attributable to us or persons acting on our behalf are expressly qualified in their entirety by this cautionary statement.

34

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table provides information regarding repurchases of our common stock during the quarter ended March 31, 2023:

Period (1)	Total Number of Shares Purchased	Average Price Paid per Share ($)	Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs	Approximate Dollar value of Shares that May Yet be Purchased Under the Plans or Programs (in millions) ($)
January 1, 2023 - January 27, 2023	—	—	—	3,000.0
January 28, 2023 - February 24, 2023	123,481	76.76	48,479	2,996.0
February 25, 2023 - March 31, 2023	1,293,768	78.46	1,275,672	2,896.0
Total	1,417,249	78.31	1,324,151

(1)    These time periods represent our fiscal month start and end dates for the first quarter of 2023.

Shares withheld to satisfy statutory tax withholding requirements related to the vesting of share-based awards are not issued or considered repurchases of our common stock under our Share Repurchase Program and, therefore, are excluded from the table above.

Share Repurchase Program

In February 2023, the Board of Directors approved a new share repurchase program (the “Share Repurchase Program”), which allows for the repurchase of our common stock from time to time in privately negotiated transactions or open market transactions, including pursuant to a trading plan in accordance with Rule 10b5-1 and Rule 10b-18 of the Exchange Act, or by any combination of such methods or other methods. The Share Repurchase Program, which does not require us to purchase any minimum amount of our common stock, has an aggregate limit of $3.0 billion from February 8, 2023 through December 31, 2025 (exclusive of fees, commissions and other expenses). Any repurchases will be at the Company’s discretion and will be subject to market conditions, the price of our shares and other factors. The share repurchase program may be modified, suspended or terminated by the Board of Directors at any time without prior notice.

There were 1.3 million shares of the Company's common stock repurchased under the Share Repurchase Program during the quarter ended March 31, 2023. As of March 31, 2023, the authorized amount remaining under the Share Repurchase Program was approximately $2.9 billion.

Item 3. Defaults Upon Senior Securities

None.

Item 4. Mine Safety Disclosures

Not applicable.

Item 5. Other Information

None.

35

Item 6. Exhibits

EXHIBIT INDEX

Exhibit No.		Exhibit Description*
	4.1	Indenture, dated as of February 28, 2023, among the Company, the guarantors party thereto and Computershare Trust Company, National Association (incorporated by reference to Exhibit 4.1 to the Company’s Current Report on Form 8-K dated March 1, 2023)
	4.2	Form of Global 0.50% Convertible Senior Note due 2029 (included in Exhibit 4.1)
	10.1	Form of Confirmation for Convertible Note Hedges (incorporated by reference to Exhibit 10.1 to the Company’s Current Report on Form 8-K/A dated March 2, 2023)
	10.2	Form of Confirmation for Warrants (incorporated by reference to Exhibit 10.2 to the Company’s Current Report on Form 8-K/A dated March 2, 2023)
	10.3	Form of Annual Performance-Based Restricted Stock Unit Award Agreement under the ON Semiconductor Corporation Amended and Restated Stock Incentive Plan (2023 form agreement)(1)(2)
	31.1	Certification by CEO pursuant to Rule 13(a)-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002(1).
	31.2	Certification by CFO pursuant to Rule 13(a)-14(a) or 15d-14(a) of the Securities Exchange Act of 1934, as adopted pursuant to Section 302 of Sarbanes-Oxley Act of 2002(1).
	32	Certification by CEO and CFO pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002(3).
	101.INS	XBRL Instance Document(1)
	101.SCH	XBRL Taxonomy Extension Schema Document(1)
	101.CAL	XBRL Taxonomy Extension Calculation Linkbase Document(1)
	101.DEF	XBRL Taxonomy Extension Definition Linkbase Document(1)
	101.LAB	XBRL Taxonomy Extension Label Linkbase Document(1)
	101.PRE	XBRL Taxonomy Extension Presentation Linkbase Document(1)
	104	Cover Page Interactive Data File - the cover page XBRL tags are embedded within the Inline XBRL document.

*	Reports filed under the Exchange Act (Form 10-K, Form 10-Q and Form 8-K) are filed under File No. 000-30419 and File No. 001-39317.
†	The Company has omitted certain schedules and exhibits pursuant to Item 601(b)(2) of Regulation S-K and, upon request by the Commission, agrees to furnish supplementally to the Commission a copy of any omitted schedule or exhibit.
(1)	Filed herewith.
(2)	Management contract or compensatory plan, contract or arrangement.
(3)	Furnished herewith.

36

SIGNATURES

Pursuant to the requirements of the Exchange Act, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

		ON SEMICONDUCTOR CORPORATION                       (Registrant)
Date:	May [XX], 2023	By:	/s/ THAD TRENT
			Thad Trent
			Executive Vice President, Chief Financial Officer and Treasurer
			(Principal Financial Officer and officer duly authorized to sign this report)
		By:	/s/ BERNARD R. COLPITTS, JR.
			Bernard R. Colpitts, Jr.
			Chief Accounting Officer
			(Principal Accounting Officer and officer duly authorized to sign this report)

37

EX-10.3

Exhibit 10.3

NOTICE OF GRANT OF PERFORMANCE-BASED RESTRICTED STOCK UNITS

Congratulations! You have been granted an Award of Performance-Based Restricted Stock Units (the “Units” or the “Award”) by onsemi under the Amended and Restated Stock Incentive Plan (as it may be amended and in effect from time to time, the “Plan”) as follows:

GRANTEE NAME:
EMPLOYEE ID:
TARGET NUMBER OF UNITS GRANTED:
The number of Units granted above represents the target number of Units that may be earned under this Award (the “Target Units”). Each Unit represents the right to receive one share of common stock of ON Semiconductor Corporation (the “Company” or “onsemi”), provided that you remained employed with the Company and its affiliates through the applicable vesting date below and subject to all the other terms and conditions of this Notice of Grant of Performance-Based Restricted Stock Units (this “Notice”), the performance-based restricted stock unit award agreement attached as Exhibit A (the “Award Agreement”), any other exhibits or appendices to this Notice or the Award Agreement, and the Plan (together, the “Award Documents”). Except as otherwise provided in the Award Documents, if your employment or service relationship terminates prior to the full vesting of your Award, any unvested Units will be forfeited automatically as of your date of termination. All capitalized terms used but not defined in this Notice have the meanings ascribed to them in the Plan or the Award Agreement. Additional terms of your Award are as follows:
GRANT NUMBER:
GRANT DATE:
VESTING DATES:	Tranche 1 of Earned Units – first business day after the later of: (1) filing of the 10-K for the fiscal year ended December 31, [YEAR 1] or (2) the First Determination Date (as defined below) Tranche 2 of Earned Units – first business day after the Second Determination Date (as defined below) Tranche 3 of Earned Units – first business day after the Third Determination Date (as defined below)
PERFORMANCE PERIOD:	January 1, [YEAR 1]-December 31, [YEAR 1]

PERFORMANCE CRITERIA:

The Performance Criteria applicable to your Award are detailed below. Definitions for capitalized terms not defined in the Award Documents or in the text below are included at the end of this section.

Payout on this Award may range between 0% (if performance does not exceed Threshold levels on any Goals in Step 1) and a maximum of [__]% of the Target Units (assuming we meet or exceed stretch levels on all Goals in Step 1 and the maximum TSR Adjustment is achieved for all three TSR Performance Periods in Step 2), subject to all other terms and conditions of the Award Documents.

Step 1 – Calculate Achievement on Financial and Strategic Goals1
Type	Goal	Weighting (% of Target Units)	Stretch Level (150% Financial/ 200% Strategic)	Target Level (100%)	Threshold Level (0%)
Financial
Financial
Strategic
Strategic
Step 1 Calculation Principles. The achievement of each Goal, measured over the Performance Period, will be calculated separately according to the chart above and as follows: •If the Target for the Goal is met, 100% of the related Target Units will be earned; •If our performance falls at or below Threshold, none of the related Target Units will be earned; •If our performance meets or exceeds the Stretch level, 150% (for Financial Goals) or 200% (for Strategic Goals) of the related Target Units will be earned; and •For performance between Threshold and Target or between Target and Stretch, the number of related Target Units earned will be determined by straight line linear interpolation. Following the end of the Performance Period, the Committee will review and certify our degree of achievement of each Goal as described under “Step 3 – Certification by Committee” below. Units calculated as earned under this Step 1 for each of the Goals will be divided into three equal tranches (“Tranches”). For Strategic Goals, the number of Units calculated as earned in each Tranche under this Step 1 will vest and settle in shares of Stock as described under “Vesting Dates” above. For Financial Goals, the Units calculated as earned in each of the three Tranches under this Step 1 (“Step 1 Financial Units”) will be subject to further adjustment under Step 2 before vesting and settlement occurs as described under “Vesting Dates” above.
Step 2 – TSR Adjustment to Step 1 Results for Financial Goals
Relative TSR			TSR Adjustment (applied to Step 1 Financial Units in that Tranche)
Equal to or greater than 75th percentile			150% (fixed)
Greater than 50th but less than 75th percentile			% determined by straight line linear interpolation
At least 25th but no greater than 50th percentile			100% (fixed)
Less than 25th percentile			50% (fixed)

1 The number and type of Goals may vary year to year but combined weighting will always equal 100%.

2

Step 2 Calculation for Financial Goals – TSR Adjustment on a Tranche-by-Tranche Basis. As a second step adjustment to the payout of any Units related to Financial Goals, each of the three Tranches of any Step 1 Financial Units will be further adjusted by our TSR relative to that of a defined group of peers for the one-, two- or three-year period beginning on January 1, [YEAR 1] and ending on the December 31 of the year immediately preceding the Vesting Date for that Tranche (each, a “TSR Adjustment”).

Specifically, for Tranche 1, the TSR Adjustment will be based on our Relative TSR over the Performance Period; for Tranche 2, the TSR Adjustment will be based on our Relative TSR from January 1, [YEAR 1] to December 31, [YEAR 2]; and for Tranche 3, the TSR Adjustment will be based on our Relative TSR from January 1, [YEAR 1] to December 31, [YEAR 3] (each, a “TSR Performance Period”).

As detailed in the table above, the TSR Adjustment is fixed percentage if our Relative TSR for a given TSR Performance Period is equal or greater than the 75th percentile (150%), less than the 25Th percentile (50%), or at least at the 25th percentile but no greater than the 50th percentile (100%). However, if our Relative TSR falls between the 50th and 75th percentile, the TSR Adjustment will be determined based on straight-line linear interpolation.

Once certified by the Committee as described below, the TSR Adjustment applicable to a given Tranche will be multiplied by number of Step 1 Financial Units in that Tranche, if any, to determine the number of Earned Units related to Financial Goals for that Tranche.

Step 3 – Certification by Committee

3

Prior to any payout under this Award, the Committee will certify the degree to which each performance criterion has been achieved, as follows (each, a “Determination”):

•for each Goal and the TSR Adjustment to any Step 1 Financial Units in Tranche 1, no later than the date on which the Company files its Annual Report on Form 10-K for fiscal [YEAR 1] with the SEC (the date on which such determination is made, the “First Determination Date”);

•for the TSR Adjustment to any Step 1 Financial Units in Tranche 2, no later than the date on which the Company files its Annual Report on Form 10-K for fiscal [YEAR 2] with the SEC (the date on which such determination is made, the “Second Determination Date”); and

•for the TSR Adjustment to any Step 1 Financial Units in Tranche 3, no later than the date on which the Company files its Annual Report on Form 10-K for fiscal [YEAR 3] with the SEC (the date on which such determination is made, the “Third Determination Date”).

If no Determination is required for either Tranche 2 or 3, the applicable Determination Date will be the date on which the Company files its Annual Report on Form 10-K for the last year in the TSR Performance Period for that Tranche.

Any Units that are not earned under the relevant Performance Criteria will be forfeited automatically as of the applicable Determination Date.

Definitions. For purposes of this Award, the following definitions apply:

[GOAL-SPECIFIC DEFINITIONS OMITTED]

“Relative TSR” means the Company’s Total Stockholder Return (“TSR”) as compared to the TSR of the group of companies listed on Exhibit B (the “TSR Companies”). For this purpose, TSR for the Company and the TSR Companies will be calculated by adding any dividends paid by the Company (or such other companies) to the change in value of the Stock (or the TSR Companies’ common stock) as between the Beginning Stock Price and Ending Stock Price for the relevant period. The “Beginning Stock Price” will be the average closing price of the Stock (or the common stock of the TSR Companies) for the fiscal quarter ending on the day immediately preceding the start of the applicable TSR Performance Period. The “Ending Stock Price” will be the average closing price of the Stock (or the common stock of the TSR Companies) for the fiscal quarter ending on the last day of the applicable TSR Performance Period, providedthat, in the event that a Change in Control is consummated prior to the end of one or more TSR Performance Periods: (a) following which the Stock is no longer listed for trading on NASDAQ or another U.S. national securities trading exchange and (b) in connection with which the fair value of a Share is determinable as of the effective time of such Change in Control, then the “Ending Stock Price” will be based on the value of a share of Stock under the applicable transaction agreement relating to such Change in Control.

“Earned Units” means (1) for Units associated with Strategic Goals, the number of Units earned based on performance under Step 1 and (2) for Units associated with Financial Goals, the Step 1 Financial Units as further adjusted under Step 2; in all cases, as certified by the Committee and subject to continued employment requirements and all other terms and conditions of the Award Documents.

You acknowledge and agree that this Notice (including the vesting schedule above) does not constitute an express or implied promise of continued engagement as an employee or consultant for the vesting period, for any other period or at all.

You will not receive any shares of common stock upon vesting unless and until the criteria set forth in this Notice and the Award Agreement, including satisfaction of all Tax Obligations, are satisfied. Please confirm your acceptance of this Award by signing below or, in the case of a Notice provided to you in electronic format, by following the instructions below:

[INSTRUCTIONS OMITTED]

By your acceptance of this Award:

•you acknowledge receiving and reviewing the Award Documents, including this Notice, the Award Agreement and the Plan, and related documentation;

4

•you agree that this Award is granted under, and governed by the terms and conditions, of the Award Documents, and you agree to be bound by all such terms and conditions;

•you agree to accept as binding, conclusive and final all decisions or interpretations of the Plan administrator or the administrator’s delegatee; and

•you consent to the collection, use and transfer, in electronic or other form, of your personal data as described in the Award Agreement for the purposes of implementing, administering and managing your participation in the Plan.

This Notice will be interpreted and administered under the laws of the State of Delaware (without giving effect to its conflict of laws principles) and upon acceptance will be deemed to have been executed and delivered as of the grant date shown above.

GRANTEE

Name:

ON SEMICONDUCTOR CORPORATION

By:     

Name:

Title:

5

EXHIBIT A

PERFORMANCE-BASED RESTRICTED STOCK UNIT AWARD AGREEMENT

1.Grant of Units.

1.1.ON Semiconductor Corporation, a Delaware corporation (the “Company”), hereby grants to the grantee (the “Grantee”) set forth in the Notice of Grant of Performance-Based Restricted Stock Units (the “Notice”) an award of performance-based restricted stock units (the “Units” or the “Award”), as set forth in the Notice and subject to the terms and conditions in this Performance-Based Restricted Stock Unit Award Agreement (this “Award Agreement”), the ON Semiconductor CorporationAmended and RestatedStock Incentive Plan (as it may be amendedand in effect from time to time, the “Plan”), and, if applicable, the Appendix described in Section 22 (collectively, the “Award Documents”). All capitalized terms used but not defined in this Award Agreement have the meaning set forth in the Plan unless a contrary meaning is set forth in the Grantee’s offer letter, employment agreement or comparable agreement with the Company or one of its Affiliates (as amended and in effect from time to time, the “Employment Agreement”).

1.2.The number of Units granted in the Notice represents the target number of Units that may ultimately be earned under this Award (the “Target Units”); as detailed in the Notice, the number of Units that are ultimately earned under this Award may vary from 0% to a maximum percentage of Target Units as stated in the Notice, depending upon the satisfaction of certain performance criteria as specified in the Notice (the “Performance Criteria”). Each Unit represents the right to receive one share of common stock of the Company (“Stock”), subject to Section 6, on the applicable Vesting Date (as defined below) if and to the extent that the vesting conditions of the Award Documents have been satisfied. Unless and until the Units vest, the Grantee will have no right to receive any shares of Stock (or any other payment or right) in connection with such Units. Prior to the actual distribution of shares of Stock in settlement of any vested Units, if applicable, this Award represents an unsecured obligation of the Company, payable (if at all) only from the general assets of the Company.

2.Company Obligations.

2.1    Subject to this Section 2 and Section 3, the vesting of Units on each scheduled vesting date set forth in the Notice (each, a “Vesting Date”) is subject to (a) satisfaction of the Performance Criteria, certified by the Committee as described in Section 2.2, and (b) the Grantee’s continuous service as an employee, consultant or other service provider from the grant date set forth in Notice (the “Grant Date”) to the applicable Vesting Date (the “Service Condition”). Employment or service for only a portion of the vesting period described in the prior sentence, even if a substantial portion, will not entitle the Grantee to any proportionate vesting or avoid or mitigate a termination of rights or benefits upon or following a termination of employment or services as stated in Section 3 or in the Plan.

2.2    The Notice specifies the Performance Criteria applicable to this Award, the period of time over which each Performance Criterion is measured (the “Performance Period”), and the methodology for determining how many Units may be earned. Following the end of each Performance Period, the Committee (or, for any Grantee who is not the CEO or another “senior executive” of the Company, as defined in the Committee’s charter, such other officers as may be specified in the Notice) will certify the results and determine the number of Units that vest. If the number of Units vesting based on actual performance is less than the Target Units, then the Units for which that Performance Criterion were not met will be cancelled and forfeited automatically upon such certification.

3.Termination of Employment or Services. Subject to the provisions of any Employment Agreement then in effect, if the Grantee’s employment or service relationship with the Company and its Affiliates terminates for any reason (regardless of who initiates the termination or whether the termination is with or without Cause), any unvested Units will be canceled and forfeited automatically as of the date of the Grantee’s termination of employment or service. In other words, unless otherwise provided in the Grantee’s Employment Agreement, the Grantee must be employed by, or performing services for, the Company on a given Vesting Date to receive any shares of Stock in settlement of the Units that are scheduled to vest on such date.

6

4.Time and Form of Payment. Subject to the provisions of the Award Documents, upon vesting, the Company will deliver to the Grantee the same number of whole shares of Stock as the number of vested Units, rounded to the nearest whole share, without payment for any fractional share. Subject to Section 20, the Company will deliver the Stock to the Grantee within 15 days after the applicable Vesting Date.

5.Nontransferability. Prior to vesting, the Units may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, either voluntarily or involuntarily, other than by will or by the laws of descent and distribution, except as otherwise provided under Article 12 of the Plan.

6.Adjustments. In the event of a stock dividend or in the event the Stock is changed into or exchanged for a different number or class of shares of stock of the Company or of another corporation, whether through reorganization, recapitalization, stock split-up, combination of shares, merger or consolidation or other similar corporate change, the Award will be adjusted by the Committee in its discretion in accordance with, and to the extent provided in, Section 5.3 of the Plan.

7.Delivery of Shares. No shares of Stock will be delivered under this Award Agreement until: (i) the Units vest in accordance with the terms and conditions of the Award Documents; (ii) approval of any governmental authority required in connection with this Award Agreement, or the issuance of shares of Stock thereunder, has been received by the Company; (iii) if required by the Committee, the Grantee has delivered to the Company documentation (in form and content acceptable to the Company in its sole and absolute discretion) to assist the Company in concluding that the issuance to the Grantee of any shares of Stock under this Award Agreement would not violate the Securities Act of 1933, as amended (the “Securities Act”), or any other applicable federal, state or local securities or other laws or regulations; (iv) the Grantee has complied with Section 13 below, in order for the proper provision for required tax withholdings to be made; and (v) the Grantee has executed and returned the Notice to the Company (which, in the case of an Notice provided to the Grantee in electronic format, requires that the Grantee click the “ACCEPT” or “SUBMIT” button). The Award must be accepted by the Grantee within 150 days following the Grant Date, unless otherwise determined by the Committee.

8.Securities Act. The Company will not be required to deliver any shares of Stock upon the vesting of Units if, in the opinion of counsel for the Company, such issuance would violate the Securities Act or any other applicable federal, state or local securities laws or regulations.

9.No Voting and Other Stockholder Rights. The Grantee will have no voting rights or any other rights as a stockholder of the Company (such as rights to any cash dividends or distributions) with respect to the Units before the Company issues shares of Stock to the Grantee in settlement of vested Units.

10.Delivery of Documents and Notices. Any document relating to participation in the Plan or any notice required or permitted under the Award Documents must be given in writing and will be deemed effectively given (except to the extent that this Award Agreement provides for effectiveness only upon actual receipt of such notice) upon personal delivery, electronic delivery at the e-mail address, if any, provided for the Grantee by the Company or an Affiliate, or upon deposit in the U.S. Post Office or foreign postal service, or with a nationally recognized overnight courier service, with postage and fees prepaid, addressed to the other party at the current address on file with the Company or at such other address as such party may designate in writing from time to time to the other party.

10.1    Description of Electronic Delivery. The Award Documents and all other documents related to participation in the Plan (which may include the Plan, the Notice, this Award Agreement, any prospectus delivered pursuant to the Plan or applicable law and any reports of the Company provided generally to the Company’s stockholders) may be delivered to the Grantee electronically. In addition, the Grantee may deliver electronically the Notice and this Award Agreement to the Company or to such third party involved in administering the Plan as the Company may designate from time to time. Such means of electronic delivery may include but do not necessarily include the delivery of a link to a Company intranet or the internet site of a third

7

party involved in administering the Plan, the delivery of the document via e-mail or such other means of electronic delivery specified by the Company.

10.2    Consent to Electronic Delivery. The Grantee acknowledges that the Grantee has read Section 10.1 and consents to the electronic delivery of the Plan documents as described in Section 10.1. The Grantee acknowledges that the Grantee may receive from the Company a paper copy of any documents delivered electronically at no cost to the Grantee by contacting the Company by telephone, in writing, or by email.

11.Administration. The Notice and this Award Agreement are subject to the terms and conditions of the Plan and will be administered by the Committeein accordance with the terms and provisions of the Plan in all respects. The Committee has the sole and complete discretion with respect to all matters reserved to it by the Plan and decisions of the Committee with respect to the Plan and this Award Agreement will be final and binding upon the Grantee and the Company. In the event of any conflict between the terms and conditions of this Award Agreement and the Plan, the provisions of the Plan will control.

12.Continuation of Employment or Services. This Award Agreement does not, and should not be construed to, confer upon the Grantee any right to continue employment with, or to provide services to, the Company and its Affiliates and does not limit the right of the Company, in its sole and absolute discretion, to terminate the Grantee’s employment or services at any time and for any reason.

13.Responsibility for Taxes and Withholdings.

13.1    Liability for Tax Obligations. The Grantee acknowledges that, regardless of any action the Company or the Grantee’s actual employer (the “Employer”) takes with respect to any or all income tax, social insurance, payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Grantee’s participation in the Plan and legally applicable to the Grantee (the “Tax Obligations”), the ultimate liability for all Tax Obligations is and remains the Grantee’s responsibility and may exceed the amount actually withheld by the Company or the Employer. The Grantee further acknowledges that the Company and/or the Employer: (i) make no representations or undertakings regarding the treatment of any Tax Obligations in connection with any aspect of the Award, including the grant of the Award, the vesting of Units, the conversion of the Units into shares of Stock or the receipt of an equivalent cash payment, the subsequent sale of any shares of Stock acquired at vesting and the receipt of any dividends and/or dividend equivalents; and (ii) do not commit to and are under no obligation to structure the terms of the Award or any aspect of the Units to reduce or eliminate the Grantee’s liability for Tax Obligations or achieve any particular tax result. Further, if the Grantee has become subject to tax in more than one jurisdiction between the Grant Date and the date of any relevant taxable event, the Grantee acknowledges that the Company and/or the Employer (or former employer, as applicable) may be required to withhold or account for Tax Obligations in more than one jurisdiction.

13.2    Satisfaction of Tax Obligations. Prior to any relevant taxable or tax-withholding event, as applicable, the Grantee must pay, or make adequate arrangements satisfactory to the Company and/or the Employer to satisfy, all Tax Obligations. In this regard, pursuant to Article 16 of the Plan, if permissible under local law and subject to any restrictions provided by the Committee prior to the vesting of the shares of Stock, the Grantee authorizes the Company or the Employer, or their respective agents, to withhold all applicable Tax Obligations in shares of Stock to be issued upon vesting and settlement of the Units. Alternatively, or in addition, subject to any restrictions provided by the Committee prior to the vesting of the shares of Stock, the Grantee authorizes the Company and/or the Employer, or their respective agents, to satisfy the obligations with regard to all Tax Obligations by one or a combination of the following: (i) withholding from the Grantee’s wages or other cash compensation paid to the Grantee by the Company and/or the Employer; (ii) withholding from proceeds of the sale of shares of Stock acquired upon vesting/settlement of the Units either through a voluntary sale or through a mandatory sale arranged by the Company (on the Grantee’s behalf pursuant to this authorization); (iii) personal check or other cash equivalent acceptable to the Company; or (iv) any other means as determined appropriate by the Company or the Committee.

13.3    Withholding Amounts. Depending on the withholding method, the Company may withhold or account for Tax Obligations by considering applicable minimum

8

statutory withholding amounts or such greater amounts not to exceed the maximum statutory rate necessary, in the applicable jurisdiction, to satisfy federal, state and local withholding tax requirements (but only if withholding at a rate greater than the minimum statutory rate will not result in adverse financial or accounting consequences for the Company). In the event that the Company withholds an amount for Tax Obligations that exceeds the maximum withholding amount under applicable law, the Grantee will receive a refund of such over-withheld amount in cash and will have no entitlement to an equivalent amount in Stock. If the obligation for Tax Obligations is satisfied by withholding a number of shares of Stock as described in Section 13.2, the Grantee will be deemed to have been issued the full number of shares of Stock subject to the Award, notwithstanding that a number of the shares of Stock are held back solely for the purpose of paying the Tax Obligations due as a result of the Grantee’s participation in the Plan.

13.4    Consequences of Failure to Satisfy Tax Obligations. Finally, the Grantee understands and agrees that the Grantee must pay to the Company or to the Employer any amount of Tax Obligations that cannot be satisfied by the means described in Section 13.2. The Company may refuse to issue or deliver shares of Stock or pay any other amounts due to the Grantee under the Award Documents if the Grantee fails to fully satisfy the Tax Obligations.

14.Amendments. The Notice and this Award Agreement may not be amended or modified so as to materially adversely affect the Grantee’s rights except (a) by a written agreement executed by the Company and the Grantee or (b) as otherwise provided in the Plan.

15.Integrated Agreement. The Award Documents constitute the entire understanding and agreement of the Grantee and the Company with respect to the Award and supersede any prior agreements, understandings, restrictions, representations or warranties between the Grantee and the Company with respect to such subject matter. To the extent contemplated in the Award Documents, the provisions of the Award Documents will survive any vesting and settlement of the Award and will remain in full force and effect.

16.Severability. If one or more of the provisions of the Notice and this Award Agreement is held to be invalid, illegal or unenforceable in any respect, the validity, legality and enforceability of the remaining provisions will not in any way be affected or impaired by such holding and the invalid, illegal or unenforceable provisions will be deemed null and void; however, to the extent permissible by law, any provisions that could be deemed null and void should first be construed, interpreted or revised retroactively to permit the Notice and this Award Agreement to be construed so as to foster the intent of the Award Documents.

17.Governing Law and Venue. The Award Documents will be interpreted and administered under the laws of the State of Delaware. For purposes of litigating any dispute that arises under the Award Documents, the parties hereby submit to and consent to the jurisdiction of the State of Arizona and agree that such litigation will be conducted in the courts of Maricopa County, Arizona, or the federal courts for the United States for the District of Arizona, where this grant is made and/or to be performed.

18.Grantee Representations. The Grantee represents that he or she has read and is familiar with the provisions of the Award Documents and accepts the Award subject to all such terms and conditions. The Notice and this Agreement will be deemed to have been accepted and signed by the Grantee and the Company as of the Grant Date upon the Grantee’s online acceptance or deemed acceptance as set forth in the Notice or otherwise agreed in writing by the Grantee.

19.Counterparts. The Notice and this Agreement may be executed (or, as provided in Section 18, accepted and signed) in counterparts, each of which will be deemed an original, but all of which together will constitute one and the same instrument.

20.Section 409A Compliance. The Company intends and believes, but does not and cannot warrant or guaranty, that the payments due pursuant to this Award comply with, or are exempt from, the requirements of Section 409A of the Code and each provision of the Award Documents will be interpreted, to the extent possible, consistent with that intent and belief. For any payments due pursuant to this Award that the Company determines must comply with Section 409A, (a) the provisions of Section 18.3 of the Plan will apply, including any payment delays that may be required to comply with Section 409A, and (b) each payment under these Award

9

Documents will be treated as a separate payment. As provided in the Plan, the Company reserves the right to amend the Award or the Award Documents to ensure any payments pursuant to this Award comply with, or are exempt from, Section 409A. Notwithstanding the foregoing, the Grantee remains solely responsible for any adverse tax consequences that may be imposed upon the Grantee by Section 409A and nothing in the Award Document provides a basis for any person to take any action against the Company or any of its Subsidiaries or affiliates based on matters covered by Section 409A, including the tax treatment of any amounts payable or paid under the Award Documents.

21.Confidentiality; Reaffirmation of Restrictive Covenants; Violation.

21.1    Confidentiality of Agreement. The Grantee acknowledges and agrees that the terms of this Award are considered proprietary information of the Company. The Grantee agrees to maintain the confidentiality of these matters to the fullest extent permitted by law and not to disclose them to any third party other than the Grantee’s spouse or legal, financial or tax advisors provided, in each case, that the recipient agrees to maintain confidentiality as required by this Section 21.1.

21.2    Exceptions. There are limited exceptions to the above confidentiality requirement if the Grantee is providing information to government agencies, including but not limited to the Equal Employment Opportunity Commission, the National Labor Relations Board, the Occupational Safety and Health Administration (or its state equivalent) and the Securities and Exchange Commission. The Award Documents do not limit the Grantee’s ability to communicate with any government agencies regarding matters within their jurisdiction or otherwise participate in any investigation or proceeding that may be conducted by any government agency, including providing documents or other information, without notice, to the government agencies. Nothing in this Award Agreement will prevent the Grantee from disclosing confidential information or trade secrets that: (i) is made: (A) in confidence to a federal, state or local government official, either directly or indirectly, or to an attorney; and (B) solely for the purpose of reporting or investigating a suspected violation of law; or (ii) is made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. In the event that the Grantee files a lawsuit alleging retaliation by the Company for reporting a suspected violation of law, the Grantee may disclose confidential information or trade secrets related to the suspected violation of law or alleged retaliation to the Grantee’s attorney and use the confidential information or trade secrets in the court proceeding if the Grantee or the Grantee’s attorney: (x) files any document containing confidential information or trade secrets under seal; and (y) does not disclose the confidential information or trade secrets, except pursuant to court order. The Company provides this notice in compliance with applicable law including, among others, the Defend Trade Secrets Act of 2016.

21.3    Reaffirmation of Restrictive Covenants. By accepting this Award, the Grantee reaffirms the Grantee’s obligation to comply with any confidentiality, non-competition, non-solicitation, non-disclosure, confidential information and similar restrictive covenant provisions set forth in the Grantee’s Employment Agreement or any other agreement to which the Grantee and the Company or any Affiliate are parties (such provisions, the “Restrictive Covenants”).

21.4    Violation. If the Grantee violates the confidentiality provisions of this Section 21 or any Restrictive Covenants, the Company, without waiving any other remedy available, may revoke this Award without further obligation or liability, and the Grantee may be subject to disciplinary action, up to and including the Company’s termination of the Grantee’s employment or service relationship.

22.Appendix. Notwithstanding any provisions in the Award Documents, the grant of the Units will be subject to any special terms and conditions set forth in any appendix (or any appendices) to this Award Agreement for the Grantee’s country (the “Appendix”). Moreover, if the Grantee relocates to one of the countries included in the Appendix, the special terms and conditions for such country will apply to the Grantee, to the extent the Company determines that the application of such terms and conditions is necessary or advisable in order to comply with local law or facilitate the administration of the Plan. The Appendix constitutes part of this Award Agreement.

10

23.    Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Grantee’s participation in the Plan, on the Units and on any shares of Stock acquired under the Plan, to the extent the Company determines it is necessary or advisable in order to comply with local law or facilitate the administration of the Plan, and to require the Grantee to sign any additional agreements or undertakings that may be necessary to accomplish the foregoing. Further, the Award, any Shares issued in settlement of vested Units and any other amounts realized under the Award Documents are subject to the Company’s compensation recovery policy or policies (and related Company practices) as in effect from time to time, regardless of whether such policies were adopted in response to Section 954 of the Dodd-Frank Wall Street Reform and Consumer Protection Act, as amended, and similar or related laws, rules and regulations. In addition to the Company’s compensation recovery policy or policies, and notwithstanding anything in the Plan or any Employment Agreement to the contrary, the Company may require the Grantee to forfeit all or a portion of any unvested Units, any shares of Stock delivered pursuant to, and any other amounts realized under, the Award Documents if: (i) the Grantee’s employment is terminated for Cause; or (ii) the Committee, in its sole and absolute discretion, determines that the Grantee engaged in serious misconduct that results or might reasonably be expected to result in financial or reputational harm to the Company. The Grantee agrees to fully cooperate with the Company in assuring compliance with the provisions of this Section 23 and such compensation recovery policies and the provisions of applicable law, including, but not limited to, promptly returning any compensation subject to recovery by the Company pursuant to the provisions of this Section 23, such policies and applicable law.

24.    Data Privacy.The Grantee hereby explicitly and unambiguously consents to the collection, use and transfer, in electronic or other form, of the Grantee's personal data as described in this Award Agreement by and among, as applicable, the Employer and the Company and its Affiliates for the exclusive purpose of implementing, administering and managing the Grantee's participation in the Plan. The Grantee understands that the Company and the Employer may hold certain personal information about the Grantee, including, but not limited to, the Grantee's name, home address and telephone number, date of birth, social insurance number, passport number, or other identification number, salary, nationality, job title, any shares of stock or directorships held in the Company, details of all Units or any other entitlement to shares awarded, canceled, vested, unvested or outstanding in the Grantee’s favor, for the purpose of implementing, administering and managing the Plan (“Data”).

The Grantee understands that Data may be transferred to such stock plan service provider (or providers) as may be selected by the Company which is (or are) assisting in the implementation, administration and management of the Plan and awards granted under it. The Grantee understands that these recipients of Data may be located in the United States, or elsewhere, and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Grantee’s country. The Grantee understands that the Grantee may request a list with the names and addresses of any potential recipients of the Data by contacting the Grantee's local human resources representative. The Grantee hereby authorizes the Company and any other possible recipients which may assist the Company (presently or in the future) with implementing, administering and managing the Plan and awards granted thereunder to receive, possess, use, retain and transfer the Data, in electronic or other form, for the sole purpose of implementing, administering and managing the Grantee's participation in the Plan.

11

The Grantee understands that Data will be held only as long as is necessary to implement, administer and manage the Grantee’s participation in the Plan. The Grantee understands that the Grantee may, at any time, view Data, request additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents given in this Section 24, in any case without cost, by contacting the Grantee's local human resources representative in writing. The Grantee understands, however, that refusing or withdrawing such consent may affect the Grantee’s ability to participate in the Plan and the Grantee’s continued eligibility for this Award or eligibility to be granted any other awards under the Plan. For more information on the consequences of the Grantee’s refusal to consent or withdrawal of consent, the Grantee understands that the Grantee may contact the local human resources representative.

12

Exhibit B
TSR Companies and Calculation Principles

1.Ambarella Inc.

1.ams AG

1.Analog Devices, Inc.

1.Broadcom Inc.

1.Cirrus Logic, Inc.

1.Diodes Incorporated

1.Infineon Technologies AG

1.Knowles Corporation

1.Lattice Semiconductor Corporation

1.Littelfuse, Inc.

1.Macom Technology Solutions Holdings, Inc.

1.Marvell Technology, Inc.

1.Maxlinear Inc.

1.Melexis N.V.

1.Microchip Technology Incorporated

1.MKS Instruments, Inc.

1.Monolithic Power Systems, Inc.

1.Murata Manufacturing Co., Ltd.

1.National Instruments Corporation

1.NXP Semiconductors N.V.

1.Parade Technologies Ltd

1.Power Integrations, Inc.

1.Qorvo, Inc.

1.Realtek Semiconductor Corp.

1.Renesas Electronics Corp.

1.Rohm Co. Ltd.

1.Semtech Corporation

1.Sensata Technologies Holdings PLC

1.Silicon Laboratories Inc.

1.Skyworks Solutions, Inc.

1.STMicroelectronics N.V.

1.Synaptics Incorporated

1.Texas Instruments Incorporated

1.Vishay Intertechnology, Inc.

1.Wolfspeed, Inc.

13

Unless determined otherwise by the Committee, any company the shares of which are not readily tradable on a national securities market as of the last day of the applicable TSR Performance Period shall be deemed removed from the foregoing list for purposes of that TSR Performance Period.

14

EX-31.1

Exhibit 31.1

CERTIFICATIONS

I, Hassane El-Khoury, certify that:

1.I have reviewed this quarterly report on Form 10-Q of ON Semiconductor Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 1, 2023	/s/ HASSANE EL-KHOURY
	Hassane El-Khoury
	Chief Executive Officer

EX-31.2

Exhibit 31.2

CERTIFICATIONS

I, Thad Trent, certify that:

1.I have reviewed this quarterly report on Form 10-Q of ON Semiconductor Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a)    Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b)    Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c)    Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d)    Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a)    All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b)    Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 1, 2023	/s/ THAD TRENT
	Thad Trent
	Chief Financial Officer

EX-32

Exhibit 32

Certification

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906

of the Sarbanes-Oxley Act of 2002

For purposes of Section 1350 of Chapter 63 of Title 18 of the United States Code, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of ON Semiconductor Corporation, a Delaware corporation (the “Company”), does hereby certify, to such officer’s knowledge, that:

The Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2023 (the “Form 10-Q”) of the Company fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) and information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: May 1, 2023	/s/ HASSANE EL-KHOURY
	Hassane El-Khoury
	President and Chief Executive Officer

Dated: May 1, 2023	/s/ THAD TRENT
	Thad Trent
	Executive Vice President,
	Chief Financial Officer and Treasurer

XML

Cover Page - shares	3 Months Ended
	Mar. 31, 2023	Apr. 26, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2023
Document Transition Report	false
Entity File Number	001-39317
Entity Registrant Name	ON SEMICONDUCTOR CORPORATION
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	36-3840979
Entity Address, Address Line One	5701 N. Pima Road
Entity Address, City or Town	Scottsdale
Entity Address, State or Province	AZ
Entity Address, Postal Zip Code	85250
City Area Code	602
Local Phone Number	244-6600
Title of 12(b) Security	Common Stock, par value $0.01 per share
Trading Symbol	ON
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		431,872,829
Entity Central Index Key	0001097864
Current Fiscal Year End	--12-31
Document Fiscal Period Focus	Q1
Document Fiscal Year Focus	2023
Amendment Flag	false

XML

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Assets
Cash and cash equivalents	$ 2,702.4	$ 2,919.0
Receivables, net	880.9	842.3
Inventories	1,814.9	1,616.8
Other current assets	318.1	351.3
Total current assets	5,716.3	5,729.4
Property, plant and equipment, net	3,692.9	3,450.7
Goodwill	1,577.6	1,577.6
Intangible assets, net	339.8	359.7
Deferred tax assets	473.1	376.7
Right-of-use financing lease	45.2	45.8
Other assets	429.4	438.6
Total assets	12,274.3	11,978.5
Liabilities and Stockholders’ Equity
Accounts payable	976.2	852.1
Accrued expenses and other current liabilities	666.0	1,047.3
Current portion of financing lease liabilities	11.6	14.2
Current portion of long-term debt	926.2	147.8
Total current liabilities	2,580.0	2,061.4
Long-term debt	2,538.0	3,045.7
Deferred tax liabilities	36.6	34.1
Long-term financing lease liabilities	24.0	23.0
Other long-term liabilities	628.7	607.3
Total liabilities	5,807.3	5,771.5
Commitments and contingencies
ON Semiconductor Corporation stockholders’ equity:
Common stock ($0.01 par value, 1,250,000,000 shares authorized, 610,278,043 and 608,367,713 issued, 431,851,090 and 431,936,415 outstanding, respectively)	6.1	6.1
Additional paid-in capital	4,633.6	4,670.9
Accumulated other comprehensive loss	(29.6)	(23.2)
Accumulated earnings	4,826.1	4,364.4
Less: Treasury stock, at cost: 178,426,953 and 176,431,298 shares, respectively	(2,988.2)	(2,829.7)
Total ON Semiconductor Corporation stockholders’ equity	6,448.0	6,188.5
Non-controlling interest	19.0	18.5
Total stockholders’ equity	6,467.0	6,207.0
Total liabilities and stockholders’ equity	$ 12,274.3	$ 11,978.5

XML

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Mar. 31, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	1,250,000,000	1,250,000,000
Common stock, shares issued (in shares)	610,278,043	608,367,713
Common stock, shares outstanding (in shares)	431,851,090	431,936,415
Treasury stock, shares (in shares)	178,426,953	176,431,298

XML

CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Income Statement [Abstract]
Revenue	$ 1,959.7	$ 1,945.0
Cost of revenue	1,042.2	983.7
Gross profit	917.5	961.3
Operating expenses:
Research and development	138.4	156.8
Selling and marketing	71.8	71.1
General and administrative	75.9	77.9
Amortization of acquisition-related intangible assets	15.0	21.3
Restructuring, asset impairments and other charges, net	51.5	(13.0)
Total operating expenses	352.6	314.1
Operating income	564.9	647.2
Other income (expense), net:
Interest expense	(26.4)	(21.6)
Interest income	17.1	0.4
Loss on debt prepayment	(13.3)	0.0
Loss on divestiture of business	(1.1)	0.0
Other income	4.7	2.1
Other income (expense), net	(19.0)	(19.1)
Income before income taxes	545.9	628.1
Income tax provision	(83.7)	(97.1)
Net income	462.2	531.0
Less: Net income attributable to non-controlling interest	(0.5)	(0.8)
Net income attributable to ON Semiconductor Corporation	461.7	530.2
Net income for diluted earnings per share of common stock	$ 462.1	$ 530.7
Net income per share of common stock attributable to ON Semiconductor Corporation:
Basic (in dollars per share)	$ 1.07	$ 1.22
Diluted (in dollars per share)	$ 1.03	$ 1.18
Weighted-average shares of common stock outstanding:
Basic (in shares)	431.9	433.3
Diluted (in shares)	448.5	448.9
Comprehensive income (loss), net of tax:
Net income	$ 462.2	$ 531.0
Foreign currency translation adjustments	0.3	(2.4)
Effects of cash flow hedges and other adjustments	(6.7)	16.6
Other comprehensive income (loss), net of tax	(6.4)	14.2
Comprehensive income	455.8	545.2
Comprehensive income attributable to non-controlling interest	(0.5)	(0.8)
Comprehensive income attributable to ON Semiconductor Corporation	$ 455.3	$ 544.4

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($) $ in Millions	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Additional Paid-in Capital	Additional Paid-in Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Loss	Accumulated Earnings	Accumulated Earnings Cumulative Effect, Period of Adoption, Adjustment	Treasury Stock	Non-Controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock ending balance (in shares)									(170,571,261)
Beginning Balance (in shares) at Dec. 31, 2021			603,044,079
Treasury stock beginning balance (in shares) at Dec. 31, 2021									(170,571,261)
Balance, beginning at Dec. 31, 2021	$ 4,604.4	$ (102.0)	$ 6.0	$ 4,633.3	$ (129.1)	$ (40.6)	$ 2,435.1	$ 27.1	$ (2,448.4)	$ 19.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to the ESPP (in shares)			126,388
Shares issued pursuant to the ESPP	6.7			6.7
RSUs and stock grant awards issued (in shares)			2,851,188
RSUs released and stock grant awards issued	0.0		$ 0.1	(0.1)
Payment of tax withholding for RSUs (in shares)									(955,641)
Payment of tax withholding for RSUs	(58.8)								$ (58.8)
Share-based compensation	22.5			22.5
Comprehensive income (loss)	545.2					14.2	530.2			0.8
Ending Balance (in shares) at Apr. 01, 2022			606,021,655
Balance, ending at Apr. 01, 2022	$ 5,018.0		$ 6.1	4,533.3		(26.4)	2,992.4		$ (2,507.2)	19.8
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock ending balance (in shares)									(171,526,902)
Treasury stock ending balance (in shares)	176,431,298								(176,431,298)
Beginning Balance (in shares) at Dec. 31, 2022	431,936,415		608,367,713
Treasury stock beginning balance (in shares) at Dec. 31, 2022	176,431,298								(176,431,298)
Balance, beginning at Dec. 31, 2022	$ 6,207.0		$ 6.1	4,670.9		(23.2)	4,364.4		$ (2,829.7)	18.5
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Shares issued pursuant to the ESPP (in shares)			136,856
Shares issued pursuant to the ESPP	7.3			7.3
RSUs and stock grant awards issued (in shares)			1,680,376
RSUs released and stock grant awards issued	0.0		$ 0.0	0.0
Partial settlement - 1.625% Notes (in shares)			93,098
Partial settlement - 1.625% Notes	0.0		$ 0.0	0.0
Partial settlement of bond hedges - 1.625% Notes (in shares)									(93,098)
Partial settlement of bond hedges - 1.625% Notes	0.0			6.9					$ (6.9)
Warrants and bond hedges, net - 0% Notes	(171.5)			(171.5)
Tax impact of convertible notes, warrants and bond hedges, net	92.3			92.3
Payment of tax withholding for RSUs (in shares)									(578,406)
Payment of tax withholding for RSUs	(47.6)								$ (47.6)
Share-based compensation	27.7			27.7
Repurchase of common stock (in shares)									(1,324,151)
Repurchase of common stock	(104.0)								$ (104.0)
Comprehensive income (loss)	$ 455.8					(6.4)	461.7			0.5
Ending Balance (in shares) at Mar. 31, 2023	431,851,090		610,278,043
Balance, ending at Mar. 31, 2023	$ 6,467.0		$ 6.1	$ 4,633.6		$ (29.6)	$ 4,826.1		$ (2,988.2)	$ 19.0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Treasury stock ending balance (in shares)	178,426,953								(178,426,953)

XML

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Parenthetical) - Convertible Debt	Mar. 31, 2023	Feb. 28, 2023	Dec. 31, 2022
1.625% Notes
Debt instrument, interest rate	1.625%		1.625%
0.50% Notes
Debt instrument, interest rate	0.50%	0.50%	0.50%

XML

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Cash flows from operating activities:
Net income	$ 462.2	$ 531.0
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	145.0	140.6
Loss (gain) on sale or disposal of fixed assets	1.2	(16.6)
Loss on divestiture of business	1.1	0.0
Loss on debt prepayment	13.3	0.0
Amortization of debt discount and issuance costs	2.9	3.2
Share-based compensation	27.7	22.5
Non-cash asset impairment charges	12.7	6.7
Change in deferred tax balances	(1.5)	38.3
Other	(7.0)	0.5
Changes in assets and liabilities (exclusive of divestitures):
Receivables	(37.7)	(107.2)
Inventories	(198.1)	(116.7)
Other assets	54.8	(0.8)
Accounts payable	53.5	35.7
Accrued expenses and other current liabilities	(154.6)	(83.2)
Other long-term liabilities	33.4	24.6
Net cash provided by operating activities	408.9	478.6
Cash flows from investing activities:
Purchase of property, plant and equipment	(321.5)	(173.8)
Proceeds from sale of property, plant and equipment	1.7	36.7
Deposits utilized (made) for purchase of property, plant and equipment	(16.7)	1.6
Divestiture of business, net of cash transferred and deposits received	0.0	12.9
Purchase of available-for-sale securities	0.0	(7.8)
Proceeds from sale or maturity of available-for-sale securities	10.8	3.4
Payments related to acquisition of business, net of cash acquired	(236.3)	(2.4)
Net cash used in investing activities	(562.0)	(129.4)
Cash flows from financing activities:
Proceeds for the issuance of common stock under the ESPP	7.3	7.8
Payment of tax withholding for RSUs	(47.6)	(58.8)
Repurchase of common stock	(104.0)	0.0
Issuance and borrowings under debt agreements	1,470.0	0.0
Reimbursement of debt issuance and other financing costs	4.5	0.0
Payment of debt issuance and other financing costs	(4.8)	0.0
Repayment of borrowings under debt agreements	(1,213.7)	(4.1)
Payment for purchase of bond hedges	(414.0)	0.0
Proceeds from issuance of warrants	242.5	0.0
Payment of financing lease obligations	(3.6)	0.0
Dividend to non-controlling shareholder	0.0	(2.2)
Net cash used in financing activities	(63.4)	(57.3)
Effect of exchange rate changes on cash, cash equivalents and restricted cash	0.1	(0.7)
Net (decrease) increase in cash, cash equivalents and restricted cash	(216.4)	291.2
Cash, cash equivalents and restricted cash, beginning of period	2,933.0	1,377.7
Cash, cash equivalents and restricted cash, end of period	$ 2,716.6	$ 1,668.9

XML

Background and Basis of Presentation

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Background and Basis of Presentation

Note 1: Background and Basis of Presentation

ON Semiconductor Corporation (“onsemi,” “we,” “us,” “our,” or the “Company”), with its wholly and majority-owned subsidiaries, operates under the onsemiTM brand.

The Company is organized into three operating and reportable segments: the Power Solutions Group ("PSG"), the Advanced Solutions Group ("ASG"), and the Intelligent Sensing Group ("ISG").

The Company's fiscal calendar year begins on January 1 and ends on December 31. The fiscal quarters contain a thirteen-week accounting period. Minor day adjustments are required in the first and fourth quarters to account for the Company's fiscal calendar year's starting and ending dates. The quarters ended March 31, 2023 and April 1, 2022 contained 90 days and 91 days, respectively.

The accompanying unaudited financial statements as of and for the quarter ended March 31, 2023 have been prepared following generally accepted accounting principles in the United States of America ("GAAP") for interim financial reporting and the rules and regulations of the SEC for interim reporting. Accordingly, the unaudited financial statements do not include all of the information and footnotes required by GAAP for audited financial statements. The balance sheet as of December 31, 2022 was derived from the Company's audited financial statements but does not include all disclosures required by GAAP for annual financial statements. In the opinion of the Company's management, the interim information contains all adjustments, which include normal recurring adjustments necessary for a fair statement of the results for the interim periods. The footnote disclosures related to the interim financial information contained herein are also unaudited. Such financial information should be read in conjunction with the consolidated financial statements and related notes thereto for the year ended December 31, 2022, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022, which was filed with the SEC on February 6, 2023 (the "2022 Form 10-K").

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances. Significant estimates have been used by management in conjunction with the following: (i) future payouts for customer incentives and amounts subject to allowances and returns; (ii) valuation and obsolescence relating to inventories; (iii) measurement of valuation allowances against deferred tax assets and evaluations of uncertain tax positions and (iv) testing for impairment of long-lived assets and goodwill. Additionally, during periods where it becomes applicable, significant estimates will be used by management in determining the future cash flows used in connection with business combinations. Actual results may differ from the estimates and assumptions used in the consolidated financial statements.

XML

Revenue and Segment Information

3 Months Ended

Apr. 01, 2022

Segment Reporting [Abstract]

Revenue and Segment Information

Note 2: Revenue and Segment Information

The Company is organized into three operating and reportable segments consisting of PSG, ASG and ISG. These segments represent the Company's view of the business, and its gross profit is used to evaluate the performance of the Company's segments, the progress of major initiatives and the allocation of resources.

A significant portion of the Company’s orders are firm commitments that are non-cancellable, including certain orders or contracts with a duration of less than one year. Certain of the Company's customer contracts are multi-year agreements that include committed amounts ("Long-term Supply Agreements" or "LTSA's").

The estimated remaining performance obligations as of March 31, 2023, are approximately $17.6 billion (excluding the remaining performance obligations for contracts having an original duration of one year or less). This amount is subject to contractual increases based on negotiated contract prices and volumes, defined product mix flexibility, and the timing of new part introductions, among other contractual provisions. The Company expects to recognize approximately 33% of the remaining purchase obligation as revenue during the next twelve months upon shipment of products under these contracts. Total revenue estimates could be influenced by risks and uncertainties including manufacturing or supply chain constraints, modifications to customer agreements, and regulatory changes, among other factors. Accordingly, our actual revenue recognized for the remaining performance obligation in future periods may fluctuate from estimates.

Certain of the Company’s LTSA’s include non-cancellable capacity payments from the customer, which are generally due within 30 days of the agreement. These payments reserve production availability or are prepayments to secure production availability and are not recognized as revenue until the performance obligations are satisfied. For the periods ending March 31, 2023, and April 1, 2022, the Company recognized revenue of $14.8 million and $4.5 million, respectively, for the portion of performance obligations fulfilled during those periods.

As of March 31, 2023, and December 31, 2022, the remaining capacity payments were $225.5 million and $190.4 million, respectively, of which $69.0 million and $60.5 million were recorded as current liabilities, with the remainder recorded as other long-term liabilities.

Revenue and gross profit for the Company’s operating and reportable segments are as follows (in millions):

	PSG		ASG		ISG		Total
For the quarter ended March 31, 2023:
Revenue from external customers	$	1,012.8	$	592.8	$	354.1	$	1,959.7
Gross profit	$	480.3	$	260.1	$	177.1	$	917.5
For the quarter ended April 1, 2022:
Revenue from external customers	$	986.7	$	689.3	$	269.0	$	1,945.0
Gross profit	$	474.7	$	366.7	$	119.9	$	961.3

The Company had one customer, a distributor, whose revenue accounted for approximately 10.1% and 12.4% of the Company's total revenue for the quarters ended March 31, 2023 and April 1, 2022, respectively.

Revenue for the Company's operating and reportable segments disaggregated into geographic locations based on sales billed from the respective country and sales channels are as follows (in millions):

	Quarter Ended March 31, 2023
	PSG		ASG		ISG		Total
Geographic Location
Hong Kong	$	286.9	$	139.7	$	63.8	490.4
Singapore	276.4		116.1		58.2		450.7
United Kingdom	204.1		128.1		81.1		413.3
United States	166.3		121.3		101.5		389.1
Other	79.1		87.6		49.5		216.2
Total	$	1,012.8	$	592.8	$	354.1	$	1,959.7
Sales Channel
Distributors	$	629.3	$	222.8	$	187.1	$	1,039.2
Direct Customers	383.5		370.0		167.0		920.5
Total	$	1,012.8	$	592.8	$	354.1	$	1,959.7

	Quarter Ended April 1, 2022
	PSG		ASG		ISG		Total
Geographic Location
Singapore	$	280.5	$	233.8	$	41.4	$	555.7
Hong Kong	303.1		173.9		52.6		529.6
United Kingdom	186.9		106.6		52.0		345.5
United States	144.9		92.3		74.5		311.7
Other	71.3		82.7		48.5		202.5
Total	$	986.7	$	689.3	$	269.0	$	1,945.0
Sales Channel
Distributors	$	633.9	$	356.9	$	150.6	$	1,141.4
Direct Customers	352.8		332.4		118.4		803.6
Total	$	986.7	$	689.3	$	269.0	$	1,945.0

The Company operates in various geographic locations. Sales to external customers have little correlation with the location of the Company's manufacturing or the location of the end-customers. It is, therefore, not meaningful to present operating profit by geographical location. The Company does not discretely allocate assets to its operating segments, nor does management evaluate operating segments using discrete asset information. The Company’s consolidated assets are not specifically ascribed to its individual reportable segments. Instead, assets used in operations are generally shared across the Company’s operating and reportable segments.

Property, plant and equipment, net by geographic location, is summarized as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
United States	$	1,360.8	$	1,329.2
South Korea	990.9		871.0
Czech Republic	335.3		279.3
Philippines	287.1		296.8
China	227.4		215.3
Malaysia	199.0		190.2
Japan	128.1		133.2
Other	164.3		135.7
Total	$	3,692.9	$	3,450.7

XML

Acquisition and Divestitures

3 Months Ended

Mar. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Acquisition and Divestitures

Note 3: Acquisition and Divestitures

Acquisition:

During the year ended December 31, 2022, the Company closed the acquisition of EFK. The preliminary allocation of the purchase price of EFK to the assets acquired and liabilities assumed based on their relative fair values is as follows (in millions):

	Purchase Price Allocation
Inventory	$	3.3
Other current assets	4.4
Property, plant and equipment	396.5
Other non-current assets	11.4
Total assets acquired	415.6
Current liabilities	3.0
Other long-term liabilities	6.3
Total liabilities assumed	9.3
Net assets acquired/purchase price	$	406.3

The preliminary allocation, assumptions and disclosures are materially consistent with the amounts included in the 2022 Form 10-K.

The Company paid the remaining acquisition consideration of $236.3 million on January 3, 2023, which is disclosed under investing activities in the Consolidated statement of cash flows.

XML

Restructuring, Asset Impairments and Other, Net

3 Months Ended

Mar. 31, 2023

Restructuring Charges [Abstract]

Restructuring, Asset Impairments and Other, Net

Note 4: Restructuring, Asset Impairments and Other, Net

Details of restructuring, asset impairments and other charges, net are as follows (in millions):        

	Restructuring		Asset Impairments			Other		Total
Quarter ended March 31, 2023
2023 Business Realignment	$	36.1	$	2.5	(1)	$	2.8	$	41.4
QCS wind down	—		—			(2.3)		(2.3)
Other	—		10.2		(2)	2.2		12.4
Total	$	36.1	$	12.7		$	2.7	$	51.5

(1)Includes $1.7 million property, plant and equipment asset impairments charges and $0.8 million of ROU asset impairment charges associated with the 2023 Business Realignment efforts.

(2)Includes $10.2 million of property, plant and equipment and ROU lease asset impairment charges associated with site consolidation efforts in the United States.

A summary of changes in accrued restructuring balance is as follows (in millions):

	As of						As of
	December 31, 2022		Charges		Usage		March 31, 2023
Employee separation charges	$	4.4	$	36.1	$	(4.9)	$	35.6
Total	$	4.4	$	36.1	$	(4.9)	$	35.6

2023 Business Realignment

During the first quarter of 2023, the Company announced the elimination of approximately 400 jobs in an effort to realign its operating models, drive organizational effectiveness and efficiencies, and increase collaboration primarily within its ASG business unit and IT support organizations. As a result, ASG ceased its design and test operations in certain Asia and U.S.-based locations and initiated a plan to exit its Toulouse, France design center location. The announcement also included changes in the Company's IT operating model by transferring selected IT functions to strategic service providers.

In connection with these actions, the Company recognized severance costs, related benefit expenses and other ancillary charges of $36.1 million and expects to record an additional $1.5 million during the remainder of 2023. The Company paid approximately $2.5 million of the aggregate expense and had $33.6 million accrued as of March 31, 2023, which is expected to be paid during the remainder of 2023. As of March 31, 2023, 137 employees have been terminated.

The Company continues to evaluate employee positions and locations for potential operating improvements and efficiencies, and may incur additional severance and related charges in the future.

QCS wind down

On September 16, 2022, the Company's Board of Directors approved an exit plan to wind down QCS as part of its ongoing efforts to focus on growth drivers and key markets and to streamline its operations. As part of the exit plan, during the third quarter of 2022, the Company notified approximately 330 employees of their employment termination and incurred severance costs and other benefits of approximately $12.7 million.

As of March 31, 2023, $1.5 million of severance costs and other benefits remained accrued and, based on the exit dates of the notified employees, is expected to be paid during the fourth quarter of 2023.

XML

Balance Sheet Information and Other Supplemental Disclosures

3 Months Ended

Mar. 31, 2023

Balance Sheet Related Disclosures [Abstract]

Balance Sheet Information and Other Supplemental Disclosures

Note 5: Balance Sheet Information and Other Supplemental Disclosures

Goodwill

There was no change in the balance of goodwill from December 31, 2022 to March 31, 2023. Goodwill is tested for impairment annually on the first day of the fourth quarter or more frequently if events or changes in circumstances (each, a "triggering event") would more likely-than-not reduce the fair value of a reporting unit below its carrying value. Management did not identify any triggering events during the quarter ended March 31, 2023 that would require an interim impairment analysis.

Inventory

Details of Inventory included in the Company’s Consolidated Balance Sheets are as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
Inventories:
Raw materials	$	271.3	$	236.8
Work in process	1,053.5		951.0
Finished goods	490.1		429.0
	$	1,814.9	$	1,616.8

Defined Benefit Plans

The Company recognizes the aggregate amount of all over-funded plans as assets and the aggregate amount of all underfunded plans as liabilities in its financial statements. As of March 31, 2023, the net assets for the over-funded plans totaled $13.5 million. The total accrued pension liability for underfunded plans was $69.1 million, of which the current portion of $1.5 million was classified as accrued expenses and other current liabilities. As of December 31, 2022, the net funded status for all the plans was a liability of $53.8 million, of which the current portion of $0.4 million was classified as accrued expenses and other current liabilities.

The components of the net periodic pension expense were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Service cost	$	1.2	$	2.2
Interest cost	1.6		1.1
Expected return on plan assets	(1.2)		(1.2)
Total net periodic pension cost	$	1.6	$	2.1

Leases

Operating lease arrangements are comprised primarily of real estate and equipment agreements. The components of lease expense were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Operating lease	$	12.4	$	11.2
Variable lease	1.8		1.6
Short-term lease	0.5		0.4
Total lease expense	$	14.7	$	13.2

The ROU assets and lease liabilities recognized in the Consolidated Balance Sheets are as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
Operating lease liabilities included in:
Accrued expenses and other current liabilities	$	33.5	$	35.2
Other long-term liabilities	244.8		246.5
Total	$	278.3	$	281.7
Operating ROU assets included in:
Other assets	$	251.9	$	262.1
Current portion of financing lease liabilities	$	11.6	$	14.2
Long-term financing lease liabilities	24.0		23.0
Total	$	35.6	$	37.2
Right-of-use financing lease	$	45.2	$	45.8

As of March 31, 2023, the weighted-average remaining lease-terms were 10.8 years and 18.8 years, and the weighted-average discount rates were 4.8% and 6.0%, for operating and financing leases, respectively.

Supplemental Disclosure of Cash Flow Information

Certain of the Company's cash and non-cash activities were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Non-cash investing activities:
Capital expenditures in accounts payable and other long-term liabilities	$	388.8	$	225.4
Operating ROU assets obtained in exchange of lease liabilities	4.6		10.7
Cash paid for:
Interest expense	$	29.1	$	24.0
Income taxes	35.2		15.7
Operating lease payments in operating cash flows	11.2		11.0

Reconciliation of the captions in the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows (in millions):

	As of
	March 31, 2023		December 31, 2022		April 1, 2022		December 31, 2021
Consolidated Balance Sheets:
Cash and cash equivalents	$	2,702.4	$	2,919.0	$	1,645.1	$	1,352.6
Restricted cash (included in other current assets)	14.2		14.0		18.8		20.1
Restricted cash (included in other non-current assets)	—		—		5.0		5.0
Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$	2,716.6	$	2,933.0	$	1,668.9	$	1,377.7

As of March 31, 2023, $5.8 million of the restricted cash balance relating to the acquisition of GTAT was held in escrow and will be released during the fourth quarter of 2023 upon satisfaction of certain outstanding items contained in the Agreement and Plan of Merger relating to such acquisition.

XML

Long-Term Debt

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Long-Term Debt

Note 6: Long-Term Debt

The Company's long-term debt consists of the following (annualized interest rates, dollars in millions):

	As of
	March 31, 2023		December 31, 2022
Amended Credit Agreement:
Revolving Credit Facility due 2024, interest payable monthly at 6.16% and 5.67%, respectively	$	375.0	$	500.0
Term Loan "B" Facility due 2026, interest payable monthly at 6.91% and 6.42%, respectively	—		1,086.0
0.50% Notes due 2029 (1)	1,500.0		—
0% Notes due 2027	805.0		805.0
3.875% Notes due 2028 (2)	700.0		700.0
1.625% Notes due 2023 (3)	134.6		137.3
Gross long-term debt, including current maturities	$	3,514.6	$	3,228.3
Less: Debt discount (4)	(4.7)		(9.2)
Less: Debt issuance costs (5)	(45.7)		(25.6)
Net long-term debt, including current maturities	$	3,464.2	$	3,193.5
Less: Current maturities	(926.2)		(147.8)
Net long-term debt	$	2,538.0	$	3,045.7

(1)Interest is payable on March 1 and September 1 of each year at 0.50% annually.

(2)Interest is payable on March 1 and September 1 of each year at 3.875% annually.

(3)Interest is payable on April 15 and October 15 of each year at 1.625% annually.

(4)Debt discount of $0.0 million and $4.2 million for the Term Loan "B" Facility and $4.7 million and $5.0 million for the 3.875% Notes, in each case as of March 31, 2023 and December 31, 2022, respectively.

(5)Debt issuance costs of $0.0 million and $9.7 million for the Term Loan "B" Facility, $30.7 million and $0.0 million for the 0.50% Notes, $13.1 million and $13.9 million for the 0% Notes, $1.7 million and $1.7 million for the 3.875% Notes and $0.2 million and $0.3 million for the 1.625% Notes, in each case as of March 31, 2023 and December 31, 2022, respectively.

Expected maturities of gross long-term debt (including current portion - see section regarding 1.625% and 0% Notes below) as of March 31, 2023 were as follows (in millions):

Period	Expected Maturities
Remainder of 2023	$	939.6
2024	375.0
2025	—
2026	—
2027	—
Thereafter	2,200.0
Total	$	3,514.6

The Company was in compliance with its covenants under all debt agreements as of March 31, 2023.

0.50% Convertible Senior Notes due 2029

On February 28, 2023, the Company completed a private unregistered offering of $1.5 billion aggregate principal amount of its 0.50% Convertible Senior Notes due 2029 (the "0.50% Notes"). The Company received net proceeds of approximately $1,470 million after deducting the initial purchasers' discount. The Company used the net proceeds to repay $1,086.0 million of the existing outstanding indebtedness under the Company’s Term Loan “B” Facility, the related transaction fees and expenses, to pay approximately $171.5 million net cost of the related convertible note hedges after such costs were offset by the proceeds from the sale of warrants, and for general corporate purposes. The 0.50% Notes were issued under an indenture (the "0.50% Indenture"), dated as of February 28, 2023, by and among the Company, the guarantors (as defined therein) and Computershare Trust Company, National Association, as trustee, which provides, among other things, that the 0.50% Notes will mature on March 1, 2029, unless earlier repurchased or redeemed by the Company or converted pursuant to their terms. On or after December 1, 2028, until the close of business on the second scheduled trading day immediately preceding the maturity date, holders of the 0.50% Notes may convert all or a portion of their 0.50% Notes at any time. The 0.50% Notes are the Company’s senior unsecured obligations and are fully and unconditionally guaranteed, on a joint and several basis, by each of the Company’s subsidiaries that is a borrower or guarantor under the Company’s Amended Credit Agreement. The Company may satisfy any conversion elections by paying cash up to the aggregate principal amount of the 0.50% Notes to be converted, and paying or delivering, as the case may be, cash, shares of common stock or a combination of cash and shares of common stock, at the Company’s election, in respect of the remainder, if any, of its conversion obligation in excess of the aggregate principal amount of the 0.50% Notes to be converted.

The initial conversion rate of the 0.50% Notes is 9.6277 shares of common stock per $1,000 principal amount, which is equivalent to an initial conversion price of approximately $103.87 per share of common stock. The Company may redeem for cash all or any portion of the 0.50% Notes, at the Company’s option, on or after March 6, 2026, if the last reported sale price of the Company’s common stock has been at least 130% of the conversion price then in effect for at least 20 trading days (whether or not consecutive) during any 30 consecutive trading-day period (including the last trading day of such period) ending on, and including, the trading day immediately preceding the date on which the Company provides the related notice of redemption at a redemption price equal to 100% of the principal amount of the notes to be redeemed, plus accrued and unpaid interest, if any, to, but excluding, the redemption date. Prior to December 1, 2028, the holders may convert their 0.50% Notes at their option only under the following circumstances: (i) during any calendar quarter commencing after the calendar quarter ending on June 30, 2023 (and only during such calendar quarter), if the last reported sale price of the Company’s common stock for at least 20 trading days (whether or not consecutive) during the period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding calendar quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five consecutive business-day period after any five consecutive trading-day period in which the trading price per $1,000 principal amount of the 0.50% Notes for each trading day of such period was less than 98% of the product of the last reported sale price of the Company’s common stock and the conversion rate on each such trading day; (iii) if the Company calls any or all of the 0.50% Notes for redemption, at any time prior to the close of business on the second scheduled trading day immediately preceding the redemption date; or (iv) upon the occurrence of specified corporate transactions described in the 0.50% Indenture.

The conversion rate is subject to adjustment upon the occurrence of certain specified events as set forth in the 0.50% Indenture. The maximum number of shares of common stock issuable in connection with the conversion of the 0.50% Notes is approximately 19.1 million. In addition to the initial purchasers' discount of $30.0 million, the Company also incurred issuance

costs of approximately $1.3 million, all of which was capitalized as debt issuance costs. The effective interest rate, including the impact of the debt discount and debt issuance costs is approximately 0.85% over the contractual term of the 0.50% Notes.

In addition, the Company entered into convertible note hedge transactions with respect to the common stock with the initial purchasers or their affiliates and certain other financial institutions. The Company will exercise the note hedges simultaneously when the 0.50% Notes are settled. The convertible note hedges cover, subject to customary anti-dilution adjustments, the number of shares of common stock that initially underlie the 0.50% Notes, and are expected to reduce the potential dilution to the common stock and/or offset potential cash payments in excess of the principal amount upon conversion of the 0.50% Notes. The Company paid approximately $414.0 million in cash for the convertible note hedges, which was recorded to stockholders’ equity.

The Company also entered into warrant transactions with certain other financial institutions, whereby the Company sold warrants to acquire 14.4 million shares of the Company's common stock, which is the same number of shares of the Company’s common stock covered by the convertible note hedges at an initial strike price of $156.78 per share, which represents a 100% premium over the closing price of the Company's common stock of $78.39 per share on February 23, 2023, subject to antidilution adjustments. The warrants expire on June 1, 2029. The maximum number of shares of common stock issuable in connection with the warrants is approximately 28.9 million. The Company received $242.5 million in cash for the sale of warrants, which was recorded to stockholders’ equity.

The Company recorded $92.3 million deferred tax asset related to the tax treatment of entering into the 0.50% Notes and the convertible note hedge.

Loss on debt prepayment

As mentioned above, with a portion of the proceeds of 0.50% Convertible Senior Notes due 2029, the Company repaid the remaining principal balance of $1.1 billion associated with its Term Loan "B" Facility. As a result of the prepayment, $13.3 million of unamortized debt discount and issuance costs were expensed and recorded as loss on debt prepayment.

Repayments under the Revolving Credit Facility

During the quarter ended March 31, 2023, the Company repaid $125.0 million of the outstanding balance under the Revolving Credit Facility. As of March 31, 2023, the Company had approximately $1.6 billion available under the Revolving Credit Facility for future borrowings, except for amounts utilized for the letters of credit.

1.625% Notes due 2023

Pursuant to the indenture governing the 1.625% Notes, as of March 31, 2023, the $134.4 million remaining outstanding principal amount of the 1.625% Notes, net of unamortized issuance costs, continued to be classified as a current portion of long-term debt since the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on March 31, 2023 was greater than or equal to $26.94 (130% of the conversion price) on each applicable trading day. This condition gives holders the right to surrender any portion of their 1.625% Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending June 30, 2023, and only during such calendar quarter.

0% Notes due 2027

Pursuant to the indenture governing the 0% Notes, as of March 31, 2023, the $791.9 million outstanding principal amount of the 0% Notes, net of unamortized issuance costs, was classified as a current portion of long-term debt since the last reported sale price of the Company’s common stock for at least 20 trading days during the period of 30 consecutive trading days ending on March 31, 2023 was greater than or equal to $68.86 (130% of the conversion price) on each applicable trading day. This condition gives holders the right to surrender any portion of their 0% Notes (in minimum denominations of $1,000 in principal amount or an integral multiple thereof) for conversion during the calendar quarter ending June 30, 2023, and only during such calendar quarter.

XML

Earnings Per Share and Equity

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Earnings Per Share and Equity

Note 7: Earnings Per Share and Equity

Earnings Per Share

Net income per share of common stock for calculating basic and diluted earnings per share is calculated as follows (in millions, except per share data):

	Quarters Ended
	March 31, 2023		April 1, 2022
Net income for basic earnings per share of common stock	$	461.7	$	530.2
Add: Interest on 1.625% Notes	0.4		0.5
Net income for diluted earnings per share of common stock	$	462.1	$	530.7
Basic weighted-average shares of common stock outstanding	431.9		433.3
Dilutive effect of share-based awards	1.4		2.4
Dilutive effect of convertible notes and warrants	15.2		13.2
Diluted weighted-average shares of common stock outstanding	448.5		448.9
Net income per share of common stock attributable to ON Semiconductor Corporation:
Basic	$	1.07	$	1.22
Diluted	$	1.03	$	1.18

Basic income per share of common stock is computed by dividing net income for basic earnings by the weighted-average number of shares of common stock outstanding during the period. To calculate the diluted weighted-average shares of common stock outstanding, the treasury stock method has been applied to calculate the number of incremental shares from the assumed issuance of shares relating to RSUs. The excluded number of anti-dilutive share-based awards was 0.2 million and 0.2 million for the quarters ended March 31, 2023 and April 1, 2022, respectively.

The dilutive impacts related to the 0.50% Notes, 0% Notes and 1.625% Notes have been calculated using the if-converted method. The 0.50% Notes and the 0% Notes are repayable in cash up to the par value and in cash or shares of common stock for the excess over par value, while the 1.625% Notes are repayable in cash, shares of common stock, or any combination of cash and shares of common stock at the election of the Company for their entire value. Prior to conversion, the convertible note hedges are not considered for purposes of the earnings per share calculations, as their effect would be anti-dilutive. Upon conversion, the convertible note hedges are expected to offset the dilutive effect of the 0.50% Notes, 0% Notes, and 1.625% Notes when the stock price is above $103.87, $52.97 and $20.72 per share, respectively.

The dilutive impact of the warrants issued concurrently with the issuance of the 0.50% Notes, 0% Notes and 1.625% Notes with exercise prices of $156.78, $74.34 and $30.70, respectively, has been included in the calculation of diluted weighted-average common shares outstanding, if applicable.

Equity

Share Repurchase Program

Under the Company's share repurchase program announced on February 6, 2023 (the "Share Repurchase Program"), the Company may repurchase up to $3.0 billion (exclusive of fees, commissions and other expenses) of the Company's common stock through December 31, 2025.

The Company repurchased approximately 1.3 million shares of common stock for an aggregate purchase price of $104.0 million during the quarter ended March 31, 2023. As of March 31, 2023, the authorized amount remaining under the Share Repurchase Program was approximately $2.9 billion.

Shares for Restricted Stock Units Tax Withholding

The amounts remitted for employee withholding taxes during the quarters ended March 31, 2023 and April 1, 2022 were $47.6 million and $58.8 million, respectively, for which the Company withheld approximately 0.6 million and 1.0 million shares of common stock, respectively, that were underlying the RSUs that vested. This tax withholding activity is separate from our Share Repurchase Program.

Non-Controlling Interest in Leshan-Phoenix Semiconductor Company Limited (“Leshan”)

The results of Leshan have been consolidated in the Company's financial statements. As of December 31, 2022, the non-controlling interest, which represents 20% of the Leshan balance, amounted to $18.5 million. This amount increased to $19.0 million as of March 31, 2023, after including the $0.5 million share of earnings for the quarter ending March 31, 2023.

XML

Share-Based Compensation

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Share-Based Compensation

Note 8: Share-Based Compensation

Total share-based compensation expense related to the Company's RSUs, stock grant awards and the ESPP was recorded within the Consolidated Statements of Operations and Comprehensive Income as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Cost of revenue	$	3.7	$	2.6
Research and development	4.5		4.4
Selling and marketing	4.1		3.8
General and administrative	15.4		11.7
Share-based compensation expense	$	27.7	$	22.5
Income tax benefit	(5.8)		(4.7)
Share-based compensation expense, net of taxes	$	21.9	$	17.8

As of March 31, 2023, total unrecognized expected share-based compensation expense, net of estimated forfeitures, related to non-vested RSUs with service, performance and market conditions was $149.4 million, which is expected to be recognized over a weighted-average period of 1.7 years. Upon vesting of RSUs, stock grant awards or completion of a purchase under the ESPP, the Company issues new shares of common stock. The annualized pre-vesting forfeiture rate for RSUs was estimated to be 8% for the quarter ended March 31, 2023 and 6% for the quarter ended April 1, 2022.

Shares Available

As of March 31, 2023 and December 31, 2022, there was an aggregate of 38.3 million and 40.1 million shares of common stock, respectively, available for grant under the Amended and Restated SIP.

Restricted Stock Units

RSUs generally vest ratably over three years for awards with service conditions and over two or three years for awards with performance or market conditions, or a combination thereof, and are settled in shares of the Company's common stock upon vesting. A summary of the RSU transactions for the quarter ended March 31, 2023 is as follows (in millions, except per share data):

	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
Non-vested RSUs at December 31, 2022	3.8	$	46.56
Granted	0.9	77.85
Achieved	0.3	54.16
Released	(1.7)	42.12
Forfeited	(0.1)	48.33
Non-vested RSUs at March 31, 2023	3.2	58.00

XML

Commitments and Contingencies

3 Months Ended

Mar. 31, 2023

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

Note 9: Commitments and Contingencies

Environmental Contingencies

The Company has encountered and dealt with a number of environmental issues over time relating to the various locations that comprise its operations, and has incurred certain costs related to clean-up activities and environmental remediation efforts. In certain instances, the Company has been indemnified for such costs, often times from third parties who were the prior owners of such facilities. Any costs to the Company in connection with such environmental matters have generally not been, and, based on the information available, are not expected to be material.

Financing Contingencies

In the ordinary course of business, the Company provides standby letters of credit or other guarantee instruments to certain parties initiated by either the Company or its subsidiaries, as required for transactions, including, but not limited to, material purchase commitments, agreements to mitigate collection risk, leases, utilities or customs guarantees. As of March 31, 2023, the Company's Revolving Credit Facility included $15.0 million available for the issuance of letters of credit. There were $0.9 million in letters of credit outstanding under the Revolving Credit Facility as of March 31, 2023, which reduced the Company's borrowing capacity. As of March 31, 2023, the Company also had outstanding guarantees and letters of credit outside of its Revolving Credit Facility totaling $16.5 million.

As part of obtaining financing in the ordinary course of business, the Company issued guarantees related to certain of its subsidiaries, which totaled $0.9 million as of March 31, 2023. Based on historical experience and information currently available, the Company believes that it will not be required to make payments under the standby letters of credit or guarantee arrangements for the foreseeable future.

Indemnification Contingencies

The Company is a party to a variety of agreements entered into in the ordinary course of business, including acquisition agreements, pursuant to which it may be obligated to indemnify the other parties for certain liabilities that arise out of or relate to the subject matter of the agreements. Some of the agreements entered into by the Company require it to indemnify the other party against losses due to IP infringement, property damage (including environmental contamination), personal injury, failure to comply with applicable laws, the Company’s negligence or willful misconduct or breach of representations and warranties and covenants related to such matters as title to sold assets. In the case of certain acquisition agreements, these agreements may require us to maintain such indemnification provisions for the acquiree’s directors, officers and other employees and agents, in certain cases for a number of years following the acquisition.

While the Company’s future obligations under certain agreements may contain limitations on liability for indemnification, other agreements do not contain such limitations and under such agreements it is not possible to predict the maximum potential amount of future payments due to the conditional nature of the Company’s obligations and the unique facts and circumstances involved in each particular agreement. Historically, payments made by the Company under any of these indemnities have not had a material effect on the Company’s business, financial condition, results of operations or cash flows. Additionally, the Company does not believe that any amounts that it may be required to pay under these indemnities in the future will be material to the Company’s business, financial position, results of operations, or cash flows.

Legal Matters

The Company is currently involved in a variety of legal matters that arise in the ordinary course of business. Based on information currently available, the Company is not involved in any pending or threatened legal proceedings that it believes could reasonably be expected to have a material adverse effect on its financial condition, results of operations or liquidity. The litigation process is inherently uncertain, and the Company cannot guarantee that the outcome of any litigation matter will be favorable to the Company.

Intellectual Property Matters

The Company faces risk of exposure from claims of infringement of the IP rights of others. In the ordinary course of business, the Company receives letters asserting that the Company’s products or components breach another party’s rights. Such letters may request royalty payments from the Company, that the Company cease and desist using certain IP, and/or request other remedies.

XML

Fair Value Measurements

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Fair Value Measurements

Note 10: Fair Value Measurements

Fair Value of Financial Instruments

During the year ended December 31, 2022, the Company began investing portions of its excess cash in different marketable

securities, which are classified as available-for-sale.

The Company uses the following fair value tier level hierarchy to determine fair values of its financial instruments:

• Level 1: based on observable inputs that reflect quoted prices for identical assets or liabilities in active markets

• Level 2: based on inputs other than quoted prices included in Level 1 that are observable for the asset or liability either

directly or indirectly.

• Level 3: based on the use of unobservable inputs for the assets and liabilities and other types of analyses.

The carrying value of cash and cash equivalents which includes time deposits, money market funds, corporate bonds and commercial paper approximates fair value because of the short-term maturity of these instruments. Demand and time deposits and money market funds are classified as Level 1 within the fair value hierarchy, while corporate bonds and commercial paper are classified as Level 2. The carrying amount of other current assets and liabilities, such as accounts receivable and accounts payable approximates fair value due to the short-term maturity of the amounts and are considered Level 2 in the fair value hierarchy.

The following table summarizes the Company's financial assets and liabilities, excluding pension assets, disaggregated by the security type, measured at fair value on a recurring basis (in millions):

As of March 31, 2023									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	371.4	$	—	$	—	$	371.4	$	371.4	$	—	$	—
Money market funds	28.4		—		—		28.4		28.4		—		—
Other current assets:
Corporate bonds	$	15.2	$	—	$	—	$	15.2	$	—	$	15.2	$	—
Certificate of deposit	2.7		—		—		2.7		—		2.7		—
Commercial paper	2.2		—		—		2.2		0.2		2.0		—
US Treasury bonds	1.7		—		—		1.7		—		1.7		—
Other assets:
Corporate bonds	$	0.5	$	—	$	—	$	0.5	$	—	$	0.5	$	—

The investments included in other assets have maturity dates ranging between one and five years.

As of December 31, 2022									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	233.1	$	—	$	—	$	233.1	$	233.1	$	—	$	—
Money market funds	17.0		—		—		17.0		17.0		—		—
Other current assets:
Corporate bonds	$	23.8	$	—	$	—	$	23.8	$	—	$	23.8	$	—
Certificate of deposit	3.1		—		—		3.1		—		3.1		—
Commercial paper	3.2		—		—		3.2		1.2		2.0		—
US Treasury bonds	2.1		—		—		2.1		—		2.1		—
Other assets:
Corporate bonds	$	0.8	$	—	$	—	$	0.8	$	—	$	0.8	$	—

Other

The carrying amounts of other current assets and liabilities, such as accounts receivable and accounts payable, approximate fair value based on the short-term nature of these instruments.

Fair Value of Long-Term Debt, including Current Portion

The carrying amounts and fair values of the Company’s long-term borrowings were as follows (in millions):

	As of
	March 31, 2023				December 31, 2022
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Long-term debt, including current portion (1)
0% Notes	$	791.9	$	1,306.2	$	791.1	$	1,057.8
0.50% Notes	1,469.3		1,572.8		—		—
1.625% Notes	134.4		517.6		137.0		417.8
3.875% Notes	693.6		641.1		693.3		618.3
Other long-term debt	375.0		377.0		1,572.1		1,549.2

(1)    Carrying amounts shown are net of debt discount, if applicable, and debt issuance costs.

The fair values of the 3.875% Notes, 1.625% Notes, 0.50% Notes and 0% Notes were estimated based on market prices in active markets (Level 1). The fair value of the Term Loan "B" Facility was estimated based on discounting the remaining principal and interest payments using current market rates for similar debt (Level 2).

XML

Financial Instruments

3 Months Ended

Mar. 31, 2023

Investments, All Other Investments [Abstract]

Financial Instruments

Note 11: Financial Instruments

Foreign Currencies

As a multinational business, the Company engages in transactions that are denominated in a variety of currencies. When appropriate, the Company uses forward foreign currency contracts to reduce its overall exposure to the effects of currency fluctuations on its results of operations and cash flows. The Company’s policy prohibits trading in currencies for which there are no underlying exposures and entering into trades for any currency to intentionally increase the underlying exposure. The Company primarily hedges existing assets and liabilities associated with transactions currently on its balance sheet, which are undesignated hedges for accounting purposes. The Company is exposed to credit-related losses if counterparties to hedge contracts fail to perform their obligations. As of March 31, 2023, the counterparties to the Company’s hedge contracts were held at financial institutions that the Company believes to be highly-rated, and no credit-related losses are anticipated.

As of March 31, 2023 and December 31, 2022, the Company had net outstanding foreign exchange contracts with notional amounts of $279.2 million and $272.0 million, respectively. Such contracts were obtained through financial institutions and were scheduled to mature within one to three months from the time of purchase. Management believes that these financial instruments should not subject the Company to increased risks from foreign exchange movements because gains and losses on these contracts should offset losses and gains on the underlying assets, liabilities and transactions to which they are related.

The following summarizes the Company’s net foreign exchange positions in U.S. Dollars (in millions):

	As of
	March 31, 2023				December 31, 2022
	Buy (Sell)		Notional Amount		Buy (Sell)		Notional Amount
Japanese Yen	69.5		69.5		27.0		27.0
Philippine Peso	49.4		49.4		63.9		63.9
Czech Koruna	40.4		40.4		41.7		41.7
Euro	39.5		39.5		26.0		26.0
Korean Won	20.0		20.0		35.7		35.7
Other Currencies - Buy	46.5		46.5		66.5		66.5
Other Currencies - Sell	(13.9)		13.9		(11.2)		11.2
	$	251.4	$	279.2	$	249.6	$	272.0

Amounts receivable or payable under the contracts were not material as of March 31, 2023 or December 31, 2022. During the quarters ended March 31, 2023 and April 1, 2022, net of the impact of the hedge positions, the realized and unrealized foreign currency transactions totaled a loss of $1.9 million and a gain of $1.9 million, respectively. The realized and unrealized foreign currency transactions are included in other income (expense) in the Company's Consolidated Statements of Operations and Comprehensive Income.

Cash Flow Hedges

All derivatives are recognized on the Company’s Consolidated Balance Sheets at their fair value and classified based on the applicable instrument's maturity date.

Interest Rate Risk

The Company uses interest rate swap contracts to mitigate its exposure to variable interest rate fluctuations.

As of March 31, 2023, the Company did not have any outstanding derivatives related to cash flow hedges as the Company terminated its interest rate swap agreements with a notional value of $500 million for fiscal years 2023 and 2024, respectively and received cash proceeds of $27.7 million (net of termination fees). The Company recognized $6.9 million of other income related to the termination of these agreements. As of March 31, 2023, approximately $20.7 million was recorded in Accumulated Other Comprehensive Income and will be amortized to income over a period of twenty-one months, which represents the remaining original period of the swap agreements. If the Company prepays the Revolving Credit Facility balance, the Company will release the corresponding amounts from Accumulated Other Comprehensive Income concurrently.

As of December 31, 2022, the Company had interest rate swap agreements for notional amounts of $750 million, $500 million and $500 million for fiscal years 2022, 2023 and 2024, respectively. The fair value of these swaps totaled $36.0 million as of December 31, 2022. The Company did not identify any ineffectiveness with respect to the notional amounts of the interest rate swap contracts effective as of December 31, 2022. These derivatives are recognized on the balance sheet at their fair value and classified based on each instrument’s maturity dates.

See Note 13: ''Changes in Accumulated Other Comprehensive Loss'' for the effective amounts related to derivative instruments designated as cash flow hedges affecting accumulated other comprehensive loss and the Consolidated Statements of Operations

and Comprehensive Income for the quarter ended March 31, 2023.

Convertible Note Hedges

The Company entered into convertible note hedges in connection with the issuance of the 0% Notes, 0.50% Notes and 1.625% Notes. See Note 6: ''Long-Term Debt'' for additional information.

Other

As of March 31, 2023, the Company had no outstanding commodity derivatives, currency swaps, options, or equity investments held at subsidiaries or affiliated companies. The Company does not hedge the value of its equity investments in its subsidiaries or affiliated companies.

The Company is exposed to credit-related losses if its hedge counterparties fail to perform their obligations. As of March 31, 2023, the counterparties to the Company's hedge contracts are held at financial institutions which the Company believes to be highly rated, and no credit related losses are anticipated.

XML

Income Taxes

3 Months Ended

Mar. 31, 2023

Income Tax Disclosure [Abstract]

Income Taxes

Note 12: Income Taxes

The Company recognizes interest and penalties related to uncertain tax positions in tax expense on the Company's Consolidated Statements of Operations and Comprehensive Income. The Company had approximately $4.3 million and $2.7 million of net interest and penalties accrued as of March 31, 2023 and December 31, 2022, respectively. It is reasonably possible that $68.2 million of its uncertain tax positions will be reduced in the next 12 months due to settlement with tax authorities or expiration of the applicable statute of limitations.

The Company maintains a partial valuation allowance on its U.S. state deferred tax assets and a valuation allowance on foreign net operating losses and tax credits in certain foreign jurisdictions, a substantial portion of which relate to Japan and Hong Kong net operating losses, which are projected to expire prior to utilization.

The Company is currently under IRS examination for the 2017 and 2018 tax years. Tax years prior to 2017 are generally not subject to examination by the IRS. For state tax returns, the Company is generally not subject to income tax examinations for tax years prior to 2018. The Company is also subject to routine examinations by various foreign tax jurisdictions in which it operates. With respect to jurisdictions outside the United States, the Company is generally not subject to examination for tax years prior to 2012. The Company believes that adequate provisions have been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner not consistent with the Company's expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs.

XML

Changes in Accumulated Other Comprehensive Loss

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Changes in Accumulated Other Comprehensive Loss

Note 13: Changes in Accumulated Other Comprehensive Loss

Amounts comprising the Company's accumulated other comprehensive loss and reclassifications are as follows (in millions):

	Currency Translation Adjustments		Effects of Cash Flow Hedges and Other Adjustments		Total
Balance as of December 31, 2022	$	(50.4)	$	27.2	$	(23.2)
Other comprehensive income (loss) prior to reclassifications	0.3		5.2		5.5
Amounts reclassified from accumulated other comprehensive loss	—		(11.9)		(11.9)
Net current period other comprehensive income (loss)	0.3		(6.7)		(6.4)
Balance as of March 31, 2023	$	(50.1)	$	20.5	$	(29.6)

Amounts reclassified from accumulated other comprehensive loss to the specific caption within Consolidated Statements of Operations and Comprehensive Income were as follows:

	Quarters Ended
	March 31, 2023		April 1, 2022		To caption
Interest rate swaps	$	(5.0)	$	0.7	Interest expense
Interest rate swaps terminations	(6.9)		—		Other Income
Total reclassifications	$	(11.9)	$	0.7

XML

Background and Basis of Presentation (Policies)

3 Months Ended

Mar. 31, 2023

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Use of Estimates

Use of Estimates

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period. Management evaluates these estimates and judgments on an ongoing basis and bases its estimates on experience, current and expected future conditions, third-party evaluations, and various other assumptions that management believes are reasonable under the circumstances. Significant estimates have been used by management in conjunction with the following: (i) future payouts for customer incentives and amounts subject to allowances and returns; (ii) valuation and obsolescence relating to inventories; (iii) measurement of valuation allowances against deferred tax assets and evaluations of uncertain tax positions and (iv) testing for impairment of long-lived assets and goodwill. Additionally, during periods where it becomes applicable, significant estimates will be used by management in determining the future cash flows used in connection with business combinations. Actual results may differ from the estimates and assumptions used in the consolidated financial statements.

XML

Revenue and Segment Information (Tables)

3 Months Ended

Mar. 31, 2023

Segment Reporting [Abstract]

Schedule of Revenues and Gross Profit From Reportable Segments

Revenue and gross profit for the Company’s operating and reportable segments are as follows (in millions):

	PSG		ASG		ISG		Total
For the quarter ended March 31, 2023:
Revenue from external customers	$	1,012.8	$	592.8	$	354.1	$	1,959.7
Gross profit	$	480.3	$	260.1	$	177.1	$	917.5
For the quarter ended April 1, 2022:
Revenue from external customers	$	986.7	$	689.3	$	269.0	$	1,945.0
Gross profit	$	474.7	$	366.7	$	119.9	$	961.3

Summary of Disaggregation of Revenue

Revenue for the Company's operating and reportable segments disaggregated into geographic locations based on sales billed from the respective country and sales channels are as follows (in millions):

	Quarter Ended March 31, 2023
	PSG		ASG		ISG		Total
Geographic Location
Hong Kong	$	286.9	$	139.7	$	63.8	490.4
Singapore	276.4		116.1		58.2		450.7
United Kingdom	204.1		128.1		81.1		413.3
United States	166.3		121.3		101.5		389.1
Other	79.1		87.6		49.5		216.2
Total	$	1,012.8	$	592.8	$	354.1	$	1,959.7
Sales Channel
Distributors	$	629.3	$	222.8	$	187.1	$	1,039.2
Direct Customers	383.5		370.0		167.0		920.5
Total	$	1,012.8	$	592.8	$	354.1	$	1,959.7

	Quarter Ended April 1, 2022
	PSG		ASG		ISG		Total
Geographic Location
Singapore	$	280.5	$	233.8	$	41.4	$	555.7
Hong Kong	303.1		173.9		52.6		529.6
United Kingdom	186.9		106.6		52.0		345.5
United States	144.9		92.3		74.5		311.7
Other	71.3		82.7		48.5		202.5
Total	$	986.7	$	689.3	$	269.0	$	1,945.0
Sales Channel
Distributors	$	633.9	$	356.9	$	150.6	$	1,141.4
Direct Customers	352.8		332.4		118.4		803.6
Total	$	986.7	$	689.3	$	269.0	$	1,945.0

Summary of Property, Plant and Equipment by Geographic Location

Property, plant and equipment, net by geographic location, is summarized as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
United States	$	1,360.8	$	1,329.2
South Korea	990.9		871.0
Czech Republic	335.3		279.3
Philippines	287.1		296.8
China	227.4		215.3
Malaysia	199.0		190.2
Japan	128.1		133.2
Other	164.3		135.7
Total	$	3,692.9	$	3,450.7

XML

Acquisition and Divestitures - (Tables)

3 Months Ended

Mar. 31, 2023

Business Combination and Asset Acquisition [Abstract]

Summary of Assets Acquired and Liabilities Assumed

The preliminary allocation of the purchase price of EFK to the assets acquired and liabilities assumed based on their relative fair values is as follows (in millions):

	Purchase Price Allocation
Inventory	$	3.3
Other current assets	4.4
Property, plant and equipment	396.5
Other non-current assets	11.4
Total assets acquired	415.6
Current liabilities	3.0
Other long-term liabilities	6.3
Total liabilities assumed	9.3
Net assets acquired/purchase price	$	406.3

XML

Restructuring, Asset Impairments and Other, Net - (Tables)

3 Months Ended

Mar. 31, 2023

Restructuring Charges [Abstract]

Schedule of Activity Included in Restructuring, Asset Impairments, and Other, Net

Details of restructuring, asset impairments and other charges, net are as follows (in millions):        

	Restructuring		Asset Impairments			Other		Total
Quarter ended March 31, 2023
2023 Business Realignment	$	36.1	$	2.5	(1)	$	2.8	$	41.4
QCS wind down	—		—			(2.3)		(2.3)
Other	—		10.2		(2)	2.2		12.4
Total	$	36.1	$	12.7		$	2.7	$	51.5

(1)Includes $1.7 million property, plant and equipment asset impairments charges and $0.8 million of ROU asset impairment charges associated with the 2023 Business Realignment efforts.

(2)Includes $10.2 million of property, plant and equipment and ROU lease asset impairment charges associated with site consolidation efforts in the United States.

Schedule of Changes in Accrued Restructuring Reserve

A summary of changes in accrued restructuring balance is as follows (in millions):

	As of						As of
	December 31, 2022		Charges		Usage		March 31, 2023
Employee separation charges	$	4.4	$	36.1	$	(4.9)	$	35.6
Total	$	4.4	$	36.1	$	(4.9)	$	35.6

XML

Balance Sheet Information and Other Supplemental Disclosures (Tables)

3 Months Ended

Mar. 31, 2023

Balance Sheet Related Disclosures [Abstract]

Schedule of Inventory

Details of Inventory included in the Company’s Consolidated Balance Sheets are as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
Inventories:
Raw materials	$	271.3	$	236.8
Work in process	1,053.5		951.0
Finished goods	490.1		429.0
	$	1,814.9	$	1,616.8

Schedule of Net Periodic Pension Expense

The components of the net periodic pension expense were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Service cost	$	1.2	$	2.2
Interest cost	1.6		1.1
Expected return on plan assets	(1.2)		(1.2)
Total net periodic pension cost	$	1.6	$	2.1

Schedule of Components of Lease Expense

The components of lease expense were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Operating lease	$	12.4	$	11.2
Variable lease	1.8		1.6
Short-term lease	0.5		0.4
Total lease expense	$	14.7	$	13.2

The ROU assets and lease liabilities recognized in the Consolidated Balance Sheets are as follows (in millions):

	As of
	March 31, 2023		December 31, 2022
Operating lease liabilities included in:
Accrued expenses and other current liabilities	$	33.5	$	35.2
Other long-term liabilities	244.8		246.5
Total	$	278.3	$	281.7
Operating ROU assets included in:
Other assets	$	251.9	$	262.1
Current portion of financing lease liabilities	$	11.6	$	14.2
Long-term financing lease liabilities	24.0		23.0
Total	$	35.6	$	37.2
Right-of-use financing lease	$	45.2	$	45.8

Schedule of Cash and Non-cash Activities

Certain of the Company's cash and non-cash activities were as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Non-cash investing activities:
Capital expenditures in accounts payable and other long-term liabilities	$	388.8	$	225.4
Operating ROU assets obtained in exchange of lease liabilities	4.6		10.7
Cash paid for:
Interest expense	$	29.1	$	24.0
Income taxes	35.2		15.7
Operating lease payments in operating cash flows	11.2		11.0

Schedule of Cash and Cash Equivalents

Reconciliation of the captions in the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows (in millions):

	As of
	March 31, 2023		December 31, 2022		April 1, 2022		December 31, 2021
Consolidated Balance Sheets:
Cash and cash equivalents	$	2,702.4	$	2,919.0	$	1,645.1	$	1,352.6
Restricted cash (included in other current assets)	14.2		14.0		18.8		20.1
Restricted cash (included in other non-current assets)	—		—		5.0		5.0
Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$	2,716.6	$	2,933.0	$	1,668.9	$	1,377.7

Schedule of Restrictions on Cash and Cash Equivalents

Reconciliation of the captions in the Consolidated Balance Sheets to the Consolidated Statements of Cash Flows (in millions):

	As of
	March 31, 2023		December 31, 2022		April 1, 2022		December 31, 2021
Consolidated Balance Sheets:
Cash and cash equivalents	$	2,702.4	$	2,919.0	$	1,645.1	$	1,352.6
Restricted cash (included in other current assets)	14.2		14.0		18.8		20.1
Restricted cash (included in other non-current assets)	—		—		5.0		5.0
Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$	2,716.6	$	2,933.0	$	1,668.9	$	1,377.7

XML

Long-Term Debt - (Tables)

3 Months Ended

Mar. 31, 2023

Debt Disclosure [Abstract]

Schedule of Long-Term Debt

The Company's long-term debt consists of the following (annualized interest rates, dollars in millions):

	As of
	March 31, 2023		December 31, 2022
Amended Credit Agreement:
Revolving Credit Facility due 2024, interest payable monthly at 6.16% and 5.67%, respectively	$	375.0	$	500.0
Term Loan "B" Facility due 2026, interest payable monthly at 6.91% and 6.42%, respectively	—		1,086.0
0.50% Notes due 2029 (1)	1,500.0		—
0% Notes due 2027	805.0		805.0
3.875% Notes due 2028 (2)	700.0		700.0
1.625% Notes due 2023 (3)	134.6		137.3
Gross long-term debt, including current maturities	$	3,514.6	$	3,228.3
Less: Debt discount (4)	(4.7)		(9.2)
Less: Debt issuance costs (5)	(45.7)		(25.6)
Net long-term debt, including current maturities	$	3,464.2	$	3,193.5
Less: Current maturities	(926.2)		(147.8)
Net long-term debt	$	2,538.0	$	3,045.7

(1)Interest is payable on March 1 and September 1 of each year at 0.50% annually.

(2)Interest is payable on March 1 and September 1 of each year at 3.875% annually.

(3)Interest is payable on April 15 and October 15 of each year at 1.625% annually.

(4)Debt discount of $0.0 million and $4.2 million for the Term Loan "B" Facility and $4.7 million and $5.0 million for the 3.875% Notes, in each case as of March 31, 2023 and December 31, 2022, respectively.

(5)Debt issuance costs of $0.0 million and $9.7 million for the Term Loan "B" Facility, $30.7 million and $0.0 million for the 0.50% Notes, $13.1 million and $13.9 million for the 0% Notes, $1.7 million and $1.7 million for the 3.875% Notes and $0.2 million and $0.3 million for the 1.625% Notes, in each case as of March 31, 2023 and December 31, 2022, respectively.

Schedule of Annual Maturities Relating To Long-Term Debt

Expected maturities of gross long-term debt (including current portion - see section regarding 1.625% and 0% Notes below) as of March 31, 2023 were as follows (in millions):

Period	Expected Maturities
Remainder of 2023	$	939.6
2024	375.0
2025	—
2026	—
2027	—
Thereafter	2,200.0
Total	$	3,514.6

XML

Earnings Per Share and Equity - (Tables)

3 Months Ended

Mar. 31, 2023

Earnings Per Share [Abstract]

Summary of Earnings Per Share

Net income per share of common stock for calculating basic and diluted earnings per share is calculated as follows (in millions, except per share data):

	Quarters Ended
	March 31, 2023		April 1, 2022
Net income for basic earnings per share of common stock	$	461.7	$	530.2
Add: Interest on 1.625% Notes	0.4		0.5
Net income for diluted earnings per share of common stock	$	462.1	$	530.7
Basic weighted-average shares of common stock outstanding	431.9		433.3
Dilutive effect of share-based awards	1.4		2.4
Dilutive effect of convertible notes and warrants	15.2		13.2
Diluted weighted-average shares of common stock outstanding	448.5		448.9
Net income per share of common stock attributable to ON Semiconductor Corporation:
Basic	$	1.07	$	1.22
Diluted	$	1.03	$	1.18

XML

Share-Based Compensation - (Tables)

3 Months Ended

Mar. 31, 2023

Share-Based Payment Arrangement [Abstract]

Summary Of Share-Based Compensation Expense

Total share-based compensation expense related to the Company's RSUs, stock grant awards and the ESPP was recorded within the Consolidated Statements of Operations and Comprehensive Income as follows (in millions):

	Quarters Ended
	March 31, 2023		April 1, 2022
Cost of revenue	$	3.7	$	2.6
Research and development	4.5		4.4
Selling and marketing	4.1		3.8
General and administrative	15.4		11.7
Share-based compensation expense	$	27.7	$	22.5
Income tax benefit	(5.8)		(4.7)
Share-based compensation expense, net of taxes	$	21.9	$	17.8

Summary Of Restricted Stock Units Transactions

A summary of the RSU transactions for the quarter ended March 31, 2023 is as follows (in millions, except per share data):

	Number of Shares	Weighted-Average Grant Date Fair Value Per Share
Non-vested RSUs at December 31, 2022	3.8	$	46.56
Granted	0.9	77.85
Achieved	0.3	54.16
Released	(1.7)	42.12
Forfeited	(0.1)	48.33
Non-vested RSUs at March 31, 2023	3.2	58.00

XML

Fair Value Measurements - (Tables)

3 Months Ended

Mar. 31, 2023

Fair Value Disclosures [Abstract]

Summary of Fair Value Available-for-sale Securities

The following table summarizes the Company's financial assets and liabilities, excluding pension assets, disaggregated by the security type, measured at fair value on a recurring basis (in millions):

As of March 31, 2023									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	371.4	$	—	$	—	$	371.4	$	371.4	$	—	$	—
Money market funds	28.4		—		—		28.4		28.4		—		—
Other current assets:
Corporate bonds	$	15.2	$	—	$	—	$	15.2	$	—	$	15.2	$	—
Certificate of deposit	2.7		—		—		2.7		—		2.7		—
Commercial paper	2.2		—		—		2.2		0.2		2.0		—
US Treasury bonds	1.7		—		—		1.7		—		1.7		—
Other assets:
Corporate bonds	$	0.5	$	—	$	—	$	0.5	$	—	$	0.5	$	—

The investments included in other assets have maturity dates ranging between one and five years.

As of December 31, 2022									Fair Value Level
Description	Amortized Cost		Unrealized gains		Unrealized losses		Fair value		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Demand and time deposits	$	233.1	$	—	$	—	$	233.1	$	233.1	$	—	$	—
Money market funds	17.0		—		—		17.0		17.0		—		—
Other current assets:
Corporate bonds	$	23.8	$	—	$	—	$	23.8	$	—	$	23.8	$	—
Certificate of deposit	3.1		—		—		3.1		—		3.1		—
Commercial paper	3.2		—		—		3.2		1.2		2.0		—
US Treasury bonds	2.1		—		—		2.1		—		2.1		—
Other assets:
Corporate bonds	$	0.8	$	—	$	—	$	0.8	$	—	$	0.8	$	—

Summary of Fair Value, by Balance Sheet Grouping

The carrying amounts and fair values of the Company’s long-term borrowings were as follows (in millions):

	As of
	March 31, 2023				December 31, 2022
	Carrying Amount		Fair Value		Carrying Amount		Fair Value
Long-term debt, including current portion (1)
0% Notes	$	791.9	$	1,306.2	$	791.1	$	1,057.8
0.50% Notes	1,469.3		1,572.8		—		—
1.625% Notes	134.4		517.6		137.0		417.8
3.875% Notes	693.6		641.1		693.3		618.3
Other long-term debt	375.0		377.0		1,572.1		1,549.2

(1)    Carrying amounts shown are net of debt discount, if applicable, and debt issuance costs.

XML

Financial Instruments - (Tables)

3 Months Ended

Mar. 31, 2023

Investments, All Other Investments [Abstract]

Schedule of Net Foreign Exchange Positions

The following summarizes the Company’s net foreign exchange positions in U.S. Dollars (in millions):

	As of
	March 31, 2023				December 31, 2022
	Buy (Sell)		Notional Amount		Buy (Sell)		Notional Amount
Japanese Yen	69.5		69.5		27.0		27.0
Philippine Peso	49.4		49.4		63.9		63.9
Czech Koruna	40.4		40.4		41.7		41.7
Euro	39.5		39.5		26.0		26.0
Korean Won	20.0		20.0		35.7		35.7
Other Currencies - Buy	46.5		46.5		66.5		66.5
Other Currencies - Sell	(13.9)		13.9		(11.2)		11.2
	$	251.4	$	279.2	$	249.6	$	272.0

XML

Changes in Accumulated Other Comprehensive Loss - (Tables)

3 Months Ended

Mar. 31, 2023

Equity [Abstract]

Schedule of Accumulated Other Comprehensive Loss

Amounts comprising the Company's accumulated other comprehensive loss and reclassifications are as follows (in millions):

	Currency Translation Adjustments		Effects of Cash Flow Hedges and Other Adjustments		Total
Balance as of December 31, 2022	$	(50.4)	$	27.2	$	(23.2)
Other comprehensive income (loss) prior to reclassifications	0.3		5.2		5.5
Amounts reclassified from accumulated other comprehensive loss	—		(11.9)		(11.9)
Net current period other comprehensive income (loss)	0.3		(6.7)		(6.4)
Balance as of March 31, 2023	$	(50.1)	$	20.5	$	(29.6)

Schedule of Reclassifications from Accumulated Other Comprehensive Loss

Amounts reclassified from accumulated other comprehensive loss to the specific caption within Consolidated Statements of Operations and Comprehensive Income were as follows:

	Quarters Ended
	March 31, 2023		April 1, 2022		To caption
Interest rate swaps	$	(5.0)	$	0.7	Interest expense
Interest rate swaps terminations	(6.9)		—		Other Income
Total reclassifications	$	(11.9)	$	0.7

XML

Background and Basis of Presentation (Details) - segment	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of operating segments	3
Number of reportable segments	3
Fiscal period duration	90 days	91 days

XML

Revenue and Segment Information - Narrative (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) segment	Apr. 01, 2022 USD ($)	Dec. 31, 2022 USD ($)
Segment Reporting Information [Line Items]
Number of operating segments | segment	3
Number of reportable segments | segment	3
Revenue, remaining performance obligation, amount (one year of less)	$ 17,600.0
Revenue, remaining performance obligation, expected timing of satisfaction, current period (or less)	1 year
Revenue remaining performance obligation, percentage (one year or less)	33.00%
LTSA, non-cancellable capacity payments, maturity term	30 days
Revenue recognized from contract liabilities	$ 14.8	$ 4.5
Contract liability	225.5		$ 190.4
Current contract liability	$ 69.0		$ 60.5
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-04-01
Segment Reporting Information [Line Items]
Revenue, remaining performance obligation, expected timing of satisfaction, period	12 months
One Customer | Revenue from Contract with Customer Benchmark | Customer Concentration Risk
Segment Reporting Information [Line Items]
Concentration risk, percentage	10.10%	12.40%

XML

Revenue and Segment Information - Segment Information of Revenues, Gross Profit and Operating Income (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Segment Reporting Information [Line Items]
Revenue from external customers	$ 1,959.7	$ 1,945.0
Gross profit	917.5	961.3
PSG
Segment Reporting Information [Line Items]
Revenue from external customers	1,012.8	986.7
Gross profit	480.3	474.7
ASG
Segment Reporting Information [Line Items]
Revenue from external customers	592.8	689.3
Gross profit	260.1	366.7
ISG
Segment Reporting Information [Line Items]
Revenue from external customers	354.1	269.0
Gross profit	$ 177.1	$ 119.9

XML

Revenue and Segment Information - Disaggregation of Revenue (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Segment Reporting Information [Line Items]
Revenue	$ 1,959.7	$ 1,945.0
Distributors
Segment Reporting Information [Line Items]
Revenue	1,039.2	1,141.4
Direct Customers
Segment Reporting Information [Line Items]
Revenue	920.5	803.6
Hong Kong
Segment Reporting Information [Line Items]
Revenue	490.4	529.6
Singapore
Segment Reporting Information [Line Items]
Revenue	450.7	555.7
United Kingdom
Segment Reporting Information [Line Items]
Revenue	413.3	345.5
United States
Segment Reporting Information [Line Items]
Revenue	389.1	311.7
Other
Segment Reporting Information [Line Items]
Revenue	216.2	202.5
PSG
Segment Reporting Information [Line Items]
Revenue	1,012.8	986.7
PSG | Distributors
Segment Reporting Information [Line Items]
Revenue	629.3	633.9
PSG | Direct Customers
Segment Reporting Information [Line Items]
Revenue	383.5	352.8
PSG | Hong Kong
Segment Reporting Information [Line Items]
Revenue	286.9	303.1
PSG | Singapore
Segment Reporting Information [Line Items]
Revenue	276.4	280.5
PSG | United Kingdom
Segment Reporting Information [Line Items]
Revenue	204.1	186.9
PSG | United States
Segment Reporting Information [Line Items]
Revenue	166.3	144.9
PSG | Other
Segment Reporting Information [Line Items]
Revenue	79.1	71.3
ASG
Segment Reporting Information [Line Items]
Revenue	592.8	689.3
ASG | Distributors
Segment Reporting Information [Line Items]
Revenue	222.8	356.9
ASG | Direct Customers
Segment Reporting Information [Line Items]
Revenue	370.0	332.4
ASG | Hong Kong
Segment Reporting Information [Line Items]
Revenue	139.7	173.9
ASG | Singapore
Segment Reporting Information [Line Items]
Revenue	116.1	233.8
ASG | United Kingdom
Segment Reporting Information [Line Items]
Revenue	128.1	106.6
ASG | United States
Segment Reporting Information [Line Items]
Revenue	121.3	92.3
ASG | Other
Segment Reporting Information [Line Items]
Revenue	87.6	82.7
ISG
Segment Reporting Information [Line Items]
Revenue	354.1	269.0
ISG | Distributors
Segment Reporting Information [Line Items]
Revenue	187.1	150.6
ISG | Direct Customers
Segment Reporting Information [Line Items]
Revenue	167.0	118.4
ISG | Hong Kong
Segment Reporting Information [Line Items]
Revenue	63.8	52.6
ISG | Singapore
Segment Reporting Information [Line Items]
Revenue	58.2	41.4
ISG | United Kingdom
Segment Reporting Information [Line Items]
Revenue	81.1	52.0
ISG | United States
Segment Reporting Information [Line Items]
Revenue	101.5	74.5
ISG | Other
Segment Reporting Information [Line Items]
Revenue	$ 49.5	$ 48.5

XML

Revenue and Segment Information - Summary of Property, Plant and Equipment by Geographic Location (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 3,692.9	$ 3,450.7
United States
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	1,360.8	1,329.2
South Korea
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	990.9	871.0
Czech Republic
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	335.3	279.3
Philippines
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	287.1	296.8
China
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	227.4	215.3
Malaysia
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	199.0	190.2
Japan
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	128.1	133.2
Other
Revenues from External Customers and Long-Lived Assets [Line Items]
Property, plant and equipment, net	$ 164.3	$ 135.7

XML

Acquisitions and Divestitures - Purchase Price Allocation (Details) - USD ($) $ in Millions		3 Months Ended
	Jan. 03, 2023	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Business Acquisition [Line Items]
Payments for remaining acquisition consideration		$ 236.3	$ 2.4
EFK
Business Acquisition [Line Items]
Inventory				$ 3.3
Other current assets				4.4
Property, plant and equipment				396.5
Other non-current assets				11.4
Total assets acquired				415.6
Current liabilities				3.0
Other long-term liabilities				6.3
Total liabilities assumed				9.3
Net assets acquired/purchase price				$ 406.3
Payments for remaining acquisition consideration	$ 236.3

XML

Restructuring, Asset Impairments and Other, Net - Schedule of Activity Included in Restructuring, Asset Impairments, and Other, Net (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Restructuring Cost and Reserve [Line Items]
Restructuring	$ 36.1
Asset Impairments	12.7
Other	2.7
Total	51.5	$ (13.0)
Impairment of property, plant and equipment and ROU lease assets	12.7	$ 6.7
2023 Business Realignment
Restructuring Cost and Reserve [Line Items]
Restructuring	36.1
Asset Impairments	2.5
Other	2.8
Total	41.4
Impairment of property, plant and equipment and ROU lease assets	1.7
Impairment charges for ROU assets	0.8
QCS wind down
Restructuring Cost and Reserve [Line Items]
Restructuring	0.0
Asset Impairments	0.0
Other	(2.3)
Total	(2.3)
Other
Restructuring Cost and Reserve [Line Items]
Restructuring	0.0
Asset Impairments	10.2
Other	2.2
Total	12.4
Impairment of property, plant and equipment and ROU lease assets	$ 10.2

XML

Restructuring, Asset Impairments and Other, Net - Summary of Changes in Accrued Restructuring Charges (Details) $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Restructuring Reserve [Roll Forward]
Balance at beginning of period	$ 4.4
Charges	36.1
Usage	(4.9)
Balance at end of period	35.6
Employee separation charges
Restructuring Reserve [Roll Forward]
Balance at beginning of period	4.4
Charges	36.1
Usage	(4.9)
Balance at end of period	$ 35.6

XML

Restructuring, Asset Impairments and Other, Net - Narrative (Details) $ in Millions		3 Months Ended
	Sep. 16, 2022 USD ($) employee	Mar. 31, 2023 USD ($) segment employee	Dec. 31, 2022 USD ($)
Restructuring Cost and Reserve [Line Items]
Restructuring		$ 36.1
Payments for restructuring		4.9
Restructuring reserve		$ 35.6	$ 4.4
2023 Business Realignment
Restructuring Cost and Reserve [Line Items]
Expected number of positions eliminated | segment		400
Payments for restructuring		$ 2.5
Restructuring reserve		$ 33.6
Number of positions eliminated | employee		137
2023 Business Realignment | Employee severance
Restructuring Cost and Reserve [Line Items]
Restructuring		$ 36.1
Additional restructuring cost		1.5
QCS wind down
Restructuring Cost and Reserve [Line Items]
Restructuring		0.0
QCS wind down | Workforce reduction | Legacy Quantenna Business
Restructuring Cost and Reserve [Line Items]
Restructuring reserve		$ 1.5
Number of positions eliminated | employee	330
Severance costs	$ 12.7

XML

Balance Sheet Information and Other Supplemental Disclosures - Narrative (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Net assets for overfunded plans	$ 13.5
Accrued pension liability	69.1	$ 53.8
Current portion accrued pension liability	$ 1.5	$ 0.4
Operating lease weighted average remaining lease term	10 years 9 months 18 days
Finance lease weighted average remaining lease term	18 years 9 months 18 days
Operating lease weighted average discount rate percent	4.80%
Finance lease weighted average discount rate percent	6.00%
GT Advanced Technologies Inc
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Restricted cash	$ 5.8

XML

Balance Sheet Information and Other Supplemental Disclosures - Inventory (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Inventories:
Raw materials	$ 271.3	$ 236.8
Work in process	1,053.5	951.0
Finished goods	490.1	429.0
Inventories	$ 1,814.9	$ 1,616.8

XML

Balance Sheet Information and Other Supplemental Disclosures - Pension Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Balance Sheet Related Disclosures [Abstract]
Service cost	$ 1.2	$ 2.2
Interest cost	1.6	1.1
Expected return on plan assets	(1.2)	(1.2)
Total net periodic pension cost	$ 1.6	$ 2.1

XML

Balance Sheet Information and Other Supplemental Disclosures - Lease Expense (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Balance Sheet Related Disclosures [Abstract]
Operating lease	$ 12.4	$ 11.2
Variable lease	1.8	1.6
Short-term lease	0.5	0.4
Total lease expense	14.7	$ 13.2
Operating lease liabilities included in:
Accrued expenses and other current liabilities	33.5		$ 35.2
Other long-term liabilities	244.8		246.5
Total	278.3		281.7
Operating ROU assets included in:
Other assets	251.9		262.1
Finance Lease, Liability [Abstract]
Current portion of financing lease liabilities	11.6		14.2
Long-term financing lease liabilities	24.0		23.0
Total	35.6		37.2
Right-of-use financing lease	$ 45.2		$ 45.8
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]	Accrued Liabilities, Current		Accrued Liabilities, Current
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List]	Other long-term liabilities		Other long-term liabilities
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets		Other assets
Finance Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration]	Accrued Liabilities, Current		Accrued Liabilities, Current
Finance Lease, Liability, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other long-term liabilities		Other long-term liabilities
Finance Lease, Right-of-Use Asset, Statement of Financial Position [Extensible Enumeration]	Other assets		Other assets

XML

Balance Sheet Information and Other Supplemental Disclosures - Cash and Non-cash Activity (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Non-cash investing activities:
Capital expenditures in accounts payable and other long-term liabilities	$ 388.8	$ 225.4
Operating ROU assets obtained in exchange of lease liabilities	4.6	10.7
Cash paid for:
Interest expense	29.1	24.0
Income taxes	35.2	15.7
Operating lease payments in operating cash flows	$ 11.2	$ 11.0

XML

Balance Sheet Information and Other Supplemental Disclosures - Summary of Cash and Cash Equivalents (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022	Apr. 01, 2022	Dec. 31, 2021
Balance Sheet Related Disclosures [Abstract]
Cash and cash equivalents	$ 2,702.4	$ 2,919.0	$ 1,645.1	$ 1,352.6
Restricted cash (included in other current assets)	14.2	14.0	18.8	20.1
Restricted cash (included in other non-current assets)	0.0	0.0	5.0	5.0
Cash, cash equivalents and restricted cash in Consolidated Statements of Cash Flows	$ 2,716.6	$ 2,933.0	$ 1,668.9	$ 1,377.7

XML

Long-Term Debt - Schedule of Long-Term Debt (Details) - USD ($) $ in Millions	Mar. 31, 2023	Feb. 28, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Long-term debt	$ 3,514.6		$ 3,228.3
Less: Debt discount	(4.7)		(9.2)
Less: Debt issuance costs	(45.7)		(25.6)
Net long-term debt, including current maturities	3,464.2		3,193.5
Less: Current maturities	(926.2)		(147.8)
Net long-term debt	2,538.0		3,045.7
Senior Revolving Credit Facility
Debt Instrument [Line Items]
Long-term debt	$ 375.0		$ 500.0
Debt instrument, interest rate	6.16%		5.67%
Term Loan B Facility
Debt Instrument [Line Items]
Long-term debt	$ 0.0		$ 1,086.0
Less: Debt discount	0.0		(4.2)
Less: Debt issuance costs	$ 0.0		$ (9.7)
Debt instrument, interest rate	6.91%		6.42%
Convertible Debt | 0.50% Notes
Debt Instrument [Line Items]
Long-term debt	$ 1,500.0		$ 0.0
Less: Debt issuance costs	$ (30.7)		$ 0.0
Debt instrument, interest rate	0.50%	0.50%	0.50%
Convertible Debt | 0% Notes
Debt Instrument [Line Items]
Long-term debt	$ 805.0		$ 805.0
Less: Debt issuance costs	(13.1)		$ (13.9)
Less: Current maturities	$ (791.9)
Debt instrument, interest rate	0.00%		0.00%
Convertible Debt | 3.875% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	3.875%
Convertible Debt | 1.625% Notes
Debt Instrument [Line Items]
Long-term debt	$ 134.6		$ 137.3
Less: Debt issuance costs	(0.2)		$ (0.3)
Less: Current maturities	$ (134.4)
Debt instrument, interest rate	1.625%		1.625%
Notes Payable | 3.875% Notes
Debt Instrument [Line Items]
Long-term debt	$ 700.0		$ 700.0
Less: Debt discount	(4.7)		(5.0)
Less: Debt issuance costs	$ (1.7)		$ (1.7)
Debt instrument, interest rate	3.875%		3.875%

XML

Long-Term Debt - Annual Maturities Relating To Long-Term Debt (Details) $ in Millions	Mar. 31, 2023 USD ($)
Long-term Debt, Fiscal Year Maturity [Abstract]
Remainder of 2023	$ 939.6
2024	375.0
2025	0.0
2026	0.0
2027	0.0
Thereafter	2,200.0
Total	$ 3,514.6

XML

Long-Term Debt - 0.50% Convertible Senior Notes due 2029 (Details) $ / shares in Units, shares in Millions, $ in Millions		3 Months Ended
	Feb. 28, 2023 USD ($) day $ / shares shares	Mar. 31, 2023 USD ($) $ / shares	Apr. 01, 2022 USD ($)	Feb. 23, 2023 $ / shares shares	Dec. 31, 2022	Feb. 28, 2022 USD ($)
Debt Instrument [Line Items]
Repayments of borrowings under term loan		$ 1,213.7	$ 4.1
Payment for purchase of bond hedges		414.0	0.0
Share price | $ / shares				$ 78.39
Proceeds from issuance of warrants		$ 242.5	$ 0.0
0% Notes Warrants
Debt Instrument [Line Items]
Number of warrants (in shares) | shares	28.9
Price per unit (in dollars per share) | $ / shares				$ 156.78
Premium over closing share price				100.00%
Proceeds from issuance of warrants	$ 242.5
Convertible Debt | 0% Notes Warrants
Debt Instrument [Line Items]
Number of warrants (in shares) | shares				14.4
0.50% Notes
Debt Instrument [Line Items]
Price per unit (in dollars per share) | $ / shares		$ 156.78
0.50% Notes | Term Loan B Facility
Debt Instrument [Line Items]
Repayments of borrowings under term loan	$ 1,086.0
0.50% Notes | Convertible Debt
Debt Instrument [Line Items]
Debt instrument, interest rate	0.50%	0.50%			0.50%
Aggregate principal amount						$ 1,500.0
Proceeds from convertible debt	$ 1,470.0
Payments for fees and expenses	$ 171.5
Conversion rate	0.0962770
Conversion price per share (in dollars per share) | $ / shares	$ 103.87	$ 103.87
Threshold percentage of stock price trigger (greater than or equal to)	130.00%
Threshold consecutive trading days | day	30
Threshold trading days | day	20
Percentage of Principal Amount Redeemed	100.00%
Maximum shares issuable (in shares) | shares	19.1
Discount on Initial purchase of shares	$ 30.0
Debt issuance costs	$ 1.3
Effective interest rate	0.85%
Deferred tax asset		$ 92.3
Expense of unamortized debt discount and issuance costs		$ 13.3
0.50% Notes | Convertible Debt | Embedded Derivative Financial Instruments
Debt Instrument [Line Items]
Payment for purchase of bond hedges	$ 414.0
0.50% Notes | Convertible Debt | Debt Conversion One
Debt Instrument [Line Items]
Threshold percentage of stock price trigger (greater than or equal to)	130.00%
Threshold consecutive trading days | day	30
Threshold trading days | day	20
0.50% Notes | Convertible Debt | Debt Conversion Two
Debt Instrument [Line Items]
Threshold consecutive trading days | day	5
Period immediately following consecutive trading days (in business days)	5 days
Ratio of trading price per 1000 principal amount (as a percent) (less than)	0.98

XML

Long-Term Debt - Repayments under the Revolving Credit Facility (Details) - Revolving Credit Facility - Line of Credit $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($)
Line of Credit Facility [Line Items]
Repayments of debt	$ 125.0
Remaining borrowing capacity	$ 1,600.0

XML

Long-Term Debt - 1.625% Notes due 2023 (Details) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) day $ / shares	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Current portion of long-term debt | $	$ 926.2	$ 147.8
1.625% Notes | Convertible Debt
Debt Instrument [Line Items]
Debt instrument, interest rate	1.625%	1.625%
Current portion of long-term debt | $	$ 134.4
Threshold trading days | day	20
Threshold consecutive trading days | day	30
Stock price trigger (in dollars per share) | $ / shares	$ 26.94
Threshold percentage of stock price trigger (greater than or equal to)	130.00%

XML

Long-Term Debt - 0% Notes (Details) $ / shares in Units, $ in Millions	3 Months Ended
	Mar. 31, 2023 USD ($) day $ / shares	Dec. 31, 2022 USD ($)
Debt Instrument [Line Items]
Current portion of long-term debt | $	$ 926.2	$ 147.8
0% Notes | Convertible Debt
Debt Instrument [Line Items]
Debt instrument, interest rate	0.00%	0.00%
Current portion of long-term debt | $	$ 791.9
Threshold trading days | day	20
Threshold consecutive trading days | day	30
Stock price trigger (in dollars per share) | $ / shares	$ 68.86
Threshold percentage of stock price trigger (greater than or equal to)	130.00%

XML

Earnings Per Share and Equity - Summary of Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Earnings Per Share [Abstract]
Net income for basic earnings per share of common stock	$ 461.7	$ 530.2
Add: Interest on 1.625% Notes	0.4	0.5
Net income for diluted earnings per share of common stock	$ 462.1	$ 530.7
Basic weighted average shares of common stock outstanding (in shares)	431.9	433.3
Dilutive effect of share-based awards (in shares)	1.4	2.4
Dilutive effect of convertible notes and warrants (in shares)	15.2	13.2
Diluted weighted-average shares of common stock outstanding (in shares)	448.5	448.9
Net income per share of common stock attributable to ON Semiconductor Corporation:
Basic (in dollars per share)	$ 1.07	$ 1.22
Diluted (in dollars per share)	$ 1.03	$ 1.18

XML

Earnings Per Share and Equity - Narrative (Details) - USD ($) $ / shares in Units, shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Feb. 28, 2023	Feb. 06, 2023	Dec. 31, 2022
Dividends Payable [Line Items]
Anti-dilutive shares	0.2	0.2
Aggregate purchase price	$ 104.0	$ 0.0
Payments of tax withholding for restricted shares	$ 47.6	$ 58.8
Common stock withheld underlying restricted stock units (in shares)	0.6	1.0
Non-controlling interest	$ 19.0				$ 18.5
Non-controlling interest share of earnings	$ 0.5
Leshan
Dividends Payable [Line Items]
Non-controlling interest					$ 18.5
Leshan | Leshan-Phoenix Semiconductor Company Limited
Dividends Payable [Line Items]
Noncontrolling interest, percentage					20.00%
Share Repurchase Program
Dividends Payable [Line Items]
Stock repurchase program, authorized amount				$ 3,000.0
Number of repurchased shares (in shares)	1.3
Aggregate purchase price	$ 104.0
Remaining authorized amount available for repurchase	$ 2,900.0
0.50% Notes
Dividends Payable [Line Items]
Exercise price (in dollars per share)	$ 156.78
0% Notes
Dividends Payable [Line Items]
Exercise price (in dollars per share)	74.34
1.625% Notes
Dividends Payable [Line Items]
Exercise price (in dollars per share)	$ 30.70
Convertible Debt | 0.50% Notes
Dividends Payable [Line Items]
Debt instrument, interest rate	0.50%		0.50%		0.50%
Conversion price per share (in dollars per share)	$ 103.87		$ 103.87
Convertible Debt | 0% Notes
Dividends Payable [Line Items]
Debt instrument, interest rate	0.00%				0.00%
Conversion price per share (in dollars per share)	$ 52.97
Convertible Debt | 1.625% Notes
Dividends Payable [Line Items]
Debt instrument, interest rate	1.625%				1.625%
Conversion price per share (in dollars per share)	$ 20.72

XML

Share-Based Compensation - Summary Of Share-Based Compensation (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 27.7	$ 22.5
Income tax benefit	(5.8)	(4.7)
Share-based compensation expense, net of taxes	21.9	17.8
Cost of revenue
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	3.7	2.6
Research and development
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	4.5	4.4
Selling and marketing
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	4.1	3.8
General and administrative
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Share-based compensation expense	$ 15.4	$ 11.7

XML

Share-Based Compensation - Narrative (Details) - USD ($) shares in Millions, $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Dec. 31, 2022
Amended And Restated Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Aggregate of common stock available for grant (in shares)	38.3		40.1
Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized share-based compensation expense on non-vested stock options	$ 149.4
Period for recognition (in years)	1 year 8 months 12 days
Options pre-vesting forfeitures rate	8.00%	6.00%
Service Based Restricted Stock Units
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum award vesting period (in years)	3 years
Performance or Market Based Restricted Stock Units | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum award vesting period (in years)	2 years
Performance or Market Based Restricted Stock Units | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Maximum award vesting period (in years)	3 years

XML

Share-Based Compensation - Summary Of Restricted Stock Units Transactions (Details) - Restricted Stock Units shares in Millions	3 Months Ended
	Mar. 31, 2023 $ / shares shares
Number of Shares
Beginning balance (in shares) | shares	3.8
Granted (in shares) | shares	0.9
Restricted stock units achieved (in shares) | shares	0.3
Released (in shares) | shares	(1.7)
Forfeited (in shares) | shares	(0.1)
Ending balance (in shares) | shares	3.2
Weighted-Average Grant Date Fair Value Per Share
Beginning balance (in dollars per share) | $ / shares	$ 46.56
Granted (in dollars per share) | $ / shares	77.85
Achieved (in dollars per share) | $ / shares	54.16
Released (in dollars per share) | $ / shares	42.12
Forfeited (in dollars per share) | $ / shares	48.33
Ending balance (in dollars per share) | $ / shares	$ 58.00

XML

Commitments and Contingencies (Details) $ in Millions	Mar. 31, 2023 USD ($)
Loss Contingencies [Line Items]
Outstanding guarantees and letters of credit	$ 16.5
Guarantees	0.9
Letter of Credit | Senior Revolving Credit Facility
Loss Contingencies [Line Items]
Revolving credit facility, letters of credit	15.0
Credit commitment outstanding	$ 0.9

XML

Fair Value Measurements - Available-for-sale Securities (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Other assets | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment maturity	1 year
Other assets | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment maturity	5 years
Demand and time deposits | Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	$ 371.4	$ 233.1
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	371.4	233.1
Demand and time deposits | Cash and cash equivalents | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	371.4	233.1
Demand and time deposits | Cash and cash equivalents | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Demand and time deposits | Cash and cash equivalents | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Money market funds | Cash and cash equivalents
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	28.4	17.0
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	28.4	17.0
Money market funds | Cash and cash equivalents | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	28.4	17.0
Money market funds | Cash and cash equivalents | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Money market funds | Cash and cash equivalents | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Corporate bonds | Other current assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	15.2	23.8
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	15.2	23.8
Corporate bonds | Other current assets | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Corporate bonds | Other current assets | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	15.2	23.8
Corporate bonds | Other current assets | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Corporate bonds | Other assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	0.5	0.8
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	0.5	0.8
Corporate bonds | Other assets | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Corporate bonds | Other assets | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.5	0.8
Corporate bonds | Other assets | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Certificate of deposit | Other current assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	2.7	3.1
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	2.7	3.1
Certificate of deposit | Other current assets | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Certificate of deposit | Other current assets | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	2.7	3.1
Certificate of deposit | Other current assets | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
Commercial paper | Other current assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	2.2	3.2
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	2.2	3.2
Commercial paper | Other current assets | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.2	1.2
Commercial paper | Other current assets | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	2.0	2.0
Commercial paper | Other current assets | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
US Treasury bonds | Other current assets
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Amortized Cost	1.7	2.1
Unrealized gains	0.0	0.0
Unrealized losses	0.0	0.0
Fair value	1.7	2.1
US Treasury bonds | Other current assets | Level 1 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	0.0	0.0
US Treasury bonds | Other current assets | Level 2 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	1.7	2.1
US Treasury bonds | Other current assets | Level 3 | Fair Value, Measurements, Recurring
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 0.0	$ 0.0

XML

Fair Value Measurements - Summary of Fair Value, by Balance Sheet Grouping (Details) - USD ($) $ in Millions	Mar. 31, 2023	Feb. 28, 2023	Dec. 31, 2022
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	$ 3,514.6
Convertible Debt | 0% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, interest rate	0.00%		0.00%
Carrying Amount	$ 791.9		$ 791.1
Fair Value	$ 1,306.2		$ 1,057.8
Convertible Debt | 0.50% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, interest rate	0.50%	0.50%	0.50%
Carrying Amount	$ 1,469.3		$ 0.0
Fair Value	$ 1,572.8		$ 0.0
Convertible Debt | 1.625% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, interest rate	1.625%		1.625%
Carrying Amount	$ 134.4		$ 137.0
Fair Value	$ 517.6		$ 417.8
Convertible Debt | 3.875% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, interest rate	3.875%
Notes Payable | 3.875% Notes
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Debt instrument, interest rate	3.875%		3.875%
Carrying Amount	$ 693.6		$ 693.3
Fair Value	641.1		618.3
Other long-term debt
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Carrying Amount	375.0		1,572.1
Fair Value	$ 377.0		$ 1,549.2

XML

Fair Value Measurements - Narrative (Details)	Mar. 31, 2023	Feb. 28, 2023	Dec. 31, 2022
Notes Payable | 3.875% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	3.875%		3.875%
Convertible Debt | 3.875% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	3.875%
Convertible Debt | 1.625% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	1.625%		1.625%
Convertible Debt | 0.50% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	0.50%	0.50%	0.50%
Convertible Debt | 0% Notes
Debt Instrument [Line Items]
Debt instrument, interest rate	0.00%		0.00%

XML

Financial Instruments - Narrative (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022	Feb. 28, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Foreign currency transaction (loss) gain realized	$ (1.9)	$ 1.9
Accumulated Other Comprehensive Income	$ (29.6)			$ (23.2)
0% Notes | Convertible Debt
Derivatives, Fair Value [Line Items]
Debt instrument, interest rate	0.00%			0.00%
0.50% Notes | Convertible Debt
Derivatives, Fair Value [Line Items]
Debt instrument, interest rate	0.50%		0.50%	0.50%
1.625% Notes | Convertible Debt
Derivatives, Fair Value [Line Items]
Debt instrument, interest rate	1.625%			1.625%
Foreign currency exchange contracts
Derivatives, Fair Value [Line Items]
Notional Amount	$ 279.2			$ 272.0
Foreign currency exchange contracts | Minimum
Derivatives, Fair Value [Line Items]
Derivative, term of contract (in months)	1 month
Foreign currency exchange contracts | Maximum
Derivatives, Fair Value [Line Items]
Derivative, term of contract (in months)	3 months
Interest rate swap
Derivatives, Fair Value [Line Items]
Interest rate swaps, fair value				36.0
Interest rate swap agreement 2022
Derivatives, Fair Value [Line Items]
Notional Amount				750.0
Interest rate swap agreements, 2023 and 2024
Derivatives, Fair Value [Line Items]
Proceeds from termination of derivatives	$ 27.7
Other income	6.9
Accumulated Other Comprehensive Income	$ 20.7
Accumulated Other Comprehensive Income amortized to income, term	21 months
Interest rate swap agreement 2023
Derivatives, Fair Value [Line Items]
Notional Amount	$ 500.0			500.0
Interest rate swap agreement 2024
Derivatives, Fair Value [Line Items]
Notional Amount	$ 500.0			$ 500.0

XML

Financial Instruments - Schedule of Net Foreign Exchange Positions (Details) - Foreign currency exchange contracts - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Derivatives, Fair Value [Line Items]
Buy (Sell)	$ 251.4	$ 249.6
Notional Amount	279.2	272.0
Other Currencies - Buy
Derivatives, Fair Value [Line Items]
Buy (Sell)	46.5	66.5
Notional Amount	46.5	66.5
Other Currencies - Sell
Derivatives, Fair Value [Line Items]
Buy (Sell)	(13.9)	(11.2)
Notional Amount	13.9	11.2
Japanese Yen
Derivatives, Fair Value [Line Items]
Buy (Sell)	69.5	27.0
Notional Amount	69.5	27.0
Philippine Peso
Derivatives, Fair Value [Line Items]
Buy (Sell)	49.4	63.9
Notional Amount	49.4	63.9
Czech Koruna
Derivatives, Fair Value [Line Items]
Buy (Sell)	40.4	41.7
Notional Amount	40.4	41.7
Euro
Derivatives, Fair Value [Line Items]
Buy (Sell)	39.5	26.0
Notional Amount	39.5	26.0
Korean Won
Derivatives, Fair Value [Line Items]
Buy (Sell)	20.0	35.7
Notional Amount	$ 20.0	$ 35.7

XML

Income Taxes (Details) - USD ($) $ in Millions	Mar. 31, 2023	Dec. 31, 2022
Income Tax Disclosure [Abstract]
Unrecognized tax benefits, income tax penalties and interest accrued	$ 4.3	$ 2.7
Possible reduction in unrecognized tax benefits in next twelve months	$ 68.2

XML

Changes in Accumulated Other Comprehensive Loss - Schedule of Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Accumulated Other Comprehensive Income [Roll Forward]
Balance, beginning	$ 6,207.0	$ 4,604.4
Other comprehensive income (loss) prior to reclassifications	5.5
Amounts reclassified from accumulated other comprehensive loss	(11.9)
Other comprehensive income (loss), net of tax	(6.4)	14.2
Balance, ending	6,467.0	$ 5,018.0
Currency Translation Adjustments
Accumulated Other Comprehensive Income [Roll Forward]
Balance, beginning	(50.4)
Other comprehensive income (loss) prior to reclassifications	0.3
Amounts reclassified from accumulated other comprehensive loss	0.0
Other comprehensive income (loss), net of tax	0.3
Balance, ending	(50.1)
Effects of Cash Flow Hedges and Other Adjustments
Accumulated Other Comprehensive Income [Roll Forward]
Balance, beginning	27.2
Other comprehensive income (loss) prior to reclassifications	5.2
Amounts reclassified from accumulated other comprehensive loss	(11.9)
Other comprehensive income (loss), net of tax	(6.7)
Balance, ending	20.5
Total
Accumulated Other Comprehensive Income [Roll Forward]
Balance, beginning	(23.2)
Balance, ending	$ (29.6)

XML

Changes in Accumulated Other Comprehensive Loss - Reclassifications from Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2023	Apr. 01, 2022
Accumulated Other Comprehensive Income (Loss) [Line Items]
Interest rate swaps terminations	$ 4.7	$ 2.1
Net income	462.2	531.0
Interest rate swaps
Accumulated Other Comprehensive Income (Loss) [Line Items]
Net income	(11.9)	0.7
Effects of Cash Flow Hedges and Other Adjustments | Interest rate swaps
Accumulated Other Comprehensive Income (Loss) [Line Items]
Interest rate swaps	(5.0)	0.7
Interest rate swaps terminations	$ (6.9)	$ 0.0

XML

Label	Element	Value
Accounting Standards Update [Extensible Enumeration]	us-gaap_AccountingStandardsUpdateExtensibleList	Accounting Standards Update 2020-06 [Member]